matchedPattern,context,lineNumber,columnNumber,publicationName
3303C > T,"...er organs involvement, like 3243A > G, 3260A > G, 3303C > T in the tRNALeu (UUR) gene (MTTL1); 4269A...",48,691,Acta_Myol_2011_Jul_30(1)_9-15.txt
4320C > T,"...TL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8348A > G in...",48,780,Acta_Myol_2011_Jul_30(1)_9-15.txt
8344A > G,"MTTK 8344A > G, less frequent 8356T > C mutation",144,7,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > C,Point mutations at position 8993 (8993T > G and 8993T > C) of the MT-ATP6 gene cause a neurodegene...,203,49,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993 T > G,caused by 8993 T > G mitochondrial DNA mutation: a clinical,385,11,Acta_Myol_2011_Jul_30(1)_9-15.txt
12297T > C,"14487T > C (M63V, ND6) and 12297T > C (tRNA Leu) in a Leig",398,28,Acta_Myol_2011_Jul_30(1)_9-15.txt
-590 C>T,IL4	5q31.1	-590 C>T	rs2243250	Decreasing the level of anti-in...,39,12,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
-592 C>A,IL10	1q31-q32	-592 C>A	rs1800872	Inhibiting replication of T-cel...,45,15,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
-308 G>A,TNF 	6p21.3	-308 G>A	rs1800629	Activation of osteoclasts and m...,51,13,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
-308 G>A,TNF 	6p21.3	-308 G>A	rs1800629	Activation of osteoclasts and m...,51,13,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
26 A>C,3	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,86,9,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
26 A>C,7	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,90,9,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
26 A>T,13	MC	c.626 A>T (p.Gln209Leu)	wt	wt	na,96,10,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
561C>T,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,10,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1G > C,...dentified a disease-causing missense mutation (c.91G > C) in the feline MYBPC3 gene in a colony of M...,22,69,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
9-1237T>C,"...ed the risk of Hodgkin lymphoma in relation to TLR9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 1...",79,71,Adv_Hematol_2011_Nov_29_2011_736261.txt
14943C>T,"... in exon (1858C>T) and three in intron (13145A>G, 14943C>T and 20628A>G), based on previous reported...",22,244,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
-1123G>C,"... from the combination of the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4....",22,654,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...combination of the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4.2",22,664,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,...pathogenesis.18 The present study found that both 20628A>G and 14943C>T were associated with a highe...,36,393,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...18 The present study found that both 20628A>G and 14943C>T were associated with a higher prevalence ...,36,406,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...18 The present study found that both 20628A>G and 14943C>T were associated with a higher prevalence ...,36,406,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,13145A>G	Forward	tcccaaatcatcctccagaa,58,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,13145A>G (rs1217418)	AA	304 (74.3%)	293 (75.5%)	0....,96,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
677 C>T,"...with mild MTHFR deficiency, a model for the MTHFR 677 C>T polymorphism, the most studied variant in ...",31,199,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
677 C>T,"...with mild MTHFR deficiency, a model for the MTHFR 677 C>T polymorphism, the most studied variant in ...",31,199,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
677 C>T,...tions are known to modulate disease risk in MTHFR 677 C>T individuals (31). It may be important to c...,189,1161,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
21G > T,"Intron 3	Chr9: 125,823,178	n/a	c.728–21G > T	5/97 (5)	Intronic, not conserved",124,39,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
24G > A,"... of schizencephaly, we observed a heterozygous c.724G > A change, resulting in p.Ala242Thr. Though t...",135,67,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
74A > G,"...arent heterozygous missense mutation in HESX1, c.374A > G (p.Asn125Ser). However, since this polymor...",140,152,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
24G > A,"...g published SNPs. One LHX2 sequence variation, c.724G > A, had not been previously reported. Though ...",148,102,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
14G > T,"...ted individuals, which can only occur when the c.514G > T and c.515C > T are present in cis. D: Anal...",35,475,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
22+2C>T,WABS	VU1202	DDX11	IVS22+2C>T c.2689_2691delAAG	Compound heterozygous	[1...,68,22,Anemia_2010_Jul_18_2010_565268.txt
392C>T,FA-1	EUFA1333	FANCJ	IVS11–498A>T c.2392C>T	Hematopoietic mosaicism	[25],69,37,Anemia_2010_Jul_18_2010_565268.txt
22+2C>T,Con-3	VU1203	DDX11	 IVS22+2C>T	Mother of VU1202	[19],73,24,Anemia_2010_Jul_18_2010_565268.txt
326T>G,"The SNP c.1326T>G in the non‐SMC condensin I complex, subunit...",1143,12,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
109G>T,...mobility shift analysis revealed that the HBG2:g.-109G>T mutation abolishes a transcription factor b...,3,2308,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,HBG2:g.-109G>T (I-3)	Wild-type	Wild-type,25,9,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,"...positus mother (I-2) was a carrier of the HBG2:g.-158C>T (XmnI) polymorphism, while both sisters (II...",53,141,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
196C>T,"...e, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No deletional HPFH has even...",61,402,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
196C>T,"...e, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No deletional HPFH has even...",61,402,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...-158C>T (XmnI) polymorphism and the silent HBB:g.-101C>T β-thalassemia mutation, the latter being on...",63,166,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...o, compound heterozygosity with the silent HBB:g.-101C>T β-thalassemia mutation resulted in substant...",63,568,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...contrary, compound heterozygosity for the HBG2:g.-109G>T mutation and the HBG2:g.-158C>T polymorphis...",63,958,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...xplanations for this observation: (a) the HBG2:g.-158C>T polymorphism itself exerts a silencing effe...,63,1137,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...m itself exerts a silencing effect on the HBG2:g.-109G>T mutation or (b) another yet unidentified ci...,63,1205,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...point for NF-E3 [24], suggesting that the HBG2:g.-109G>T transversion activates Hb F production most...",65,476,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...1a), these data strongly suggest that the HBG2:g.-109G>T mutation is responsible for the resulting H...",65,880,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...ubstantial effect in Hb F production, the HBG2:g.-109G>T nd-HPFH mutation per se results in only mod...",67,565,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
110A>C,"... HbF levels. In addition, the neighboring HBG2:g.-110A>C mutation, leading to the Czech nd-HPFH, als...",67,682,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...e adult stage, (b) the HBG1:g.-117G>A and HBG2:g.-109G>T reside on different genes, hence their rela...",67,1224,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...e adult stage, (b) the HBG1:g.-117G>A and HBG2:g.-109G>T reside on different genes, hence their rela...",67,1224,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-588 A>G,...DNA polymorphism of the Agamma globin gene (Agamma-588 A>G) is linked with the XmnI polymorphism (Gg...,84,110,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
228 G > A,"... G > C mutation in exon 8 in two patients, and c. 228 G > A mutation in exon 5 in one patient. We de...",48,636,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
803G>C,... allele has the only one nucleotide difference of 803G>C compared with the A105 allele,15,325,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
460G>A,"...alence = 2.0 × 10−5, 95% CI = 1.5–2.7 × 10−5), m.3460G>A (n = 29, minimum prevalence = 1.4 × 10−5, 9...",94,802,Ann_Neurol_2015_May_28_77(5)_753-759.txt
460G>A,"...alence = 2.0 × 10−5, 95% CI = 1.5–2.7 × 10−5), m.3460G>A (n = 29, minimum prevalence = 1.4 × 10−5, 9...",94,802,Ann_Neurol_2015_May_28_77(5)_753-759.txt
460G>A,"...alence = 2.0 × 10−5, 95% CI = 1.5–2.7 × 10−5), m.3460G>A (n = 29, minimum prevalence = 1.4 × 10−5, 9...",94,802,Ann_Neurol_2015_May_28_77(5)_753-759.txt
4484T>C,"...ce = 1.4 × 10−5, 95% CI = 0.9–2.0 × 10−5), and m.14484T>C (n = 6, minimum prevalence = 0.3 × 10−5, 9...",94,884,Ann_Neurol_2015_May_28_77(5)_753-759.txt
344A>G,"....1–0.5 × 10−5) were clinically affected by the m.8344A>G mutation, manifesting as myoclonic epilepsy...",94,1381,Ann_Neurol_2015_May_28_77(5)_753-759.txt
624C>T,"...(n = 3), m.5650A>G (n = 2), m.8993T>C (n = 2), m.1624C>T (n = 1), m.12258G>A (n = 1), m.8993T>G (n =...",94,1622,Ann_Neurol_2015_May_28_77(5)_753-759.txt
2258G>A,"...(n = 2), m.8993T>C (n = 2), m.1624C>T (n = 1), m.12258G>A (n = 1), m.8993T>G (n = 1), m.12283G>A (n ...",94,1641,Ann_Neurol_2015_May_28_77(5)_753-759.txt
993T>G,"...n = 2), m.1624C>T (n = 1), m.12258G>A (n = 1), m.8993T>G (n = 1), m.12283G>A (n = 1), m.12320A>G (n ...",94,1661,Ann_Neurol_2015_May_28_77(5)_753-759.txt
2283G>A,"...n = 1), m.12258G>A (n = 1), m.8993T>G (n = 1), m.12283G>A (n = 1), m.12320A>G (n = 1), and m.10010T>...",94,1680,Ann_Neurol_2015_May_28_77(5)_753-759.txt
2320A>G,"...n = 1), m.8993T>G (n = 1), m.12283G>A (n = 1), m.12320A>G (n = 1), and m.10010T>C (n = 1)",94,1700,Ann_Neurol_2015_May_28_77(5)_753-759.txt
0010T>C,"...), m.12283G>A (n = 1), m.12320A>G (n = 1), and m.10010T>C (n = 1)",94,1724,Ann_Neurol_2015_May_28_77(5)_753-759.txt
460G>A,"m.3460G>A, MT‐ND",103,4,Ann_Neurol_2015_May_28_77(5)_753-759.txt
1778G>A,"m.11778G>A, MT‐ND",107,4,Ann_Neurol_2015_May_28_77(5)_753-759.txt
4484T>C,"m.14484T>C, MT‐ND",111,4,Ann_Neurol_2015_May_28_77(5)_753-759.txt
816A>G,"m.5816A>G, MT‐T",130,4,Ann_Neurol_2015_May_28_77(5)_753-759.txt
816A>G,"m.5816A>G, MT‐T",130,4,Ann_Neurol_2015_May_28_77(5)_753-759.txt
993T>C,"m.8993T>C, MT‐ATP",159,4,Ann_Neurol_2015_May_28_77(5)_753-759.txt
243A>G,...ational figures in the intervening decade. The m.3243A>G mutation remains the most prevalent pathoge...,223,510,Ann_Neurol_2015_May_28_77(5)_753-759.txt
-79C>T,"...) within the human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered...",21,502,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,"...) within the human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered...",21,502,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,...according to Genbank accession number AB003688). +326T>G (V109G) and -79C>T have been previously des...,21,642,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,... analysis of the promoter sequence containing the -838C>A SNP using the MatInspector v2.2 and TRANSF...,33,602,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"Three polymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candi...",38,48,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,"...polymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candidates to ...",38,57,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,+326T>G (V109G)	F: TGCGAGTGTCTAACGGGAGC,97,2,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,"Table 3 Genotype frequencies for the -838C>A, -79C>T, and V109G p27kip1 single-nucleotide polymo...",101,47,BMC_Biol_2004_Apr_2_2_5.txt
216G>A,"...a in the inner ear cohere together.21,22 The USH1C216G>A mutation, found in all Louisiana Acadian ca...",18,628,Appl_Clin_Genet_2014_Dec_4_7_245-252.txt
438C>T,"...mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identified ...",18,905,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
35829419 C>A,... NLRP2 (F359L) rs17699678 C>T and NLRP3 (Q705K) rs35829419 C>A. The genotyping reactions were perfor...,47,295,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,"...ee Tables 4, 5).Table 4 Association analysis of rs35829419 C>A Q705K polymorphism in NLRP3 with peri...",123,516,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,"...ee Tables 4, 5).Table 4 Association analysis of rs35829419 C>A Q705K polymorphism in NLRP3 with peri...",123,516,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,Table 5 Association analysis of rs35829419 C>A polymorphism in NLRP3 with pancreatic...,143,35,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
19C>A,"...21C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH 19C>A (rs3213422). The effects of variables on ces...",7,717,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...21C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH 19C>A (rs3213422). The effects of variables on ces...",7,717,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
608C>T,"...P2C19 681G>A, rs4244285) and CYP2C19*17 (CYP2C19, 608C>T, rs12248560) [2,3]) or biliary secretion of...",20,572,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...A2*1F, (CYP1A2 163C>A, rs762551) and DHODH (DHODH 19C>A, rs3213422) [3,6,7]) were also studied. DHOD...",20,785,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...21C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH 19C>A (rs3213422). Assays were carried out accordi...",43,259,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,...ted that while 0 of 14 who had the AC genotype at 421C>A ABCG2 ceased leflunomide as a result of dia...,121,791,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
80A>G,"...nfluencing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at...",8,553,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
56A>G,"...ypes of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 of the FABP4 gen...",8,586,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
774 G>C,"...et al., 2011). In addition, two SNPs in FABP4, g.2774 G>C (intron1) and g.3631 G>A (exon3) affect ca...",19,660,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
774 G>C,"...et al., 2011). In addition, two SNPs in FABP4, g.2774 G>C (intron1) and g.3631 G>A (exon3) affect ca...",19,660,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
28 G>A,"...d back fat thickness with c.220 A>G (I74V) and c.328 G>A (V110M) (p<0.05) (Cho et al., 2007)",19,883,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
88G>A,"...(p<0.05) and 44.56 and 53.84 in GG genotype of c.388G>A SNP (p<0.05). Also, they had higher contents...",47,248,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
08G>C,"...lock included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplotypi...",51,62,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
88G>A,"...notypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased prop...",62,84,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
08G>C,"...th G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of ...",62,94,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
88G>A,"... is expected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, a...",66,66,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
08G>C,"...ed that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 are a...",66,76,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
64T>C,c.364T>C	3	F	TTATGGGATGACCTAGCACTAAAA	201,114,4,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
56A>G,c.456A>G	4	F	TTCCTGCTCAACATTGAAGG	190,123,4,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
56A>G,c.456A>G	4	F	TTCCTGCTCAACATTGAAGG	190,123,4,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
52T>G,c.352T>G	3	W98G	T,151,4,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
64T>C,c.364T>C	3	S102P	T,155,4,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
80A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,8,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
08G>C,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
56A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,35,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
80A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,10,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
08G>C,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,28,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
119846C>T,"...ted two novel mutations (NC_010450.3:g. 99514A>G, 119846C>T) by DNA sequencing and polymerase chain ...",7,759,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...ignificant relevance in Hanjiang (p = 0.017); the 119846C>T mutation suggested significant associati...,7,1300,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...ignificant relevance in Hanjiang (p = 0.017); the 119846C>T mutation suggested significant associati...,7,1300,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,... technique was used to detect the polymorphism of 99514A>G and 119846C>T loci in porcine LEF-1 gene....,36,63,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...9, P11, and P12) (Table 1) of the LEF-1 gene. The 99514A>G mutation resulted in a synonymous genetic...",52,456,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,"...ghly investigated. In previous study, there was a 1351T>C (NM_001129967.1) transition and a 1666A>C ...",81,145,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...(p = 0.017), but no significance in BM, while the 119846C>T mutation displayed significant associati...",81,980,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...ciated with higher teat numbers. In addition, the 99514A>G mutation itself demonstrated a synonymous...",81,1378,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...PIC in HJ and median level in GZ, LW, and BM; the 119846C>T showed low PIC in HJ and LW and median l...",83,143,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	TT	12.33±1.38	13.48±0.92	13.48±1.23	12.3...,189,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	TT	12.33±1.38	13.48±0.92	13.48±1.23	12.3...,189,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
002T>C,"g.15,002T>C	74,168,599	T4A	0.000	-",21,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
041G>A,"g.15,041G>A	74,168,560	V17M	0.000	-",23,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
150G>A,"g.15,150G>A	74,168,451	R53H	0.000	-",29,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...th g.15,190T>C (rs2270676 encoding F66F) and g.15,240G>A (rs17215437 encoding R83H) map to a highly ...",76,274,Behav_Brain_Funct_2011_Sep_7_7_39.txt
3773364 A>G,...ittal B.   Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epi...,158,100,Behav_Brain_Res_2013_Aug_15_251_65-74.txt
47086497C>T,"...en identified in an unrelated clinical case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (h...",91,889,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
308 G>A,"...posure. For example, SNPs in the TNF-α gene (eg, −308 G>A) affected the inflammatory response of eld...",77,298,Biologics_2011_Jan_19_5_7-19.txt
830A > T,"MB	3.5	F	c.2830A > T	c.7964A > G	Hemispheric	-	[19, 30]",30,13,Biomark_Res_2015_Jun_6_3_13.txt
9435 T > A,PFT	4.9	M	c.5946delT	9435 T > A	Midline	Ashkenazi Jewish congenital ano...,32,22,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,MB	2.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the following	[1...,38,25,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,"MB, WT (15 mo)	4.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the previous	[16...",39,37,Biomark_Res_2015_Jun_6_3_13.txt
196C > T,MB	3.1	F	c.5946delT	c.9196C > T	Cerebellum	VACTERL syndrome	[17],44,24,Biomark_Res_2015_Jun_6_3_13.txt
523A>T,... a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KI...,193,132,Biomed_Res_Int_2013_Jul_11_2013_283985.txt
19964988A>C,(g.119964988A>C)	Dominant:	 	 	 ,159,5,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
-1195G>A,COX-2 (-1195G>A) Polymorphis,40,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... 14 in controls (χ2 = 0.51, P = 0.77). For COX-1 (50C>T) polymorphism, the CC, CT, and TT genotypes ...",56,335,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,"...h smoking status was observed only for the COX-2 (-1195G>A) polymorphism (P < 0.01), in which a sign...",71,244,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...the interactions between COX-2-1195G>A and COX-1 (50C>T) polymorphisms, interaction between COX-2 (-...",74,361,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
81C>A, c.181C>A	p.Q61K	5 (2.7),197,5,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
81C>A, c.181C>A	p.Q61K	5 (2.7),197,5,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
0G>A,... the absence of association between the common c.80G>A polymorphism (rs1051266) of the gene coding f...,19,190,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
2233406C>T,...1del>ins ATTG in NFκB1; rs12769316G>A in NFκB2; rs2233406C>T and rs696 G>A in IκBα) and NPC risk in ...,41,152,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316 G>A,"...rphisms [i.e., rs28362491del>ins ATTG of NFκB1; rs12769316 G>A of NFκB2; rs2233406C>T and rs696G>A o...",48,158,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,"...0], here we focused on the functional effect of rs696 G>A polymorphism on NPC risk",52,152,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...armful role of NFκB1 rs28362491del/ins and IκBα rs696G>A polymorphism for NPC risk, individuals carr...",69,138,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"... the bioinformatics analysis, we found that the rs696G>A would change the potential bindings for the...",86,1234,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,IκBα: rs696 G>A,334,9,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,IκBα: rs696 G>A,334,9,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,IκBα: rs696 G>A,334,9,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
599839 A>G,rs599839 A>G-genotypes	 	 	 	 ,226,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
-13A>G,"...ing a weakened T7 promoter. Here, we introduced a -13A>G mutation into the T7 promoter (i.e., adenin...",65,107,Biotechnol_Biofuels_2016_Nov_1_9_234.txt
79+1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,36,Blood_2008_Oct_1_112(7)_2657-2666.txt
69C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,48,Blood_2008_Oct_1_112(7)_2657-2666.txt
69C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,48,Blood_2008_Oct_1_112(7)_2657-2666.txt
69C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,48,Blood_2008_Oct_1_112(7)_2657-2666.txt
336T>G,"...	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,58,Blood_2008_Oct_1_112(7)_2657-2666.txt
336T>G,"...	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,58,Blood_2008_Oct_1_112(7)_2657-2666.txt
69C>T,"A6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,46,Blood_2008_Oct_1_112(7)_2657-2666.txt
273C>T,"...tations are a well-known etiology of aHUS, the c.1273C>T mutation has never been reported in Caucasi...",12,65,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273 C>T,"... gene revealed that she had heterozygous mutation 1273 C>T in exon 12, that affects codon 425 result...",20,714,Blood_Res_2016_Sep_23_51(3)_210-213.txt
273C>T,...hat the penetrance of aHUS associated with the c.1273C>T mutation in the complement C3 gene is low. ...,25,868,Blood_Res_2016_Sep_23_51(3)_210-213.txt
273C>T,...uspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregulati...,27,147,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1081A>G,...ion screening of 101 samples (Table 2). An I361V (1081A>G) alteration in exon 5 was detected in a Fi...,37,174,BMC_Cancer_2006_Jun_1_6_145.txt
4446C>T,"The common French Canadian founder mutations 4446C>T and 2953delGTAinsC in BRCA1 and 8765delAG,...",72,46,BMC_Cancer_2008_May_28_8_152.txt
6085G>T,"...446C>T and 2953delGTAinsC in BRCA1 and 8765delAG, 6085G>T and 3398delAAAAG in BRCA2 were investigate...",72,97,BMC_Cancer_2008_May_28_8_152.txt
8+35 C>T,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X",167,44,BMC_Cancer_2008_May_28_8_152.txt
-271 G>A,"...lymorphisms in the investigated region except the -271 G>A polymorphism in the 5' UTR. Consequently,...",46,334,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,Table 3 Association of -271 G>A polymorphism genotypes with KDR protein e...,96,24,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,...n in NSCLC patients. Our results suggest that the -271 G>A polymorphism of the KDR gene may be a fun...,113,348,BMC_Cancer_2009_May_12_9_144.txt
1806C>T,BR386	40	1806C>T	Q563X	3	- (0)	- (0)	1+/2+	0.311	0.048	0.35...,47,10,BMC_Cancer_2009_Oct_10_9_360.txt
5221T>C,BR570	47	5221T>C	L1701P	3	- (0)	+ (3)	3+	0.094	0.169	0.264	...,95,11,BMC_Cancer_2009_Oct_10_9_360.txt
1767A>G,1767A>G	N550H,105,4,BMC_Cancer_2009_Oct_10_9_360.txt
4158A>G,BR552	70	4158A>G	R1347G	3	+ (5)	+ (3)	3+	0.000	0.012	0.012	...,130,11,BMC_Cancer_2009_Oct_10_9_360.txt
4+67A>C,BR567	50	IVS4+67A>C		3	+ (6)	+ (7)	-	0.009	0.215	0.225	3 (37 B...,134,14,BMC_Cancer_2009_Oct_10_9_360.txt
4+67A>C,BR567	50	IVS4+67A>C		3	+ (6)	+ (7)	-	0.009	0.215	0.225	3 (37 B...,134,14,BMC_Cancer_2009_Oct_10_9_360.txt
3238G>A,BR580	43	3238G>A	S1040N	3	+ (7)	+ (5)	1+	0.001	0.030	0.031	...,142,11,BMC_Cancer_2009_Oct_10_9_360.txt
-1082 G > A,...A Singh AN Dalela D Srivastava AN Mittal RD IL-10 -1082 G > A: a risk for prostate cancer but may be...,180,83,BMC_Cancer_2010_Aug_24_10_456.txt
20+1G > A,B162	NA	NA	NA	0	0	0	0	NA	c.IVS20+1G > A	27,55,31,BMC_Cancer_2010_Nov_30_10_654.txt
861539 C>T,XRCC3: rs861539 C>T	nsSNP/ T241M	0.067	0.165,81,10,BMC_Cancer_2013_May_10_13_234.txt
1799794 G>A,XRCC3: rs1799794 G>A	5' UTR	0.478	0.271,82,10,BMC_Cancer_2013_May_10_13_234.txt
15869 A>C,BRCA2: rs15869 A>C	3' UTR	0.244	0.375,85,10,BMC_Cancer_2013_May_10_13_234.txt
1051685 A>G,XRCC5: rs1051685 A>G	3' UTR	0.067	0.808,87,10,BMC_Cancer_2013_May_10_13_234.txt
1051685 A>G,XRCC5: rs1051685 A>G	3' UTR	0.067	0.808,87,10,BMC_Cancer_2013_May_10_13_234.txt
54C>T,"...d one non-synonymous SNP in LIG4 (rs1805388, Ex2 +54C>T, Thr9Ile) are associated with the increased ...",184,779,BMC_Cancer_2013_May_10_13_234.txt
7-1A>G,"...e the first evidence that the XRCC4 rs1805377 (IVS7-1A>G, splice-site) and LIG4 rs1805388 (Ex2 +54C>...",220,139,BMC_Cancer_2013_May_10_13_234.txt
699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
637G>A,c.6637G>A	p.Asp2213Asn	rs529038,44,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
238C>T,c.-238C>T		rs1800849,47,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
307C>A,c.1307C>A	p.Thr436Lys	rs4588,65,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
46C>T,...uency of the 'risk' variant T in the polymorphism 46C>T (rs1801020) ranges from 0.081 to 0.357 in th...,58,312,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...eutral FST 95% CI [-0.015, 0.082]; Mediterranean: 46C>T FST = 0.020, neutral FST 95% CI [-0.015, 0.0...",61,561,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,... This last observation suggests that polymorphism 46C>T can be treated as a 'neutral' polymorphism i...,61,666,BMC_Evol_Biol_2010_Mar_27_10_84.txt
-634G>C,...57510.1186/1471-230X-9-77Research ArticleThe VEGF -634G>C promoter polymorphism is associated with r...,3,131,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"...TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the ...",29,70,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915G>C,"...800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the exon 1] and three promot...",29,94,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-1498T>C,...471) in the exon 1] and three promoter VEGF SNPs [-1498T>C (rs833061) in the promoter and -634G>C (r...,29,158,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634G>C,"...EGF SNPs [-1498T>C (rs833061) in the promoter and -634G>C (rs2010963) in the 5'-untranslated region,...",29,198,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-509C>T,"...librium in the control subjects, except for TGFB1 -509C>T and VEGF -634G>C, indicating some possible...",69,289,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869 T >C,TGFB1 869 T >C (rs1800470)			0.805,83,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915 G >C,TGFB1 915 G >C (rs1800471)			0.447,89,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634G > C,VEGF -634G > C (rs2010963)			0.006,101,6,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C > T,VEGF +936C > T (rs3025039)			0.550,107,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-1498T>C,"...ne of four potentially functional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene o...",186,501,BMC_Gastroenterol_2009_Oct_16_9_77.txt
6+5G>A,"...er common mutations were 1638ins23, S255X, and IVS6+5G>A [20]. There is no doubt about the pathogeni...",110,336,BMC_Gastroenterol_2012_Oct_15_12_141.txt
106C>T,"...ns regularly encountered in the O1v [O02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro7...",7,798,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...tered in the O1v [O02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro74Ser) in exons 3, 4...",7,817,BMC_Genet_2003_Nov_17_4_17.txt
771C>T,"...n exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other samples, 46...",7,1096,BMC_Genet_2003_Nov_17_4_17.txt
829G>A,"...nd 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other samples, 46G>A was abs...",7,1107,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"..., a Jordanian O1 and an African O1v allele having 188G>A but lacking 189C>T. Sequencing of introns 2...",7,1244,BMC_Genet_2003_Nov_17_4_17.txt
467C>T,...s allele except for the characteristic mutations (467C>T and 1061delC in exon 7) found in the common...,41,134,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...dividual was found to have the O1v-characteristic 188G>A (Arg63His) mutation. One O1v allele from an...,49,357,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...dividual was found to have the O1v-characteristic 188G>A (Arg63His) mutation. One O1v allele from an...,49,357,BMC_Genet_2003_Nov_17_4_17.txt
205T>C,"... three adjacent mutations in intron 3. The first, 205T>C, caused a reversion to the consensus from O...",114,150,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...al interesting characteristics. The mutation, nt. 46G>A (Ala16Thr) in exon 2, has not been described...",126,87,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...one otherwise normal O1 allele (Jordanian) having 188G>A. Although infrequent, additional genetic di...",128,531,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...Ala16Thr), exon 3 at 106G>T (Val36Phe), exon 4 at 188G>A (Arg63His) and exon 5 at 220C>T (Pro74Ser)....",130,886,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...A-F	F4	CCAGGAAAACCAAAATGCCACA	exon 2	screening of 46G>A,168,57,BMC_Genet_2003_Nov_17_4_17.txt
12 G>A,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,11,BMC_Genet_2008_Apr_10_9_31.txt
12 G>A,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,11,BMC_Genet_2008_Apr_10_9_31.txt
30 C>G,p.L44V	c.130 C>G	0	0	0	0	0	0.06	0	0,43,11,BMC_Genet_2008_Apr_10_9_31.txt
78 G>T,p.V60L	c.178 G>T	0.10	0	0	0	10.69	15.75	13.21	0,47,11,BMC_Genet_2008_Apr_10_9_31.txt
41 G>C,p.A81P	c.241 G>C	0	0	0	0	0.08	0	0	0,49,11,BMC_Genet_2008_Apr_10_9_31.txt
47 T>C,p.S83P	c.247 T>C	0	0	0	0	0.15	0.12	0.19	0,50,11,BMC_Genet_2008_Apr_10_9_31.txt
09 C>T,p.A103A	c.309 C>T	0	0.43	0	0	0	0	0	0,56,12,BMC_Genet_2008_Apr_10_9_31.txt
59 T>C,p.I120T	c.359 T>C	0	0	1.75	0	0	0.06	0	0,60,12,BMC_Genet_2008_Apr_10_9_31.txt
64 G>A,p.V122M	c.364 G>A	0	0	0	0	0	0.24	0	0,61,12,BMC_Genet_2008_Apr_10_9_31.txt
56 C>A,p.Y152X	c.456 C>A	0	0	0	0	0	0.06	0	0,65,12,BMC_Genet_2008_Apr_10_9_31.txt
04 C>T,p.I168I	c.504 C>T	0	0.43	0	0	0	0	0	0,71,12,BMC_Genet_2008_Apr_10_9_31.txt
86 T>C,p.F196L	c.586 T>C	0	2.14	0.15	0	0.08	0	0	0,75,12,BMC_Genet_2008_Apr_10_9_31.txt
86 T>C,p.F196L	c.586 T>C	0	2.14	0.15	0	0.08	0	0	0,75,12,BMC_Genet_2008_Apr_10_9_31.txt
79 A>C,p.H260P	c.779 A>C	0	0	0	0	0.23	0	0	0,85,12,BMC_Genet_2008_Apr_10_9_31.txt
95 C>G,p.V265V	c.795 C>G	0	1.28	0	0	0	0	0	0,87,12,BMC_Genet_2008_Apr_10_9_31.txt
37 C>A,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,12,BMC_Genet_2008_Apr_10_9_31.txt
23 C>T,p.T308M	c.923 C>T	0	0	0	0	0	0.06	0	0,93,12,BMC_Genet_2008_Apr_10_9_31.txt
88 G>A,"... most likely due to the presence of the R163Q (c.488 G>A) SNP, which was present in 75% of Asians st...",169,575,BMC_Genet_2008_Apr_10_9_31.txt
01+1024G > T, COL1A1	c.101+1024G >,69,12,BMC_Genet_2010_Oct_21_11_95.txt
261C > T,c.3261C >,75,5,BMC_Genet_2010_Oct_21_11_95.txt
072G>A,...orges M Buys N Indirect effect of IGF2 intron3 g.3072G>A mutation on prolificacy in sows Anim Genet ...,219,148,BMC_Genomics_2014_Feb_24_15_156.txt
964A>G,"rs153109, corresponding to position c.-964A>G of the IL-27 locus, was amplified from geno...",7,40,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
964 A>G,... of IL-27p28. The genotype distribution of the c.-964 A>G polymorphism was more present in patients ...,10,225,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
-275T>A,...uypers D Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low ...,138,115,BMC_Med_2013_Jan_11_11_9.txt
-2152C>T,... Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA expo...,138,123,BMC_Med_2013_Jan_11_11_9.txt
510T>C,"...al mutations (m.A1555G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C) was performed in the GJB2 negat...",36,622,BMC_Med_Genet_2005_Mar_24_6_12.txt
445A>G,"...3S1830) and mitochondrial mutations m.1555A>G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C was negat...",50,77,BMC_Med_Genet_2005_Mar_24_6_12.txt
516G>C,...cular phenotype. The new missense mutation W172C (516G>C) was identified in trans of the 235delC all...,59,1378,BMC_Med_Genet_2005_Mar_24_6_12.txt
-207G>C,"...1173605_1, respectively. For the SLC22A5 promoter -207G>C (rs2631367), a TaqMan Assay by Design was ...",31,365,BMC_Med_Genet_2006_Jun_23_7_54.txt
-207G>C,"...rohn's disease, together with the OCTN2-promoter (-207G>C) variant. In fact, the authors found that ...",67,178,BMC_Med_Genet_2006_Jun_23_7_54.txt
-207G>C,... for alleles and genotypes of the OCTN2-promoter (-207G>C) and of the other SLC22A5 intronic variant...,67,933,BMC_Med_Genet_2006_Jun_23_7_54.txt
9 C>G,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was deter...,27,27,BMC_Med_Genet_2006_Mar_30_7_31.txt
9 C>G,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was deter...,27,27,BMC_Med_Genet_2006_Mar_30_7_31.txt
9 C>G,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was deter...,27,27,BMC_Med_Genet_2006_Mar_30_7_31.txt
-1131T > C,...e reported that in these patients carriers of the -1131T > C and S19W variants in the APOA5 gene wer...,180,63,BMC_Med_Genet_2007_Aug_29_8_56.txt
948976 A>G,"...ies in our population were 0.74 for A allele in rs948976 A>G, 0.57 for G allele in rs4945140 G>A, 0....",84,163,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,...the presence of the polymorphic A allele at the rs4945140 G>A locus is associated with increased BMI...,102,362,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,"...ur polymorphisms analysed are in two LD blocks: rs948976 A>G and rs4945140 G>A in intron 1 (D' = -1,...",114,57,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,"...analysed are in two LD blocks: rs948976 A>G and rs4945140 G>A in intron 1 (D' = -1, r2 = 0.26) and r...",114,74,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140G>A,BASE SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	POPULATION FRE...,118,30,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546G>A,... SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	POPULATION FREQUENCY,118,55,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546G>A,... SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	POPULATION FREQUENCY,118,55,BMC_Med_Genet_2007_Jan_16_8_1.txt
30A > G,"...s in the BRCA1 gene (c.187-188delAG [p.Q23fs], c.330A > G, [p.64-71del], c.5236G > A [p.G1706A], c.5...",20,148,BMC_Med_Genet_2007_Jun_29_8_40.txt
236 G > C,BRCA1 c.5236 G > C	F gacttgaacggacactgaaatattttctag	30	G/C,59,10,BMC_Med_Genet_2007_Jun_29_8_40.txt
242C > A,"...i-sense DNA strand, for the detection of BRCA1 c.5242C > A mutation we used anti-sense primer. The p...",70,182,BMC_Med_Genet_2007_Jun_29_8_40.txt
75C>T,...p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C,12,450,BMC_Med_Genet_2007_Nov_9_8_67.txt
06C>T,A	Saudi	c.406C>T	3	p.Arg110>Cys	EGF2	ND,40,12,BMC_Med_Genet_2007_Nov_9_8_67.txt
06C>T,B	Kuwait	c.406C>T	3	p.Arg110>Cys	EGF2	ND,41,13,BMC_Med_Genet_2007_Nov_9_8_67.txt
06C>T,B	Kuwait	c.406C>T	3	p.Arg110>Cys	EGF2	ND,41,13,BMC_Med_Genet_2007_Nov_9_8_67.txt
06C>T,"...H3 gene, revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exon 3...",55,807,BMC_Med_Genet_2007_Nov_9_8_67.txt
1025G>C,"...SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was repo...",6,60,BMC_Med_Genet_2008_Dec_23_9_117.txt
1025G>C,"...SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was repo...",6,60,BMC_Med_Genet_2008_Dec_23_9_117.txt
95G>C,"...de substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p.E34V, p.G332A...",12,850,BMC_Med_Genet_2008_Jun_20_9_54.txt
71G>A,Si	F	27	1.2	2.4	1975	9.20	371	+/-	c.471G>A/del exon5,50,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
71G>A,Si	F	27	1.2	2.4	1975	9.20	371	+/-	c.471G>A/del exon5,50,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
01A>T,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,VII	P	F	28	2.0	1.9	948	8.00	428	-/+	c. 995 G>C/pG332A,59,40,BMC_Med_Genet_2008_Jun_20_9_54.txt
70T>G,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
03G>A,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
17A>C,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,42,BMC_Med_Genet_2008_Jun_20_9_54.txt
808-1 G>C,...ransversion G> C in the last base of intrón 7 (c. 808-1 G>C),185,125,BMC_Med_Genet_2008_Jun_20_9_54.txt
08-1G>C,C	15.58	46.85	c.808-1G>C/r.spl?,194,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,VII	P	15.84	47.64	c. 995 G>C/pG332A,198,22,BMC_Med_Genet_2008_Jun_20_9_54.txt
71G>A,"... of them were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was ...",238,295,BMC_Med_Genet_2008_Jun_20_9_54.txt
07 G>A,"...ere single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was a small in...",238,305,BMC_Med_Genet_2008_Jun_20_9_54.txt
01A>T,"...e transversions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10...",240,94,BMC_Med_Genet_2008_Jun_20_9_54.txt
70 T>G,"...sions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectiv...",240,104,BMC_Med_Genet_2008_Jun_20_9_54.txt
70 T>G,"...sions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectiv...",240,104,BMC_Med_Genet_2008_Jun_20_9_54.txt
70 T>G,"...sions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectiv...",240,104,BMC_Med_Genet_2008_Jun_20_9_54.txt
341T>C,"...1G>A (rs1801279), 282C>T (rs1041983, rs59855457), 341T>C (rs1801280, rs56935242), 481C>T (rs1799929,...",27,195,BMC_Med_Genet_2009_Dec_31_10_148.txt
857G>A,"...29), 803A>G (rs1208, rs56599719, rs58999469), and 857G>A (rs1799931, rs58803786)) and for which geno...",27,336,BMC_Med_Genet_2009_Dec_31_10_148.txt
191G>A,"...ier implemented in NAT2PRED of the functional SNP 191G>A which, although monomorphic in most worldwi...",34,661,BMC_Med_Genet_2009_Dec_31_10_148.txt
22T>C,"...ions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK...",12,77,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,... CAC CAT AG-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 hea...,36,437,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,...) primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 healthy adults wi...,36,451,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...on of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of these polymorp...",49,447,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...e distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those expect...",49,1286,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,c.-27A>C	A/A	61	112.1 ± 41.7	0.173	1.34 ± 0.46	0.473,60,4,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"To test if c.-22T>C affected transcription, reporter analysis wa...",80,15,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,Figure 3 c.-22T>C mutation resulted in increased reporter acti...,82,13,BMC_Med_Genet_2009_Mar_24_10_29.txt
819C > T,"...0delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified in the group of 73 AN pa...",10,97,BMC_Med_Genet_2010_May_26_11_79.txt
194T > A,"...mature termination codon at position 1000; (c) c.1194T > A (p.D398E), the consequence of a transvers...",35,602,BMC_Med_Genet_2010_May_26_11_79.txt
819C > T,"...n from glutamate to lysine in exon 16; and (e) c.4819C > T (p.R1607 W), a transition from C to T, wh...",35,919,BMC_Med_Genet_2010_May_26_11_79.txt
819C > T,"... Apart from c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607 W), which were identified in one...",35,1125,BMC_Med_Genet_2010_May_26_11_79.txt
194 T > A,13	c.1194 T > A	p.D398 E	Missense	0501207	19	0/184,40,7,BMC_Med_Genet_2010_May_26_11_79.txt
44C > T,"..., c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82C). Some of these polymorphisms have...",54,170,BMC_Med_Genet_2010_May_26_11_79.txt
819C > T,"...nt, namely c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T (p.R1607W). The frameshift mutation (c.29...",69,122,BMC_Med_Genet_2010_May_26_11_79.txt
-786T > C,"...te R Gensini GF Endothelial nitric oxide synthase -786T > C, but not 894G > T and 4a4b, polymorphism...",212,128,BMC_Med_Genet_2010_Sep_20_11_133.txt
-786T > C,"...te R Gensini GF Endothelial nitric oxide synthase -786T > C, but not 894G > T and 4a4b, polymorphism...",212,128,BMC_Med_Genet_2010_Sep_20_11_133.txt
2251471	T > C,2	158955976	rs2251471	T > C	6.7	CCDC148	0.09	0.123	0.12	0.027	0....,95,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
2251471	T > C,2	158955976	rs2251471	T > C	6.7	CCDC148	0.09	0.123	0.12	0.027	0....,95,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10517393	G > T,4	57967285	rs10517393	G > T	22.8	IGFBP7	0.01	0.795	-0.03	0.341	...,102,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
2055391	C > T,4	132163115	rs2055391	C > T	8.4		-0.01	0.920	0.00	0.996	0.01	0.7...,103,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
2099082	T > C,5	54231548	rs2099082	T > C	23.6	ESM1	0.00	0.903	-0.01	0.767	0.0...,105,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
9294466	A > T,6	91568115	rs9294466	A > T	15.0	MAP3K7	0.04	0.301	0.05	0.211	0....,107,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6462230	G > C,7	30896348	rs6462230	G > C	10.7	FLJ22374	0.04	0.396	0.06	0.221	...,111,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10513893	C > T,14	86696500	rs10513893	C > T	7.2		0.01	0.830	-0.01	0.821	0.04	0....,118,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
206-2 A>G,"... of intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literatu...",7,847,BMC_Med_Genet_2011_Jun_27_12_86.txt
206-2A>G,"...etion of the first 21 bp of exon 17. Thus, the c.2206-2A>G mutation leads to the production of two d...",42,1019,BMC_Med_Genet_2011_Jun_27_12_86.txt
74+1G>C,"...other of the patient, who is a carrier for the c.574+1G>C mutation, whereas the mRNA variants with t...",42,1701,BMC_Med_Genet_2011_Jun_27_12_86.txt
206-2A>G,"...ister of the proband, who are carriers for the c.2206-2A>G mutation",42,1894,BMC_Med_Genet_2011_Jun_27_12_86.txt
206-2A>G,"...ister of the proband, who are carriers for the c.2206-2A>G mutation",42,1894,BMC_Med_Genet_2011_Jun_27_12_86.txt
74+1G>C,"...an effect was provided. Here, we show that the c.574+1G>C change does, in fact, lead to skipping of ...",44,611,BMC_Med_Genet_2011_Jun_27_12_86.txt
206-2A>G,"...The second mutation identified in our patient (c.2206-2A>G) disrupts the 3'splice site of IVS 16, an...",44,719,BMC_Med_Genet_2011_Jun_27_12_86.txt
13-1112C > T,"...tive enhancement of human IL13 transcription by IL13-1112C > T, a polymorphism associated with aller...",231,210,BMC_Med_Genet_2011_Oct_25_12_143.txt
794133G>A,"...ns are kept. For example, mutation NC_000011.8:g.9794133G>A may be located either in gene LOC283104 ...",29,313,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
-634 G-->C,... suggest a potential implication of the VEGF gene -634 G-->C polymorphism in the development of seve...,67,1048,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
055G > A,...ed that in the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highest...,6,194,BMC_Neurol_2008_Jan_22_8_1.txt
055G > A,"...and apparently sporadic PD. The LRRK2 mutation c.6055G > A; p.G2019S, accounts for 1–2% of typical s...",20,607,BMC_Neurol_2008_Jan_22_8_1.txt
183G > T,... (S4) showed data consistent with a homozygous c.1183G > T; p.E395X mutation and a duplication of ex...,45,597,BMC_Neurol_2008_Jan_22_8_1.txt
055G > A,...rtuguese population. While we did not find any c.6055G > A; p.G2019S carriers in the 20 late-onset p...,76,180,BMC_Neurol_2008_Jan_22_8_1.txt
531G>A,"...ed in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3, r...",37,671,BMC_Neurol_2011_Oct_1_11_119.txt
531G>A,"...ed in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3, r...",37,671,BMC_Neurol_2011_Oct_1_11_119.txt
671 G>C,4	671 G>C	Trp224Ser	Exon 6	-	[1],53,3,BMC_Neurol_2011_Oct_1_11_119.txt
1043+1 G>A,6	1043+1 G>A	Ser348RfsX63	Intron 8	Turkish	[3],57,3,BMC_Neurol_2011_Oct_1_11_119.txt
1408C>T,8	1408C>T	Gln470X	Exon 11	-	[1],61,3,BMC_Neurol_2011_Oct_1_11_119.txt
1576 G>T,10	1576 G>T	Glu526X	Exon 12	-	[1],65,4,BMC_Neurol_2011_Oct_1_11_119.txt
85A > G,... to guanine transition at coding position 985 (c.985A > G); this leads to a substitution of glutamat...,24,309,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,"...sting, 15 (52%) were homozygous for the common c.985A > G mutation, 5 (17%) were compound heterozygo...",67,241,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,"...(17%) were presumed compound heterozygotes for c.985A > G, however a second mutation could not be id...",67,385,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,"Compound heterozygotes: c.985A > G, no detectable 2nd mutation	5	2.69",83,28,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,...red to compound heterozygotes with one copy of c.985A > G (both with and without a detectable second...,102,738,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,... individuals with MCADD who are homozygous for c.985A > G may be likely to experience more severe cl...,102,1192,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,"...tion severity (with severe mutations including c.985A > G as well as deletions, nonsense and splice ...",104,1034,BMC_Pediatr_2010_Nov_17_10_82.txt
85A > G,"...12,14]. As noted above, testing for the common c.985A > G was not performed on all screen positive c...",104,1773,BMC_Pediatr_2010_Nov_17_10_82.txt
03	M>E,...oms	50.32 ± 0.87	53.77 ± 0.61	51.44 ± 1.12	5.6	0.003	M>E; M >H;H = E,78,65,BMC_Public_Health_2007_Dec_5_7_347.txt
555T >C,...ngs revealed a homozygote state of the variant c.2555T >C (p.I852T),70,396,BMC_Res_Notes_2016_Feb_13_9_91.txt
555T >C,"...tients who have CRB1 mutations, especially the c.2555T >C (p.I852T) homozygote variant searching for...",83,226,BMC_Res_Notes_2016_Feb_13_9_91.txt
4	Ccg>Ctg,4	Ccg>Ctg	c.1250C>T	Pro417Leu	Potential tertiary s...,97,1,BMC_Womens_Health_2005_May_26_5_8.txt
809T>C,9	TTC>TTT	c.1809T>C	Phe603Leu	Aromatic to aliphatic	Polymorphis...,100,14,BMC_Womens_Health_2005_May_26_5_8.txt
621T>A,16		c.2621T>A			3' untranslated region. Polymorphism,102,8,BMC_Womens_Health_2005_May_26_5_8.txt
541G>A,...ng brain tumors and leukemias). The underlying c.1541G>A nucleotide substitution was detected in the...,107,796,BMC_Womens_Health_2005_May_26_5_8.txt
948 C>T,...enetic testing was performed and that showed a c.1948 C>T (p.Arg650Cys) mutation in fibrillin-1 gene...,47,78,Cureus_8(5)_e619.txt
4+919G>A,... of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,121,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
4+919G>A,... of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,121,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
17 G>A,...e of juxta-membrane GS domain at position 617 (c.617 G>A) responsible for both familial and sporadic...,29,315,Bone_Res_2015_Apr_14_3_15005.txt
765G>C,Table 3 COX-2 −765G>C genotype in relation to risk of colorectal ...,104,17,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
-464 T>C,c.1-464 T>C	Promotera	44	30 (68%)	6 (14%)	8 (18%)	38	...,103,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
-53 C>T,c.1-53 C>T	Promotera	44	2 (5%)	0	42 (95%)	38	1 (3%)	0...,106,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
1306C>T,"...did not show an association with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also ...",26,450,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,...ide polymorphisms of MMP-2 (−1306C>T) and MMP-9 (−1562C>T). Multivariate analyses indicated that the...,10,335,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
271T>G,"...cancer. The presence of the missense mutation, c.7271T>G (p.Val2424Gly), further increases the risk ...",21,253,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
672G>A,... in the RNA was able to allow translation. The c.8672G>A (p.Gly2891Asp) is a missense mutation locat...,58,436,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
271T>G,"...ing a severe reaction to radiotherapy (A-T109, c.7271T>G homozygous) (Stankovic et al, 1998). Althou...",63,232,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
672G>A,...ein in cells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM associ...,68,444,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
672G>A,"...this mild presentation, the two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T21...",77,660,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
672G>A,"Interestingly, the c.8672G>A missense mutation was reported in one of th...",79,23,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
271T>G,"...t cancer, were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also ident...",85,1044,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
672G>A,"...t A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. The boxed sequence triplet in (A)...",108,237,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...ted with pMEP4-ATM wt (pTAM2), pMEP4-ATM 8672G>A (8672G>A) or pMEP4 vector alone (pMEP4) all with N-...",114,1142,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,... Gatti RA Concannon P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral...,130,184,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
10-6T>G,...nnon P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral ...,130,199,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
10-6T>G,...nnon P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral ...,130,199,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
271T>G,...cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breas...,131,293,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
066-6T>G,...ssociated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Famil...,131,307,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
19T>G,"...1*28 ((TA)6>(TA)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G...",36,478,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
315A>G,"...TA)6>(TA)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>...",36,485,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
387T>G,"...T1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (who...",36,522,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
48T>G,"...tion of CYP2A6), CYP2A6*7(6558T>G) and CYP2A6*9 (−48T>G)",36,629,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
19T>G,"... among single-nucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T...",70,113,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...ucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392...",70,128,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...particular, there was a perfect LD between UGT1A6 541A>G and UGT1A7 622T>C. In other words, patients...",70,248,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
882G>A,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.Asn34...,76,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
386G>T,ARDM-198	27	19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
140T>A,...32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,60,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
943C>T,...0	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
323G>A,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,33,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
172G>T,...c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,79,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
172G>T,...c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,79,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
457C>T,ARDM-163	48	32	0.01	0.32	STGD	c.4457C>T(30)	p.Pro1486Leu	ND	ND	Yes,93,34,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
320G>A,ARDM-166	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,27,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
919G>A,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,27,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
701A>G,ARDM-131	27	15	0.9	0.7	CRD	c.2701A>G(18)	p.Thr901Ala	ND	ND	Yes,101,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
86G>T,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
64 A>T,3	c.264 A>T	p.Gly88Gly	This study,113,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
029T>C,8	c.1029T>C	p.Asn343Asn	This study,117,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
654G>A,12	c.1654G>A	p.Val552Ile	This study,119,7,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
13+16G>A,IVS13+16G>A		This study,120,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
507G>A,23	c.3507G>A	p.Gln1169Gln	This study,123,7,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
43-16G>A,IVS43-16G>A		25,125,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
21-2A>T,"... novel splice-site alterations were described, IVS21-2A>T (ARDM-90) and IVS38+5G>A (ARDM-181). Both ...",177,54,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
16255759 T>A,"...ISPD mutations at the heterozygous state: g.chr7: 16255759 T>A, c.446 C>T, causing p.Pro149Leu, whic...",116,338,Brain_2013_Jan_3_136(1)_269-281.txt
16445774 G>A,"....Pro149Leu, which is located in exon 2 and g.chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exom...",116,422,Brain_2013_Jan_3_136(1)_269-281.txt
43 C>T,"... is located in exon 2 and g.chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exome sequencing in C...",116,439,Brain_2013_Jan_3_136(1)_269-281.txt
183A>T,"...codon mutation in exon 9: g.chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozygous in-frame trip...",116,582,Brain_2013_Jan_3_136(1)_269-281.txt
637C>T,3	2 y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Nove...,49,15,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,29,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann e...,55,11,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann ...,56,13,Brain_2014_May_18_137(5)_1350-1360.txt
358G>A,"10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann et al., 2007...",56,25,Brain_2014_May_18_137(5)_1350-1360.txt
347G >A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R2...,60,36,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116...,61,12,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H +...,61,23,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	N...,61,48,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",74,5,Brain_2014_May_18_137(5)_1350-1360.txt
64-1G>A,"...a). Previous expression studies concluded that c.364-1G>A is a pathogenic mutation (Mills et al., 20...",153,1015,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",201,5,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,"R95H, R95C and E50K with c.[364-1G>A]: alleles associated with infertility, mi...",222,29,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,...ient 1 was compound heterozygous for E50K plus c.[364-1G>A] on the paternal allele and R95H on the m...,223,54,Brain_2014_May_18_137(5)_1350-1360.txt
158Val -> Met,...in schizophrenia through an interaction with COMT 158Val -> Met Proceedings of the National Academy ...,378,171,Brain_Imaging_Behav_2014_Jan_8_8(2)_153-182.txt
271T>G,...population-based study of a specific mutation (c.7271T>G) in ATM [18] and the recent report of two m...,64,783,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
271T>G,...population-based study of a specific mutation (c.7271T>G) in ATM [18] and the recent report of two m...,64,783,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
066-6T>G,...ssociated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Famil...,128,302,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
5193G-> A,...efined population with respect to the local BRCA1 5193G-> A and BRCA2 999del5 germline mutations [21...,26,92,Breast_Cancer_Res_2009_Jul_9_11(4)_R47.txt
1260C>A,... was used to assess functional expression of the –1260C>A CYP27B1 variants. The association between ...,3,2099,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,"...ociation was with a SNP in the CYP27B1 promoter (–1260C>A); association with a second, intronic SNP ...",122,591,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
2838T>C,"...60C>A); association with a second, intronic SNP (+2838T>C) could be explained by tight linkage diseq...",122,643,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
61A >G,...phisms in KRAS wildtype tumors suggested that EGF 61A >G was significantly associated with decreased...,66,336,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
61A >G,...ussen AA  The importance of KRAS mutations and EGF61A >G polymorphism to the effect of cetuximab and...,185,90,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
-1263A>G,"...e, CASP9 gene polymorphisms and their haplotypes, -1263A>G (rs4645978) and -712C>T (rs4645981), have...",23,329,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
-712C>T,"...ms and their haplotypes, -1263A>G (rs4645978) and -712C>T (rs4645981), have been reported to both af...",23,354,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
2227310C>G,...mains to be elucidated whether or not the CASP7 rs2227310C>G polymorphism itself affects protein cha...,54,1061,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
87T>C,"...f the exon 4 (rs2016520, referred as T+294C or c.-87T>C); this polymorphism is located at the linkag...",114,643,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
687G>A,"c.2687G>A, p.R896Q",89,4,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
567C>T,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,4,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
003C>T,...g results confirmed the presence of the R335X (c.1003C>T) mutation in the PTEN gene and the patient ...,33,65,Case_Rep_Oncol_Med_2015_Sep_10_2015_546297.txt
1G > T,...nsT) and a previously described mutation (c.687 + 1G > T) in the ATP6V1B1gene [10]. The c.1259 inser...,42,148,Case_Rep_Pediatr_2012_Aug_27_2012_605053.txt
1G > T,...nsT) and a previously described mutation (c.687 + 1G > T) in the ATP6V1B1gene [10]. The c.1259 inser...,42,148,Case_Rep_Pediatr_2012_Aug_27_2012_605053.txt
4G > A,"...the patient showed the nucleotide substitution c.34G > A, resulting in p.Gly12Ser amino acid change ...",91,64,Case_Rep_Pediatr_2015_Feb_28_2015_934865.txt
234G>A,"...ation at the nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the li...",46,373,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
1432A>G,"...t study, exome sequencing identified a homozygous 1432A>G DNA variant encoding the missense change N...",15,64,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,...on post-irradiation (IR). Although the homozygous 1432A>G MTPAP variant was previously associated wi...,15,399,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
48+1 G > T,"...version at the exon-intron junction of exon 6 (c.748+1 G > T), which segregated with the disease in ...",23,784,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
3243A>G,...pe-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem...,245,156,Cell_Rep_2015_May_28_11(10)_1614-1624.txt
1073C>T,...as carrier of the previously identified TMEM43 c. 1073C>T (p.S358L) mutation (Merner et al. 2008; Ch...,1153,390,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
3435C>T,"...03, exon 12), 2677G>T/A (rs2032582, exon 21), and 3435C>T (rs1045642, exon 26). These SNPs have a wi...",47,1016,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
4919510	G>C,Has-miR-608	10q25.1	rs4919510	G>C	99.85	0.835	0.425	0.245	0.408,87,23,Chin_J_Cancer_2016_Aug_11_35_77.txt
81W>X,"...HL1 mutation associated HCM, and the c.542G>A (p.181W>X) is a novel nonsense mutation. FHL1 mutation...",24,131,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
42A>G,"...his study showed a missense mutation in BMPR2, c.742A>G (p.R248G) located in exon six, and another m...",33,156,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
318C>T,...hn J  Capasso M  Lanciotti M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA...,146,57,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
49A>G,...M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic ...,146,84,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
49A>G,...M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic ...,146,84,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
824C > T,"...f three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility i...",65,468,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
824C > T,"...f three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility i...",65,468,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
947 G>A,"...program. Genotypes of the COMT gene Val158Met (c.1947 G>A, rs4680) polymorphism were defined through...",42,411,Clin_Exp_Reprod_Med_2014_Jun_30_41(2)_62-67.txt
947 G>A,"...program. Genotypes of the COMT gene Val158Met (c.1947 G>A, rs4680) polymorphism were defined through...",42,411,Clin_Exp_Reprod_Med_2014_Jun_30_41(2)_62-67.txt
947 G>A,"...program. Genotypes of the COMT gene Val158Met (c.1947 G>A, rs4680) polymorphism were defined through...",42,411,Clin_Exp_Reprod_Med_2014_Jun_30_41(2)_62-67.txt
19 G>A,...9 C>T in intron 4) and two exon 10 variations (c.919 G>A Ala307Thr and c.2039 G>A Ser680Asn) were id...,13,2777,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
039 G>A,...wo exon 10 variations (c.919 G>A Ala307Thr and c.2039 G>A Ser680Asn) were identified (Figure 2). The...,13,2801,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
374+69 T>C,"Figure 2 FSH receptor variations: (A) intron 4c374+69 T>C, (B) exon 10 Ala307Thr, and (C) exon 10...",30,48,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
14+1G>A,"...San Juan Capistrano, CA), was negative for the IVS14+1G>A mutation in the DPD gene, which accounts f...",32,472,Cureus_8(9)_e798.txt
14+1G>A,"...San Juan Capistrano, CA), was negative for the IVS14+1G>A mutation in the DPD gene, which accounts f...",32,472,Cureus_8(9)_e798.txt
1905+1 G>A,"...herapy [8]. Interestingly, DPYD*2A (also known as 1905+1 G>A) was not significantly associated with ...",37,686,Cureus_8(9)_e798.txt
31T>C,A c.731T>C CAPN5 mutation resulted in a p.Leu244Pro sub...,10,6,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
3435C-->T,...e risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance...,225,131,Clin_Pharmacol_2013_Sep_27_5_153-159.txt
-786T>C,...uded in the analysis. They were genotyped for eNOS-786T>C SNP (rs2070744) with the Taqman® allelic d...,85,287,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
830G>A,c.2830G>,50,4,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
5452C > A,... synonymous polymorphism. Only m.4216T > C and m.15452C > A provoke amino acid substitutions. The fi...,222,377,Crit_Care_2012_Jan_17_16(1)_R10.txt
854T>C,"...>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and ...",9,134,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"... NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10...",22,622,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"...s28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF ...",22,650,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...(rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast cance...",22,733,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward prime...",31,15,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"... IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-488...",320,241,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breast c...",320,288,Croat_Med_J_2014_Dec_55(6)_638-646.txt
180 G>A,"...s (c.500 G>A, c.520 C>T, c.823 C>T, c.930 G>C, c.1180 G>A) in the PRKN gene were seen in 4 exons (4,...",216,307,Curr_Genomics_2013_Dec_14(8)_502-517.txt
180 G>A,"The c.1180 G>A transition in exon 11, which is located be...",220,8,Curr_Genomics_2013_Dec_14(8)_502-517.txt
180 G>A,"The c.1180 G>A transition in exon 11, which is located be...",220,8,Curr_Genomics_2013_Dec_14(8)_502-517.txt
23 C>T,"...rrent research shows that the frequency of the c.823 C>T mutation is low. Results of our study, as w...",226,181,Curr_Genomics_2013_Dec_14(8)_502-517.txt
23 C>T,...l as the study by Sinha [151] who detected the c.823 C>T substitution in 0.2% of the PD group but no...,226,283,Curr_Genomics_2013_Dec_14(8)_502-517.txt
5A>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,51,Curr_Genomics_2013_Dec_14(8)_502-517.txt
7C>T,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G...",291,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
7C>T,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G...",291,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
36G>C,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
60T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,50,Curr_Genomics_2013_Dec_14(8)_502-517.txt
45C>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del4...",298,32,Curr_Genomics_2013_Dec_14(8)_502-517.txt
11C>T,"c.500G>A, c.511C>T, c.518C>T",301,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
88G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
19C>T,"c.719C>T, c.727G>A, c.730G>A",307,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
27G>A,"c.719C>T, c.727G>A, c.730G>A",307,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
58G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.7...",308,6,Curr_Genomics_2013_Dec_14(8)_502-517.txt
66C>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,36,Curr_Genomics_2013_Dec_14(8)_502-517.txt
99T>C,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.8...",310,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
31C>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,36,Curr_Genomics_2013_Dec_14(8)_502-517.txt
000C>T,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
051A>C,"c.1051A>C, c.1076G>A",318,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
097G>A,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,18,Curr_Genomics_2013_Dec_14(8)_502-517.txt
225G>T,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,37,Curr_Genomics_2013_Dec_14(8)_502-517.txt
286G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C...",325,7,Curr_Genomics_2013_Dec_14(8)_502-517.txt
286G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C...",325,7,Curr_Genomics_2013_Dec_14(8)_502-517.txt
330G>C,"...A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,62,Curr_Genomics_2013_Dec_14(8)_502-517.txt
393G>A,"...335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,54,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1331T>C,...traceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump ...,254,225,Curr_Med_Chem_2009_Aug_16(23)_3041-3053.txt
120C>T,"...PS were identified recently: missense mutation c.1120C>T in a highly conserved region of exon 8,107 ...",66,975,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
8+2T>G,...in conjunction with a GK splice site mutation (IVS8+2T>G) and was associated with marked hyperglycem...,153,1363,Diabetes_2011_Dec_13_60(12)_3175-3185.txt
28G>A,"... in each of the three probands: R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 ...",34,104,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
81G>A,"...d c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of ...",34,241,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
-948 G > T,"...y. However, they found an association between the -948 G > T single-nucleotide polymorphism (SNP) an...",87,447,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
-948C > A,...20). They found a significant association between -948C > A and T2DM (p = 0.021). In a non-diabetic ...,91,163,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
4478 T > G,"Robitaille, 2004 [36]	n: 217	N/D	29.6 ± 4.3	N/D	4478 T > G, 4437–4438insA and 10733G > C	No associ...",302,49,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
30249 T > C,"... +1932Ginsdel, xrs932335, rs13306422, rs6752 and +30249 T > C	No association with WHR, BMI, FPG, HbA...",308,130,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
32A>G,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,6,Diagn_Pathol_2013_May_9_8_78.txt
69C>T,"2	c.269C>T	p.Ser90Leu	dHMN, CMT2	[18,29,30]",100,6,Diagn_Pathol_2013_May_9_8_78.txt
72T>C,2	c.272T>C	p.Leu91Pro	CGL2	[27],102,6,Diagn_Pathol_2013_May_9_8_78.txt
65G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,6,Diagn_Pathol_2013_May_9_8_78.txt
171C>T,10	c.1171C>T	p.Gln391X	CGL2	[27],109,7,Diagn_Pathol_2013_May_9_8_78.txt
-2A>G,IVS6 -2A>G	Exon skipping	Protein truncation	CGL2	[7],127,6,Diagn_Pathol_2013_May_9_8_78.txt
*1906G->C,"Ellis, The founder mutation MSH2*1906G->C is an impor",522,33,Dis_Markers_2004_Oct_29_20(4-5)_269-276.txt
7510T>C,supports a pathogenic role for the 7510T>C mutation of mi,583,36,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
-469 T>C,...i G.  Mittal B.   CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and ri...,232,77,Dis_Markers_2015_Apr_6_2015_185969.txt
-762T>C,"...s control group. The SNP detection of 1513A>C and -762T>C was performed using PCR-RFLP, and the leve...",8,376,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...d. Results. AC and CC of 1513A>C and TC and CC of -762T>C had higher frequencies in case group than ...,8,539,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...d. Results. AC and CC of 1513A>C and TC and CC of -762T>C had higher frequencies in case group than ...,8,539,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"... TT. Additionally, patients carrying TC and CC of -762T>C had more MTB in sputum than those carrying...",8,767,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...e carrying TT. Conclusion. P2X7 SNPs, 1513A>C and -762T>C, may be associated with the susceptibility...",8,857,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...or function, and the most common SNPs involve the 1513A>C and -762T>C [13, 14]. Accumulating studies...",13,807,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"... and the most common SNPs involve the 1513A>C and -762T>C [13, 14]. Accumulating studies suggested t...",13,819,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"..., and 50 ng genome DNA. The PCR amplification for 1513A>C included initial denaturation at 95°C for ...",26,808,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,Genotype frequency distributions of 1513A>C and -762T>C in two groups were consistent with Hardy-W...,38,49,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,The data in Table 2 suggested that 1513A>C and -762T>C SNPs may correlate to the susceptibility t...,41,48,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...own in Table 3. TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses ...,41,258,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...ntigen in TB patients. Our results suggested that 1513A>C and -762T>C SNPs may be a risk factor for ...,47,238,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,... patients. Our results suggested that 1513A>C and -762T>C SNPs may be a risk factor for the developm...,47,250,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...or function or expression, especially 1513A>C and -762T>C SNPs [13]. A previous study published by G...",51,186,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...25]. In our study, patients carrying TC and CC of -762T>C had greater MTB in sputum than those carry...",51,884,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"... be associated with the susceptibility to TB, and -762T>C SNP may contribute to the development of M...",55,135,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Figure 1 The electropherograms of 1513A>C and 762T>C SNPs in P2X7 gene after enzyme ...,66,35,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Table 2 Genotype frequency distributions of 1513A>C and -762T>C in P2X7 gene,88,45,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,-762T>C	 	 	 	 	 ,106,1,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,-762T>C	 	 	 	 	 ,131,1,Dis_Markers_2015_Dec_20_2015_671272.txt
677 C>T,... F.  Hasbek Z.    Increased T-allele frequency of 677 C>T polymorphism in the methylenetetrahydrofol...,239,71,Dis_Markers_2015_Jan_31_2015_681313.txt
1-401T>C,...L level at HRT treatment. Among these SNPs the IVS1-401T>C was most strongly related to HDL increase...,58,854,EJIFCC_2008_Apr_3_19(1)_48-53.txt
344A>G,"...ield. Patients with a specific mtDNA mutation, m.8344A>G, show multiple symmetric lipomas, which hav...",129,113,EMBO_Mol_Med_2014_Jun_7_6(6)_721-731.txt
3243A>G,...eled phase 2 study on patients carrying the mtDNA 3243A>G mutation. The latter mutation is one of th...,207,572,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
243A>G,"...train, but not to disease progression in adult m.3243A>G carriers . JIMD Rep",1791,139,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
53C>T,c.253C>T	p.Arg85Cys	First intracellular loop	Disease-...,153,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
44C>A,...ified two de novo heterozygous mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R19...,4,890,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
57C>T,"...tations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing li...",4,923,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
154A>T,"...vel heterozygous ABCC8 gene missense mutation (c.4154A>T/ p.Lys1385Thr), who was initially responsiv...",4,565,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
2+299G > A,ALAD IVS2+299G >,308,9,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
2255T>C,"...s (−1639G>A (rs9923231), 1173C>T (rs9934438), and 2255T>C (rs2359612)) appeared to be the most impor...",94,109,EPMA_J_2012_Sep_27_3(1)_10.txt
11676382 C>G,... later study of King et al. in 2010 showed that rs11676382 C>G significantly influenced warfarin dos...,147,52,EPMA_J_2012_Sep_27_3(1)_10.txt
11676382 C>G,... later study of King et al. in 2010 showed that rs11676382 C>G significantly influenced warfarin dos...,147,52,EPMA_J_2012_Sep_27_3(1)_10.txt
-1639G>A,"On the whole, the combination of VKORC1 -1639G>A, CYP2C9 (*2 and *3), and clinical factors...",211,41,EPMA_J_2012_Sep_27_3(1)_10.txt
81G>T,...:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were detected in the r...,10,1026,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
243A>G,"to the m.3243A>G mutation, while sudden death, often with a ...",51,11,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
243A>G, MTTL1	m.3243A>G	++	+	++	+	+	+	−,236,11,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
1778G>A, MTND4	m.11778G>A	++	−	+	−	−	−	−,239,11,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
303T>C,m.3303T>C	−	+	+	+	−	−	−,246,4,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
303T>C,m.3303T>C	−	+	+	+	−	−	−,246,4,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
337G>A, MTND1	m.3337G>A	−	−	+	+	−	−	−,247,11,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
363G>A, MTTK	m.8363G>A	−	−	+	+	−	−	−,254,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
243A>G,m.3243A>G mutation and have revealed a correlation be...,307,4,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
243A>G,m.3243A>G mutation and have revealed a correlation be...,307,4,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
317A>G,and m.4317A>G in MTTI) and infrequent polypeptide genes (...,312,8,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
344A>G,"...al mitochondria,61 and have been linked to the m.8344A>",379,93,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
344A>G,"...al mitochondria,61 and have been linked to the m.8344A>",379,93,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
243A>G,"and m.3243A>G mutations, where manifest pre-excitation wa...",413,8,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,"mutations (e.g. 3243A>G, m.4300A>G) in specific clinical scenarios...",446,17,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,... 3-year clinical follow-up of adult patients with 3243A>G i,641,310,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
243A>G,...eijnse ML   Cardiac involvement in adults with m.3243A>G MELAS gen,705,181,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
88033661T > C,...8052C > A [Figure 3a] and intron 5 at position g. 88033661T > C [Figure 3b] in homozygous condition,40,933,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
521T>C,...er explore the effect of ursolic acid on OATP1B1 (521T>C)-mediated transport of rosuvastatin. This s...,24,534,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
21T>C,"...found in more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated with a...",150,116,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521 T>C,...*1a-HEK293T (P < 0.05). Gene mutation of OATP1B1 (521 T>C) may decrease its transport capacity. Howe...,160,806,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
88A>G,The c.388A>G and the c.521T>C variants occur in alleles o...,162,8,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
21T>C,The c.388A>G and the c.521T>C variants occur in alleles of OATP1B1*15. It ...,162,25,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
46G>A,"...gle-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one...",3,2002,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
096C>G,"...tide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-f...",3,2012,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
729T>A,"...loproteinase-9 from macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking of ...",18,510,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...nor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while hav...",34,82,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
729T>A,"... c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major alleles at the other pos...",34,116,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...ll rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.17...",41,66,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
729T>A,"...946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294)...",41,115,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
729T>A,"...946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294)...",41,115,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,... previously published P2RX7 SNPs revealed that c.946G>A (p.Arg307Gln) was significantly associated w...,44,70,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G >A,"... for GA subjects (P=0.7)), suggesting that the c.946G >A may be exerting effects on bone mass at an ...",44,869,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
51+1G>T,"...s (n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>...",47,138,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
513A>C,"...orff et al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are ...",50,863,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...meability studies of subjects heterozygous for c.946G>A (Figure 1 in Gu et al, 200436) show complete...",52,982,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,...nd that subjects who were heterozygous for the c.946G>A (Arg307Gln variant) had >40% greater bone lo...,52,1504,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
51+1G>T,"...t revision.46 In our study, heterozygosity for c.151+1G>T that leads to one null allele37 had no imp...",52,1992,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,...cture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with previo...,60,181,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,...cture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with previo...,60,181,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
89C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0.97 ...,106,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
729T>A,rs1653624	c.1729T>A (p.I568N)	0.02	0.97 (0.01)	0.93 (0.02)	1.22...,110,14,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
498C>T,"...n ethnicity, and c.613C>T (p.(Arg205Cys))3 and c.1498C>T (p.(Arg500*)),4 in Japanese. In one case, t...",21,605,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
78G>T, E60X	c.178G>T	p.Glu60*,168,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
040G>C, R347P	c.1040G>C	p.Arg347Pro,172,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
657C>T, R553X	c.1657C>T	p.Arg553*,176,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
766+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
988+1G>A, 3120+1G>A	c.2988+1G>A	 ,181,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
988+1G>A, 3120+1G>A	c.2988+1G>A	 ,181,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
484C>T, R1162X	c.3484C>T	p.Arg1162*,183,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
15C>T, Q39X	c.115C>T	p.Gln39*,186,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
23C>T, R75X	c.223C>T	p.Arg75*,188,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
74G>T, E92X	c.274G>T	p.Glu92*,191,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
28G>C, D110H	c.328G>C	p.Asp110His,195,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
711+5G>A, 711+5G>A	c.579+5G>A	 ,203,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
80-1G>T, 712-1G>T	c.580-1G>T	 ,204,14,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
203G>A, W401X(TGA)	c.1203G>A	p.Trp401*,222,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1341+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1525-1G>A, 1525-1G>A	c.1393-1G>A	 ,225,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1525-1G>A, 1525-1G>A	c.1393-1G>A	 ,225,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
397C>A, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
397C>G, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,24,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
585-1G>A, 1717-1G>A	c.1585-1G>A	 ,232,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
675G>A, A559T	c.1675G>A	p.Ala559Thr,238,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
679G>A, R560K	c.1679G>A	p.Arg560Lys,241,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
908G>C, G970R	c.2908G>C	p.Gly970Arg,266,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3121-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
989-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
989-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
989-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
472C>T, R1158X	c.3472C>T	p.Arg1158*,278,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
611G>A, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
937C>T, Q1313X	c.3937C>T	p.Gln1313*,290,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
930C>T, S977F	c.2930C>T	p.Ser977Phe,303,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
205G>A, G1069R	c.3205G>A	p.Gly1069Arg,305,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
209G>A, R1070Q	c.3209G>A	p.Arg1070Gln,306,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
20C>T, R74W	c.220C>T	p.Arg74Trp,313,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
20C>T, R74W	c.220C>T	p.Arg74Trp,313,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
485G>T, R1162L	c.3485G>T	p.Arg1162Leu,323,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
711+3 A>G,"...ipt such as 3849+10kbC>T, 2789+5G>A, 3272-26 A>G, 711+3 A>G",329,1289,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
601G>A,[R74W;V201M;D1270N]c.[220C>T;601G>A;3808G>A,339,30,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
601G>A,[R74W;V201M;D1270N]c.[220C>T;601G>A;3808G>A,339,30,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
220C>T,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,24,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3909C>G,...mple 2b	3849+10kbC>T and N1303K	c.[3718-2477C>T(;)3909C>G],354,82,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
350G>A,...ariants on one allele (in cis)	R117H-T5/normal	c.[350G>A;1210-12 T[5]][=],355,69,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>C,...ly reported rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is beli...,92,774,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
7669877T>G,"...84.16:g.27699318G>T), rs10208987 (NT_022184.16:g.27669877T>G), rs10439467 (NT_022184.16:g.27675088C>...",151,180,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
7674272C>T,"...184.16:g.27700623T>C), rs4148189 (NT_022184.16:g.27674272C>T), rs4148191 (NT_022184.16:g.27669646C>A...",151,502,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
7669646C>A,"...184.16:g.27674272C>T), rs4148191 (NT_022184.16:g.27669646C>A), rs4148196 (NT_022184.16:g.27664656C>G...",151,542,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
504 C>T,"...d logistics regression analysis, SPSS 17.0) of C. 504 C>T was significantly different between the ex...",39,585,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...mutation and the premature infants without the C. 504 C>T mutation in the experimental group (P>0.05...,44,244,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...mutation and the premature infants without the C. 504 C>T mutation in the experimental group (P>0.05...,44,244,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...mutation and the premature infants without the C. 504 C>T mutation in the experimental group (P>0.05...,44,244,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...and r-GGT between the preterm infants with the C. 504 C>T mutation and the preterm infants without t...,44,436,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...and r-GGT between the preterm infants with the C. 504 C>T mutation and the preterm infants without t...,44,436,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...). The results revealed that the patients with C. 504 C>T in the experimental group had raised serum...,44,575,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...was a correlation between the MDR3 gene exon 6 C. 504 C>T synonymous mutation and PNAC in premature ...,55,89,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,With C. 504 C>T mutation	19	127±20.1	128.8±20.7	70.2±10.8	...,93,9,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
04C>A,"HSPB1 was identified, a c.404C>A transversion resulted in p.(Ser135Tyr) amino...",83,28,F1000Res_2015_Feb_26_4_53.txt
722G>T,11	c.2722G>T	4	11	c.5645C>G	1,60,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1G>T,5	c.191G>A	1	6	c.516 + 1G>T	1,70,24,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
080G>T,18	c.5080G>T	1	10	c.1813insA	1,73,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
385A>G,11	c.692C>T	1	10	c.1385A>G	1,83,21,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
435C>G,23	c.5435C>G	1,89,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
987-3C>G,"...had mutation probabilities below 20%. The UVs: c.4987-3C>G (putative splice variant), and c.5216A>G ...",152,133,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
258G>T,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	[31...,157,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
258G>T,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	[31...,157,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
446G>T, 2	F11	1 (37)	Exon 2	g.5446G>T	p.Glu54X	Bil	Yes	Enucl	Epithelial	Bl (52),79,25,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
4348C>T, 10a	F4		Exon 10	g.64348C>T	p.Arg320X	Bil	No	RT	Melanoma	(25),87,21,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
60832G>T, 28	F14		Exon 21	g.160832G>T	p.Glu737X	Bil	No	RT	Osteosarcoma	(20),107,21,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
62237C>T, 30a	F28	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT	Sarcoma	Lipo (12),109,24,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
62237C>T, 30a	F28	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT	Sarcoma	Lipo (12),109,24,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
49997G>A, 35	F19	NA	Intron 17	g.149997G>A,118,25,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	Yes	RT	Epithelial	Bl (62),121,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
6460C>T,14	g.76460C>T	Arg.455X	8	0,163,7,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
6460C>T,14	g.76460C>T	Arg.455X	8	0,163,7,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
8238C>T,17	g.78238C>T	Arg.552X	3	2,165,7,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
32-13T>G,"...utation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows fo...",23,68,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
-786T>C,"...helial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy . ...",572,135,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
677 C>T,...NP) in methylenetetrahydrofolate reductase (MTHFR 677 C>T variant genotype). This enzyme catalyzes t...,98,998,Front_Genet_2014_Aug_26_5_289.txt
4756176G>A,"...: g.74755658G>A, g.74756006G>A, g.74756039T>A, g.74756176G>A, g.74756438T>C",122,58,Front_Genet_2014_Jun_4_5_167.txt
1017290A>C,"...: g.41016968T>A, g.41017103C>T, g.41017242T>C, g.41017290A>C, g.41017450A>T, g.41017478C>T, g.410174...",124,58,Front_Genet_2014_Jun_4_5_167.txt
1236C>T,...Smith P. Dandara C.   (2012a ). ABCB1 4036A>G and 1236C>T polymorphisms affect plasma efavirenz leve...,320,67,Front_Genet_2014_Jun_4_5_167.txt
5409478C>A,"NC_000019.10:g.45409478C>A		Okuda et al., 2011	90	C/C ↑ Prognosis",45,18,Front_Genet_2014_Nov_14_5_391.txt
6397T>C,NG_007067.2:g.16397T>C,104,17,Front_Genet_2014_Nov_14_5_391.txt
02845848A>G,NC_000013.11:g.102845848A>G,117,18,Front_Genet_2014_Nov_14_5_391.txt
1071C>T,NG_011516.1:g.21071C>T NG_012307.1:g.75229G>A	Breast cancer	Chew ...,152,17,Front_Genet_2014_Nov_14_5_391.txt
-8-251A >T,...g L Zhu X Liang X Ling Z Li R  . Association of IL-8-251A >T polymorphisms with oral cancer risk: ev...,208,57,Front_Immunol_2015_May_5_6_214.txt
-8-251A >T,...g L Zhu X Liang X Ling Z Li R  . Association of IL-8-251A >T polymorphisms with oral cancer risk: ev...,208,57,Front_Immunol_2015_May_5_6_214.txt
341C>T,...Li J.   (2013 ). The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analys...,237,95,Front_Pharmacol_2014_Aug_28_5_200.txt
341C>T,...Li J.   (2013 ). The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analys...,237,95,Front_Pharmacol_2014_Aug_28_5_200.txt
544T > C,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs863224900	Likely pathogen...,58,23,Front_Physiol_2016_Oct_28_7_499.txt
686G > A,NM_000257.3(MYH7):c.2686G > A (p.Asp896Asn) rs606231340	Pathogenic	Rani...,61,23,Front_Physiol_2016_Oct_28_7_499.txt
9533395 G > A,s11pl13	Sterile	CHr1:9533395 G > A	E106 > K,79,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
1117C>T,Der Polymorphismus 1117C>T im Cytochrom P450 CYP1A2 beeinträchtigt di...,218,20,Front_Vet_Sci_2016_Mar_22_3_26.txt
5665G>T,...Nitric Oxide Synthase (−786T>C) and Endothelin-1 (5665G>T) Gene Polymorphisms as Vascular Dysfunctio...,3,251,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...Nitric Oxide Synthase (−786T>C) and Endothelin-1 (5665G>T) Gene Polymorphisms as Vascular Dysfunctio...,3,251,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,The ET-1 5665G>T (rs5370) and eNOS −786T>C (rs2070744) gene...,27,10,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,The ET-1 5665G>T (rs5370) and eNOS −786T>C (rs2070744) gene polymorphisms were investi...,27,37,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,... variant allele (Table 1). The frequency of eNOS −786T>C was 54.3% (44/81) for wild-type genotype an...,40,917,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...can stimulate vascular smooth muscle.18 The eNOS −786T>C minor allele can be associated with an enha...,57,510,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Figure 1 Presence of ET-1 5665G>T alleles and occurrence of acute chest synd...,87,27,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Table 1 Frequencies of ET-1 5665G>T and eNOS −786T>C gene polymorphisms among ...,93,29,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,Table 3 ET-1 5665G>T and eNOS −786T>C gene polymorphisms association with clinica...,120,32,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	0.351	0.127	2.772	0.011,152,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
51T>A,LR03-184a1	Intron 1	g.151T>A	T/A	T/T	T/A	T/T	6/350 (1.7%),150,24,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
213T>C,8348	Intron 3	g.8213T>C	T/C	n/a	n/a	n/a	0/146 (0%),158,18,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
4718C>T,LR01-194	Intron 7	g.14718C>T	C/T	C/C	C/T	n/a	1/558(0%),160,22,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...he two unrelated patients having the identical g.-1453C>G patient variant. In all 12 cases, at least...",176,292,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
0765C>A,"...g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.20765C>A and g.21502T>C) were not detected in any c...",178,531,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...ions’. Three of the seven candidate mutations (g.-2945A>G, g.-1767G>T and g.21502T>C) were identifie...",178,729,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,...ese reside within putative regulatory regions (g.-1726C>A in a 100-bp element in the PPR that is con...,178,1353,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1559C>T,...le control subject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A allelic pairs. ...,180,429,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1559C>T,...le control subject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A allelic pairs. ...,180,429,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,Candidate mutation	g.-1767G>T	PPR	Created	lA-1	Regulator of neuronal dev...,189,23,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1559C>T,Functional polymorphism	g.11559C>T	Intron 5	No effect	n/a	n/a	C	C	C	C	na,201,28,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...t harboring candidate mutations is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromos...",221,630,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...t harboring candidate mutations is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromos...",221,630,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
213T>C,"...06 chromosomes), g.-1726C>A (716 chromosomes), g.8213T>C (334 chromosomes), g.14718C>T (746 chromoso...",221,720,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1502T>C,"...chromosomes), g.20765C>A (550 chromosomes) and g.21502T>C (532 chromosomes)",221,812,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...edicted to alter neural TFBS and one of these (g.-1726C>A) resides in the promoter region, which tog...",309,567,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1096C>G,rs2230911	1096C>G	Exon 11	Thr-357-Ser	C (+)a	0.900	0.864	0.8...,122,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1772C>T,rs1621388b	1772C>T	Exon 13	Pro-582-Pro	C (+)b	0.625	0.875	0.6...,130,12,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1965708 G>T,"...SNPs for DC-SIGN (at rs11465396 G>A), SP-A2 (at rs1965708 G>T) and SP-D (at rs721917 G>A) in lung ti...",113,99,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
41C>T,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
72C>T,A23	F	Compound Het.	c.872C>T; UND	p.Ala291Val	Nonsyn	This study,105,24,Genet_Med_2015_Aug_6_17(8)_660-667.txt
74T>G,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
114C>T,S26	F	Compound Het.	c.1114C>T,113,24,Genet_Med_2015_Aug_6_17(8)_660-667.txt
065A>T,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
14C>T,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,24,Genet_Med_2015_Aug_6_17(8)_660-667.txt
94C>T,c.994C>T	p.Ser173Phefs*25,131,4,Genet_Med_2015_Aug_6_17(8)_660-667.txt
95G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
177 A > G,"...ubstitution located in exon 1 at position 177 (c.+177 A > G, GenBank accession No. NM_214379) causes...",40,281,Genet_Mol_Biol_2011_Mar_1_Jan-Mar_34(1)_56-61.txt
115T > G,"...nger sequencing of DNM2 uncovered the mutation c.1115T > G, p.F372C, in exon 8, in a heterozygous st...",42,2075,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
179C > T,hLIG1	179C > T	A60V	Unknown	No	Neutral (83%)	0.56 ± 0.06...,146,7,Genetics_2015_Nov_9_201(3)_1263-1274.txt
664C > T,664C > T	R222C	Heterozygous	No	Neutral (63%)	0.35 ...,152,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1502T > C,1502T > C	M501T	Unknown	No	Neutral (83%)	0.61 ± 0....,156,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1969T > G,1969T > G	L657V	Heterozygous	Yes	Neutral (83%)	0.7...,158,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1441T > C,1441T > C	S481P	Unknown	No	Deleterious (61%)	Non-f...,169,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1723A > G,1723A > G	T575A	Heterozygous	No	Neutral (83%)	1.02...,171,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
11045981 T>G,...els (rs4148981C>T) and methotrextate clearance (rs11045981 T>G)	[3],23,311,Genome_Med_2012_May_25_4(5)_45.txt
124 C>T,"...>C [46]. However, when these mutations (−57 A>C, −124 C>T, −146 C>T) are introduced into tumor cells...",49,348,Genome_Med_2016_Jun_20_8_69.txt
124 C>T,...d that in undifferentiated hESCs the presence of −124 C>T caused a 2- to 3-fold increase in hTERT mR...,51,702,Genome_Med_2016_Jun_20_8_69.txt
57 A>C,... 3-fold increase in hTERT mRNA while neither the −57 A>C nor −146 C>T mutation had any effect on hTE...,51,774,Genome_Med_2016_Jun_20_8_69.txt
4883G>A,"...gene, at least one G allele (GG; AG) at the CD44 +4883G>A gene locus (rs187116) associated with clin...",53,638,Gut_Liver_2011_Dec_21_5(4)_397-405.txt
1551-9T>A,"...was an unknown functional variant (1661+12A>G and 1551-9T>A, respectively). The polymorphism in intr...",60,371,Hered_Cancer_Clin_Pract_2005_May_15_3(2)_65-70.txt
2642A>T,...eletion 2223delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRC...,3,2501,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,...delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRCA1 expressio...,3,2513,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
738A>G,MTI-627	3 (1 died)	H	c.1738A>G	p.K580E	Yes,264,26,Hum_Genome_Var_2014_Nov_6_1_14020.txt
921T>C,c.1921T>,271,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
921T>C,c.1921T>,281,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
328T>A,c.1328T>,315,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
328T>A,c.1328T>,345,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
156A>G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
714G>T,JS_3	1	H	c.4714G>T	p.E1572*	Yes,403,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
668G>T,c.5668G>,420,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
932G>A,c.5932G>A,457,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
888T>C,A1371	2	H	c.1888T>C	p.S630P	Yes,468,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
161C>T,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,17,Hum_Genome_Var_2014_Nov_6_1_14020.txt
055C>T,c.3055C>,500,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
258G>A,MTI-127	1	CH	c.4258G>,554,18,Hum_Genome_Var_2014_Nov_6_1_14020.txt
3+2T>G,MTI-429	5 (1 died)	H	c.33+2T>G	ND	Yes,637,26,Hum_Genome_Var_2014_Nov_6_1_14020.txt
437G>C,c.1437G>C	p.R479S	No	digenic	F (Emirati,741,5,Hum_Genome_Var_2014_Nov_6_1_14020.txt
773C>T,ND	1	H	c.2773C>T	p.R925*	Yes,753,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
75T>C,"....9 Sequencing FRMD7 revealed a T>C transition (c.875T>C) in exon 9 (Figure 1b), which causes a conse...",21,730,Hum_Genome_Var_2015_Feb_12_2_15002.txt
07C>A,".... Here, we report a novel hemizygous mutation, c.207C>A (Phe69 Leu), which caused a mild/late-onset ...",14,1085,Hum_Genome_Var_2015_Nov_12_2_15044.txt
07C>A,"...fied one hemizygous mutation in exon 2 of GLA, c.207C>A (p. Phe69 Leu). The mutation was absent from...",24,308,Hum_Genome_Var_2015_Nov_12_2_15044.txt
11+1G>T,"...nsG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identified in the current study. As ...",26,830,Hum_Genome_Var_2016_Feb_11_3_15052.txt
31G>A,"...reviously reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were f...",26,931,Hum_Genome_Var_2016_Feb_11_3_15052.txt
0A>G,...o missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in two sporadic patie...,26,957,Hum_Genome_Var_2016_Feb_11_3_15052.txt
11+1G>T,"...ion even in Patient no. 22–24 who had the same IVS11+1G>T mutation. However, all ocular findings wer...",29,684,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+1G>T,8	2	 	Intron5	IVS5+1G>T	Splice error	NA	PD	Yes	1	M	Total/total	+/+	...,59,18,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+2T>G,9	3	Familial	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	64	M	Total/total	−/−...,60,25,Hum_Genome_Var_2016_Feb_11_3_15052.txt
07C>T,14	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	11	M	Total/total	...,65,24,Hum_Genome_Var_2016_Feb_11_3_15052.txt
18C>T,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/total	−...,68,24,Hum_Genome_Var_2016_Feb_11_3_15052.txt
29C>T,20	 	Sporadic	Exon10	c.829C>T	Nonsense	p.Gln277X	PST	Yes	13	F	Total/total	...,71,25,Hum_Genome_Var_2016_Feb_11_3_15052.txt
894G > T,"...ss graft surgeryeNOS -786T > C polymorphism, eNOS 894G > T polymorphismsmokin",5,94,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...r activity by approximately 50 per cent [4] and a 894G >T polymorphism leading to amino acid substit...,12,344,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...r activity by approximately 50 per cent [4] and a 894G >T polymorphism leading to amino acid substit...,12,344,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,...) analysis was used for the identification of the -786T >C polymorphism in the eNOS gene. Genomic DN...,33,129,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,"... were in Hardy-Weinberg equilibrium. For the eNOS -786T >C polymorphism, the frequencies of the geno...",81,248,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T > C,-786T >,103,1,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,Table 3 Frequencies of the eNOS 894G > T genotypes and alleles in CABG patients ac...,131,33,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,eNOS 894G > T genotypes	n (%)	95% CI	n (%)	95% CI,136,6,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"..., we investigated the association of -786T >C and 894G >T polymorphisms of the eNOS gene with CAD. O...",192,418,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,...udies have reported a lack of association of eNOS -786T >C and 894G >T polymorphisms with CAD in oth...,194,204,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,...e of small-study bias in studies of the G894T and -786T >C polymorphisms [19]. Our approach was to u...,194,903,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,...e of small-study bias in studies of the G894T and -786T >C polymorphisms [19]. Our approach was to u...,194,903,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
1199G > A,ABC transporters	ABCB1	rs2229109	A	1199G > A;S400N	0.0	0.0	0.0	NA	0.0	0.03	0.0	0.0	0....,300,36,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1199G > A,ABC transporters	ABCB1	rs2229109	A	1199G > A;S400N	0.0	0.0	0.0	NA	0.0	0.03	0.0	0.0	0....,300,36,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,ABCB1	rs1128503	T	1236C > T	0.13	0.23	0.12	0.11	0.14	0.39	0.68	0.54	...,307,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1249G > A,ABCC2	rs2273697	A	1249G > A;V417I	0.11	0.18	0.21	0.2	0.23	0.23	0.07	...,311,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
-24C > T,ABCC2	rs717620	T	-24C > T	0.03	0.04	0.04	0.02	0.04	0.18	0.22	0.23	0...,312,19,Hum_Genomics_2011_May_1_5(4)_265-282.txt
516G > T,"Phase I	CYP2B6	rs3745274	T	516G > T;Q172H, *6	0.2	0.23	0.45	0.31	0.37	0.25	0....",313,28,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1846G > A,"CYP2D6	rs3892097	A	1846G > A, *4	0.0	0.01	NA	NA	NA	0.5	NA	NA	NA",322,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1247C > T,"CYP3A4	rs4986909	T	1247C > T; P416L, *13	0.0	0.0	0.0	NA	NA	0.0	0.0	NA...",324,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
485G > A,"CYP3A4	rs4986907	A	485G > A; R162Q, *15A	0.01	0.0	0.0	NA	NA	0.0	0.0	0...",326,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
566T > C,"CYP3A4	rs4987161	C	566T > C; F189S, *17	0.0	0.0	0.0	NA	NA	0.0	0.0	NA	...",327,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
566T > C,"CYP3A4	rs4987161	C	566T > C; F189S, *17	0.0	0.0	0.0	NA	NA	0.0	0.0	NA	...",327,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
211G > A,"Phase II	UGT1A1	rs4148323	A	211G > A;G71R, *6	0.0	0.0	0.0	NA	NA	0.0	0.2	0.03	0...",332,29,Hum_Genomics_2011_May_1_5(4)_265-282.txt
601324 C > T,UGT1A1	rs887829	T	601324 C > T	0.35	0.36	0.55	NA	NA	0.28	0.08	0.35	0...,333,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
560G>A,"...f translation (p.R796X). The second variant, a c.5560G>A in exon 48 is predicted to result in a miss...",46,1595,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
560G>A,... c.2386C>T inherited from the father (I-1) and c.5560G>A from the mother (I-2) (Fig. 2B),46,2485,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
386C>T,"...s does not extend to the region harbouring the c.2386C>T variant, when viewing the exome data for th...",67,258,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,27,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
824C>T,"...of the common progeroid lamin A mutation, LMNA c.1824C>T; p.G608G, to test the hypothesis that neuro...",87,543,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
94A>G,"Heme binding pocket	p.H65R	c.194A>G	22.01	30.30	S	3	PE: 11.5% WT activity, 75% P...",20,31,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
85C>G,p.T262R	c.785C>G	0.14	0.20	B	1,21,13,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
33T>C,"p.I278T	c.833T>C	0.00	0.00	B	146	PE: Vmax 0.8–1.4% of WT, Km ...",26,13,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
46C>T,p.P49L	c.146C>T	35.01	61.90	S	3,27,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
41C>T,p.A114V	c.341C>T	8.94	18.07	S	10	ECE: tetramer + aggregates [...,34,13,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
330G>A,"p.D444N	c.1330G>A	18.73	45.80	S	13	PE: 1.5 × of WTactivity, K...",41,13,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
397C>T,"p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT activity, 0.05 ...",42,13,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
616T>C,Regulatory domain-second CBS domain	p.L539S	c.1616T>C	1.93	5.70	B	2,43,48,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
397C>T,"...c.1265C>T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were prepared using the previousl...",58,291,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
28A>G,...pathogenicity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated ...,8,777,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,... of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UTR) ...,8,790,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,... of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UTR) ...,8,790,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>T,"...35del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et a...",15,188,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins et al., 2011; W...",15,222,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"... MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also signif...",15,1114,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the MLH1 5′UTR. The ...,21,1218,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated canc...,23,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated canc...,23,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...y cancer. Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations....,23,384,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...y cancer. Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations....,23,384,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...dentified three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No ...",48,271,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...dentified three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No ...",48,271,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further se...",48,281,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...gous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further sequence variant...",48,295,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...lterations within the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of th...,53,134,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...ribed in Supp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del varia...",57,1557,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,...g data of various tissues from Proband 32. The c.-93G>A site was used to distinguish between wild-ty...,67,482,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison of the initiati...",69,1032,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...s these initiation sites using the informative c.-7C>T site to distinguish between the wild-type and...,69,1341,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ome occupancy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due t...,72,940,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ription. Our observation that the c.-28A>G and c.-7C>T variants are associated with partial constitu...,74,1107,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e transcriptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, inclu...",74,1760,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cause of cancer ...,78,43,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF of 0.0003, sho...",78,934,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...s absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Therefore, the c.-28A>...",78,1905,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
55A>G,"...esence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands allowed us to dist...",84,57,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...scription factors. Due to the proximity of the c.-28A>G and c.-7C>T variants to transcription initia...,84,1865,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows that these varia...,86,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 varia...",99,37,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
-308 G>A,... Liu L  Gao T   TNF-a Gene Promoter – 238 G>A and -308 G>A Polymorphisms Alter Risk of Psoriasis Vul...,138,74,Indian_J_Dermatol_2015_Jul-Aug_60(4)_345-350.txt
73 C>A,"..., five mutations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screene...",35,207,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
1853 G>A,ATM codon 1853 G>A Asp/Asn rs1801516,95,11,Infect_Agent_Cancer_2013_May_4_8_15.txt
399 G>A,XRCC1 codon 399 G>A Arg/Gln (rs25487),132,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
9419A>C,"...SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one insertion/deletion (A...",43,400,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
367 G>C,...wo SNPs in the promoter region (AAFC02034082.1:g.9367 G>C (P=0.0288) and 9419A>C (P=0.0397)) with BM...,46,122,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"... region (AAFC02034082.1:g.9367 G>C (P=0.0288) and 9419A>C (P=0.0397)) with BMS, and a suggestive ass...",46,145,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
367G>C,"...eir posterior distribution. For AAFC02034082.1:g.9367G>C, only CG and GG genotypes exist in the F2 p...",46,461,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...n these two markers (AAFC02034082.1:g.9367G>C and 9419A>C), which were significantly associated with...",48,100,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
0364A>G,...d was also observed for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling sco...,48,977,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
419A>C,...rved for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling score was 2.40 hig...,48,992,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
419A>C,...rved for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling score was 2.40 hig...,48,992,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
367G>C,...wo SNPs in the promoter region (AAFC02034082.1:g.9367G>C and g.9419A>C) on beef marbling score under...,62,127,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
822C>A,c.− 822C>A (rs2243827)	Non-coding,267,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.-653G>A (rs2333227)	Non-coding,273,4,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
890A>C,g.9890A>C (rs2071409)	Non-coding,282,4,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
149T>C,c.2149T>C (rs2759)	Ile717Val,288,4,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
765T>C,c.− 765T>C (rs2243828)	Non-coding,302,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.− 653G>A (rs2333227)	Non-coding,306,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
234 T>G,"...t 13 families exhibited a BRCA1 exon 3 nucleotide 234 T>G mutation (pCys39Gly), which is not previou...",123,96,Int_J_Circumpolar_Health_2012_Aug_16_71_10_3402_ijch_v71i0_19155.txt
173A>C,"...phisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, and 1...",42,324,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
502T>G,"...onclusion, we demonstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene whic...",58,55,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2482 A > G,"... the A/A and the G/A + G/G genotypes of the AMHR2 2482 A > G polymorphism (rs2002555), nor the C/C a...",3,1948,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
46T > G,...us contribute to fertility [7]. The rs10407022 c.146T > G polymorphism leads to the amino acid subst...,14,804,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
763C>G,...ticleGeneticsGynecology and Female InfertilityThe 763C>G Polymorphism of The Secretory PLA2II,3,220,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...ticleGeneticsGynecology and Female InfertilityThe 763C>G Polymorphism of The Secretory PLA2II,3,220,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...ticleGeneticsGynecology and Female InfertilityThe 763C>G Polymorphism of The Secretory PLA2II,3,220,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...s to investigate the potential association of the 763C>G polymorphism in the secretory phospholipase...,16,100,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...resent study examined the association between the 763C>G sPLA2IIa gene polymorphism in patients with...,152,56,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
980C>G,EYS	chr6:65596602	NM_001142800	Exon19	c.2980C>G	p.P994A	Probably damaging	Het	0.0010	AR	RP2...,77,43,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
85T>A,WFS1	chr4:6302507	NM_001145853	Exon8	c.985T>A	p.F329I	Probably damaging	Het	–	AD/AR	Wolfra...,83,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
-634 G>C,...Q.   Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-c...,297,112,Int_J_Mol_Sci_2012_Nov_13_13(11)_14845-14864.txt
250G > A,"...eceptor (LDL-R) AvaII hepatic lipase gene (LIPC) −250G > A, endothelial lipase gene (LIPG) 584C > T,...",3,2278,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
677C > T,"... > T, methylenetetrahydrofolate reductase (MTHFR) 677C > T, the E3 ubiquitin ligase myosin regulator...",3,2373,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,...me proliferator-activated receptor delta (PPARD) +294T > C (rs2016520) and Scavenger receptor class ...,19,637,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A (rs2070895)	GG	117.1 ± 16.9	74.2 ± 9.3	42...,211,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	1.799	0.737	0.053	2.414	0.016,268,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,DBP	LIPG 584C > T genotype	1.396	0.403	0.077	3.460	0.001,271,10,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	1.734	0.466	0.083	3.718	0.000,272,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	1.734	0.466	0.083	3.718	0.000,272,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	1.734	0.466	0.083	3.718	0.000,272,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,PPARD +294T > C allele	−0.964	0.469	−0.046	−2.054	0.040,273,9,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T genotype	2.167	0.671	0.112	3.232	0.001,294,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	2.414	0.882	0.093	2.736	0.006,302,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
16 G>T,"...icing caused by single nucleotide polymorphism c.516 G>T [Q172H], a marker of CYP2B6*6 , is responsi...",137,163,Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.txt
677C>T,...R.   Methylenetetrahydrofolate Reductase (MTHFR ) 677C>T and Methionine Synthase Reductase (MTRR ) 6...,195,102,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
66A>G,... 677C>T and Methionine Synthase Reductase (MTRR ) 66A>G polymorphisms: association with serum homocy...,195,151,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
689T>C,"...dy-Weinberg equilibrium (HWE). Loci g.1687T>A, g.1689T>C and g.1693A>C in C. carpio apoA-Ib.1 were c...",37,823,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
961G>C,"...pio apoA-Ib.1 were completely linked, and loci g.1961G>C and g.1966G>C in apoA-Ib.1 were linked, as ...",37,903,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
83A>T,...r than GH itself. We speculated that apoA-Ib.2-g.183A>T in the intron of 5’-UTR may be involved in t...,55,1446,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
687T>A,g.1687T>A	Exon3	TT	0.060	T	0.23	0.340	0.356	0.777,244,5,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
728C>T,g.1728C>T	Exon3	CC	0.663	C	0.832	0.337	0.281	0.067,260,5,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
884C>T,g.1884C>T	Exon3	CC	0.837	C	0.908	0.163	0.168	0.577,287,5,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
83 A>T,...GAGCCTTGGTTCTTACTTG	genotyping locus apoA-Ib.2-g.183 A>T,522,89,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
31C > A,...ency. POMC gene sequencing showed a homozygous c.231C > A change which causes a premature terminatio...,35,330,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
235Met >Thr,"...ethionine to threonine substitution at codon 235 (235Met >Thr) in the AGT gene, a mutation associate...",115,340,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
235Met >Thr,"... births [54]. However, the mechanism by which the 235Met >Thr mutation affects maternal-placental an...",115,693,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
72G>A,...mours. She was found to carry a known mutation c.572G>A (p.Cys191Tyr) in the SDHB gene. This case il...,5,1173,Int_J_Pediatr_Endocrinol_2013_Oct_3_2013(Suppl_1)_P112.txt
75G>T,... finding of a heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. She and her mother n...,9,139,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
8C>T,... II Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk of ...,74,56,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
8C>T,GPIIIa c.98C>T,94,11,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
467G>A,... designating the variation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R1...,19,410,Ital_J_Pediatr_2013_Feb_14_39_12.txt
606 A>G,"...s before; 7 (5%) of the mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.1...",51,263,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
606 A>G,"...s before; 7 (5%) of the mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.1...",51,263,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
090 T>C,"...(5%) of the mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.13104 A>G, an...",51,275,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
4612 G>A,"... (1%), m. 12769 G>A with a frequency of 2% and m.14612 G>A with a frequency of 4%, were novel and ar...",51,620,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
147 G>A,"...rval, 0.16 to 0.94; P = 0.036). The mutations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, d...",51,1704,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
257 G>A,"...0.036). The mutations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, described subhaplogroup L...",51,1728,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
257 G>A,"...0.036). The mutations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, described subhaplogroup L...",51,1728,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
460 A>G,"...tions, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, described subhaplogroup L0a2",51,1744,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
757A>C,"...however, a novel de novo heterozygous missense c.1757A>C mutation in the desmoplakin gene (DSP) was ...",13,89,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
757A>C,"...however, a novel de novo heterozygous missense c.1757A>C mutation in the desmoplakin gene (DSP) was ...",13,89,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
757A>C,...with the exception of the novel point mutation c.1757A>C in DSP (encoding desmoplakin) predicting th...,52,728,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
681G>A,Cytochrome P450 2C19 681G>A polymorphism and high on‐clopidogrel platel...,115,22,J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.txt
300T >G,...as 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer c...,3,2202,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...es, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general populati...",3,2577,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
1G > A,...G/A transition in intron 6 at position +1 c.357 + 1G >,73,1156,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
2518 A>G,...nificant difference in the distribution of MCP-1 −2518 A>G polymorphic variants in patients with SLE...,7,198,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...ficant difference in the prevalence of the MCP-1 –2518 A>G polymorphic variant in patients with SLE ...,32,216,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,3.2. Association of MCP-1 –2518 A>G Genotypes with Clinical Symptoms of SL,34,28,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"To date, the MCP-1 –2518 A>G polymorphism has been associated with cor...",40,21,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
9909601 G>A,"...ster City, CA, USA). The primers and probes for rs9909601 G>A were listed as follows: Primer: sense,...",28,351,J_Biomed_Res_2013_May_25_27(3)_215-219.txt
18C>T,"...iants. Two novel missense LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were...",51,728,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
30C>A,...d a novel heterozygous nonsense SOST mutation (c.530C>A; p.Ser177X) predicted to prematurely truncat...,51,1316,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
93A>G,"... previously reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.2...",81,166,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	64	F	+5.9	+8.1	N	Y	Y,122,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
18C>T,...steoarthritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a ma...,357,163,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
18C>T,...steoarthritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a ma...,357,163,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
24G>T,...of exon 25 but not in the splice junction (c.3364‐24G>T). The common SNP rs2306033 (MAF 25% in 1000 ...,383,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
677 C-->T,...  Refsum H    Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk...,152,108,J_Cardiovasc_Dis_Res_2011_Jul-Sep_2(3)_156-163.txt
372C>T,...entified four deleterious mutations in exon 6 (c.1372C>,286,64,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
79+1G>A,...notype was associated with the splice mutation c.879+1G>A. Primary adrenocortical insufficiency and ...,15,741,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
79+1G>A,"... 45% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplemental Table 2). We th...",133,289,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
4590T>C,...alysis revealed a novel heterozygous mutation [c.14590T>C (p.Tyr4864His)] in exon 101 (Fig. 1B). Thi...,26,427,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
4678G>A,...s for RYR1 revealed the heterozygous mutation [c.14678G>A (p.Arg4893Gln)] in exon 102 (Fig. 1B). Thi...,33,153,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
4678G>A,"...k, which is larger than the aberrant 'A' peak (c.14678G>A)",53,376,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
03A>G,"140	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
46G>A,"148	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
46G>A,"...s	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
34G>T,"...s	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
71G>T,"...	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,72,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
78A>C,"...s	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
5G>C,"197	73	OC	Serous	IIIC	G3	NA	KRAS p.G12A, c.35G>C (1)",53,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
36A>G,"...s	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
82A>G,"... mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
8G>A,"...dometrioid, partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
5G>A,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,48,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
44C>T,"...ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,99,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
44C>T,"...ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,99,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
139C>T,"...G2	PIK3CA p.H1047Y, c.3139C>T	PIK3CA p.H1047Y, c.3139C>T (1)",66,67,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
405C>T,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
405C>T,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
45T>A,"202	63	EC	EC	IA	G1	NA	PTEN p.Y315*, c.945T>A (1)",68,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
4G>T,"...7	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
5G>T,"..., polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,81,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
27G>A,"150	51	OC	Serous	IIIC	G3	TP53 p.C176Y, c.527G>A	—",81,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
27G>A,"150	51	OC	Serous	IIIC	G3	TP53 p.C176Y, c.527G>A	—",81,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
024C>T,"174	69	OC	Serous	IV	G3	TP53 p.R342*, c.1024C>T	—",85,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
10C>T,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,44,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
681G>A,"..., Ltd, Osaka, Japan). Detection of the CYP2C19*2 (681G>A, rs4244285) and *3 (636G>A, rs4986893) alle...",37,245,J_Clin_Pharmacol_2016_Apr_8_56(4)_408-413.txt
934C>T,"...51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
745G>C,"...48/M	Insulin-dependent DM	DM, pigmentation	745G>C/745G>C in HJV	HJV-HH",52,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1100T>G,"...nsulin-dependent DM	DM, pigmentation,hypogonadism	1100T>G/2008-2009delAC in TRF2, No mutation in ATP...",54,59,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1100T>G,"...nsulin-dependent DM	DM, pigmentation,hypogonadism	1100T>G/2008-2009delAC in TRF2, No mutation in ATP...",54,59,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
714C>G,...e	Glucose-intolerance	187C>G (H63D)/wt in HFE and 714C>G/wt in TFR2	Intravenousiron load,58,82,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
11391G>A,"...41766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the adiponec...",9,119,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the adiponectin (Ad) gene with adipon...",9,144,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,"...Ps were genotyped rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−100...",43,58,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) of the ADIPOQ gene",43,105,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
677C>T,"Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate re...",169,42,J_Epidemiol_2008_May_29_18(3)_125-131.txt
677C-->T,Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate in...,204,51,J_Epidemiol_2008_May_29_18(3)_125-131.txt
5557G > A,"...is to evaluate the association between ATM exon39 5557G > A (D1853N, rs1801516) polymorphism and bre...",4,330,J_Exp_Clin_Cancer_Res_2010_Aug_27_29(1)_117.txt
-2841A>T,"...ily 2 (facilitated glucose transporter), member 1 -2841A>T, hypoxia-inducible factor 1 alpha Pro582S...",7,109,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,...se findings suggest a potential role of the VEGFA 936C>T polymorphism for the variability of FDG upt...,20,621,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
744C>T,"...HIF1A Pro582Ser (C>T, rs11549465) [NM_001530.2:c.1744C>T], and HIF1A Ala588Thr (G>A, rs11549467) [NM...",31,402,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,SLC2A1 -2841A>T	AA (n = 41)	9.40 ± 2.63	0.155	AA	9.40 ± 2...,118,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,VEGFA +936C>T	CC (n = 54)	9.29 ± 2.66	0.816	CC	9.29 ± 2.6...,121,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,... the mean SUVmax in the recessive model of SLC2A1 -2841A>T in combination with the APEX1 polymorphis...,134,261,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,... the mean SUVmax in the recessive model of SLC2A1 -2841A>T in combination with the APEX1 polymorphis...,134,261,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,Table 5 Association between the SLC2A1 -2841A>T gene polymorphism and the mean SUVmax in ...,136,40,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,...m on FDG-uptake. An association between the VEGFA+936C>T polymorphism and FDG-uptake has been rarely...,169,364,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
405G>C,".... Well-documented functional SNPs, such as VEGFA +405G>C and -460T>C, should be evaluated to identif...",169,1227,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,... Renner W Samonigg H Yazdani-Biuki B Krippl P The 936C>T polymorphism of the gene for vascular endot...,194,95,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
05 C>T,C3	Ex2/c.205 C>T	p.=	T	C	C	C	C	T	C,35,11,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
369 T>C,C3	Ex12/c.1369 T>C	p.=	C	T	T	T	C	C	C,39,12,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
369 T>C,C3	Ex12/c.1369 T>C	p.=	C	T	T	T	C	C	C,39,12,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
929 G>A,C3	Ex23/c.2929 G>A	p.=	A	G	G	G	G	A	G,40,12,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
30 T>C,Gpr108	Ex8/c.930 T>C	p.=	C	T	T	T	T	C	T,43,15,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
397 G>A,Gpr108	Ex13/c.1397 G>A	p.=	A	G	G	G	G	A	G,45,16,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
520 G>A,Gpr108	Ex15/c.1520 G>A	p.=	A	G	G	G	G	A	G,46,16,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
646T>C,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably),32,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
646T>C,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably),32,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
546T>C,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
966G>T,BRCA2	c.9966G>T	p.M3322I	36	Tolerated	Damaging (probably),34,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
007A>T,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
6C>G,DDB1	c.26C>G	p.A9G	86	Damaging	Damaging (possibly),37,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
007A>T,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	Dama...,68,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
756T>C,c.2756T>C	p.I919T	Sanger	Novel	ND	Chinese	0	Damaging	...,89,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
789A>G,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003...,90,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
789A>G,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003...,90,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
037C>A,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0.00...,91,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
360G>A,c.3360G>A	p.M1120I	454 amplicon	Novel	ND	Swedish	0	To...,98,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
221G>T,c.2221G>T	p.V741I	454 amplicon	rs28756990	ND	Swedish	...,103,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
837C>T,c.2837C>T	p.S946F	Selector	rs201441389	Germline	Chine...,104,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
522A>G,c.1522A>G	p.I508V	454 amplicon	rs2287558	ND	Swedish	0...,109,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1791+2T>G,"...ith complete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C...",96,247,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
05G>C,"...mutations, such as the most frequent mutation, c.305G>C, are closely associated with CAMT II. This i...",45,259,J_Hematol_Oncol_2013_Jan_25_6_11.txt
05G>C,"...mutations, such as the most frequent mutation, c.305G>C, are closely associated with CAMT II. This i...",45,259,J_Hematol_Oncol_2013_Jan_25_6_11.txt
515W>L,... F Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia Blo...,137,160,J_Hematol_Oncol_2013_Jan_25_6_11.txt
1106T>C,"...g all identified/validated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C...",3,1717,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,"...tified/validated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>...",3,1727,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a k...",3,1754,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...ion of the four polymorphisms, −809G>A, −616G>C, −291C>T and the 12-bp repeat, conferred a susceptib...",3,2226,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,...lele of the single nucleotide polymorphism (SNP) −521T>C and a 120-bp tandem duplication (1.2 kb ups...,13,270,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
873G>A,"...otal of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521...",41,123,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...leven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376...",41,132,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521 T>C,−521 T>C	rs1800955	626784			T/T	T/C	C/C,63,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376 C>T,−376 C>T	rs916455	626929			T/T	T/C	C/C,66,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376 C>T,−376 C>T	rs916455	626929			T/T	T/C	C/C,66,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,...1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−12-bp)] segments of the upstream regio...,82,128,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...ltaneously. A combination of four polymorphisms (−809G>A, −616G>C, −219C>T and 12-bp repeat) appeare...",82,580,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,...discrete distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (12...,83,508,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,−616G>C	0.247 	0.125 	3.872 	0.049 	1.280 	1.00–1.6...,89,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,...s testing failed to replicate the association of −809G>A in a sample set of 80 complete schizophreni...,99,1529,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521C>T,... Shu BC (2006) Dopamine D4 receptor gene and the −521C>T polymorphism of the upstream region of the ...,124,285,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
42C>T,... heterozygous for haplotype A. b) The mutation c.742C>T in the HOXD13 gene generates a restriction s...,75,250,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
42C>T,... heterozygous for haplotype A. b) The mutation c.742C>T in the HOXD13 gene generates a restriction s...,75,250,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
001+1G>A,"....416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,516,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
001+1G>A,"....416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,516,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
19-2A>G,"...t mutations in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent in the Japanese...",56,321,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
367C>T,"c. 367C>T	p. P123S	4	 	1	 	0.50	Tsukamoto et al.2, 4",84,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,c. 600+1G>T	 	Intron 5	 	1	 	0.50	This study,87,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
601-1G>A,"c. 601-1G>A	 	Intron 5	 	1	 	0.50	Tsukamoto et al.2, ...",88,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
890C>A,c. 890C>A	p. P297Q	7	 	1	 	0.50	This study,89,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1115C>T,"c. 1115C>T	p. A372V	9	 	1	 	0.50	Usami et al.2, 3",95,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1229C>T,c. 1229C>T	p. T410M	10	1	1	 	1.50	Coyle et al.22,99,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1300G>A,c. 1300G>A	p. A434T	11	 	 	1	0.50	This study,100,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1315G>A,"c. 1315G>A	p. G439R	11	 	1	 	0.50	Suzuki et al.5, 6",101,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1315G>A,"c. 1315G>A	p. G439R	11	 	1	 	0.50	Suzuki et al.5, 6",101,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1829C>A,"c. 1829C>A	p. S610X	17	 	1	 	0.50	Tsukamoto et al.2, ...",110,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1829C>A,"c. 1829C>A	p. S610X	17	 	1	 	0.50	Tsukamoto et al.2, ...",110,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168C>T,c. 2168C>T	p. H723Y	19	1	 	 	1.00	This study,117,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
601-1G>A,3994	59	p. [601-1G>A][H723R]	10	+	+	+	+	+	96.0	94	91.3,157,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,4098	26	p. [N392Y][919-2A>G]	2	−	+	+	+	−	110	37.5	71.3,162,20,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,4518	26	p. [H723R][919-2A>G]	0	+	+	+	+	−	105	97.5	98.1,180,20,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,3309	5	p. [919-2A>G][P76S]	0	+	+	+	+	−	106.25	106.25	101.3,217,12,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,SNS5500	42	p. [919-2A>G][919-2A>G]	4	+	+	+	+	+	70	81.3	64,221,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,SNS5500	42	p. [919-2A>G][919-2A>G]	4	+	+	+	+	+	70	81.3	64,221,26,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
218-2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,13,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
0519G > G,"g.20519G > G, p.180 Arg > Arg",31,4,J_Hum_Reprod_Sci_2009_Jan-Jun_2(1)_35-40.txt
579 C>A,I.45	49	M	157	7	6	Yes	No	 	Yes	No	Yes	 	c.[579 C>A];[=,208,44,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.59	25	M	Na	Na 	Na	No	No	 	No	No	No	 	c.[310 T>C];[542 C>A,210,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
215 G>A,...	M	208	0	33	No	No	 	No	No	No	NHL	c.[204_205insA];[215 G>A,212,58,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,...	No	No	 	Yes	Yes	No	Ovaric Theratoma	c.[310 T>C];[310 T>C,214,70,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
260 T>A,I.78	19	M	983	18	169	No	Yes	 	No	No	No	 	c.[260 T>A];[=,218,45,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
09G>T,P3	+	c.109G>T/c504_5delCT	20.12a	Menao et al. 2009,37,9,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
993T>G,m.8993T>G This mutation leads to NARP (typically <90-...,95,4,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
993T>G,m.8993T>G This mutation leads to NARP (typically <90-...,95,4,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
993T>G,"...posite to the positive charged arginine in the m.8993T>G mutation, proline is a non-charged amino ac...",97,275,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
176T>G,m.9176T>G/C The clinical picture is characterized by ...,99,4,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
176T>G,"... before). Taken together, the pathogenicity of m.9176T>G may not be limited to a bio-energetic defic...",99,1185,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
035T>C,"m.9035T>C, m.9185T>C, m.9191T>C, m.8851T>C These muta...",101,4,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
035T>C,"m.9035T>C, m.9185T>C, m.9191T>C, m.8851T>C These muta...",101,4,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
185T>C,...e oxygen species (ROS) (Sikorska et al. 2009). m.9185T>C (p.Leu220Pro) results in a phenotype varyin...,101,474,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
528T>C,"... together, the MT-ATP8 mutations m.8529G>A and m.8528T>C both affect the same amino acid (tryptophan...",110,808,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
993T>G,...efore been tested in fibroblasts harboring 97% m.8993T>G mutant mtDNA. It has been shown that they s...,127,234,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
993T>G,...efore been tested in fibroblasts harboring 97% m.8993T>G mutant mtDNA. It has been shown that they s...,127,234,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
993T>G,...ical defect in cybrid cell lines harboring the m.8993T>G mutation has been corrected successfully us...,137,489,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
993T>G,"... mtDNA (DiMauro et al. 2006). For example, the m.8993T>G mutation creates a unique cleavage site for...",141,144,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
052T>C,...fication of ataxia-associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their path...,289,88,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
156C>T,"... to date are reported to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and ...",164,728,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
516G>T,"... (SNPs) CYP3A5*6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained ...",9,644,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
751-2A>G,"...) and a maternal acceptor splice site mutation g.6751-2A>G (IVS85-2A>G). Therefore, one truncated (p...",18,328,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
751-2A>G,... of the COL7A1 region surrounding the maternal g.6751-2A>G mutation located in intron 85 indicated s...,18,710,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
699C>T,"...eptor/donor site mutations. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5...",4,1043,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
699C>T,"...eptor/donor site mutations. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5...",4,1043,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
4G>T,"... 15 unrelated Korean patients (60%). Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and ...",34,131,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
174-1G>A,"... Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations ide...",34,167,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
174-1G>A,"... Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations ide...",34,167,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
768+5G>A,"...22. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>...",36,374,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
965+1G>A,"...A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/...",36,405,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
19+1G>A,"...), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/donor sites; ...",36,418,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
4G> T,"...nserved in ECE-1 and the KELL antigen (8). The c.64G> T mutation, a new mutation detected in this st...",43,411,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
4G>T,"...equencing results demonstrate novel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C...",57,66,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
4G>T,"...equencing results demonstrate novel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C...",57,66,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
443T>G,...eterogenetic mutant allele in the NOTCH2 gene (c.6443T>G) (Fig. 6) leading to an amino acid substitu...,11,2520,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
443T>G,"...of DNA sequencing. DNA sequencing covering the c.6443T>G mutation of (A) the patient, (B) his mother...",32,67,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
2368392 C>T,...genotype (11.5%). The minor allele frequency of rs2368392 C>T was 0.326 and its heterozygosity was 0...,42,532,J_Korean_Med_Sci_2014_Nov_4_29(11)_1523-1527.txt
2368392 C>T,...genotype (11.5%). The minor allele frequency of rs2368392 C>T was 0.326 and its heterozygosity was 0...,42,532,J_Korean_Med_Sci_2014_Nov_4_29(11)_1523-1527.txt
2368392 C>T,"... 1.19 odds of persistent HBV infection, and the rs2368392 C>T was found to be marginally associated ...",47,193,J_Korean_Med_Sci_2014_Nov_4_29(11)_1523-1527.txt
8748C>T,"... the relationship between the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms and the risk of...",7,96,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ction fragment length polymorphism analysis of g.-8748C>T, g.-9101C>T and Taqman analysis of g.72C>T...",7,234,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
2C>T,"...l individuals. The g.-9101C>T, g.-8748C>T, and g.72C>T SNPs in CTTN and their haplotypes were analyz...",7,408,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
2C>T,"...lunteers. The CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms were analyzed in the 2 groups r...",27,277,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...e patient and control groups and the CTTN gene g.-9101C>T, g.-8748C>T polymorphisms were analyzed us...",30,123,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...e patient and control groups and the CTTN gene g.-9101C>T, g.-8748C>T polymorphisms were analyzed us...",30,123,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
-9101C>T,...s were partially amplified using a primer set for -9101C>T and -8748C>T (CTTN-PF1; TCCCAGGTGAGTACCCA...,33,136,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
-8748C>T,...lly amplified using a primer set for -9101C>T and -8748C>T (CTTN-PF1; TCCCAGGTGAGTACCCATGTGGT and CT...,33,149,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
-9101C>T,... 10-minute extension at 72℃. The PCR products for -9101C>T and -8748C>T were digested with 2 U of Ec...,33,533,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
-9101C>T,...triction enzyme digestion of the PCR products for -9101C>T (630 bp) and -8748C>T (630 bp) yielded 2 ...,33,808,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
2C>T,The assay reagents for the g.72C>T (rs2298397) polymorphism in the CTTN gene wer...,36,31,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
2C>T,"...requencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the patient group and ...",43,632,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...r, the genotype and allele frequencies of CTTN g.-9101C>T were significantly higher in the lymph nod...",46,199,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-T. The haplotype did not diff...",49,61,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The haplotype frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",52,38,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...n, the genotype and allele frequencies of CTTN g.-9101C>T were significantly higher in lymph node-po...",69,63,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,... reaction products for g.-9101C>T (630 bp) and g.-8748C>T (630 bp) yielded 2 fragments of 490 bp and...,73,175,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
48-30T>C,"...nymous mutation (A155A) and one intronic variant (48-30T>C), which were not present in 220 control a...",93,636,J_Med_Case_Rep_2013_Mar_18_7_78.txt
12+1 G>A,"...mutations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one missense (c.1978A>G [K508R]) and tw...",46,765,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
755 G>C,...nd deletions were confirmed by subcloning. The c.1755 G>C and c.1755 G>A affect the last coding nucl...,46,1032,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
844C>G,"294		12	c.1844C>G	Y463X	Nonsense	1	0	PFF, AF	0	0	0",98,12,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
9+2 T>G,"...our in intron 4 (IVS4-2 A>G), one in intron 9 (IVS9+2 T>G) and one in intron 12 (IVS12+1 G>A) (table...",110,1009,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
12+1 G>A,...in intron 9 (IVS9+2 T>G) and one in intron 12 (IVS12+1 G>A) (table 1). The most 5′ mutation (c.514de...,110,1043,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
6-1 G>A,c.IVS 6-1 G>A,161,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
207C>T,"...five pathogenic variants (MYH7 c.1436A>C, MYH7 c.1207C>T, MYBPC3 c.2373_2374dup, MYBPC3 c.676_701dup...",103,445,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
093-24C>T,...nts were variants at the same position (MYBPC3 c.1093-24C>T) and were not in the HCDiff list due to ...,103,1263,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
55665408 A>G,Patient 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probab...,119,24,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
454C>T,Patient 3	M	44	?	EMD	153609246 C>T	NM_000117.2	454C>T	p.Arg152Cys	Benign	Benign	180	0.00	C55	Not ...,122,48,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
4628T>C,...atient 7†	F	22	51	SCN5A	38595955  T>C	NM_198056.2	4628T>C	p.Val1543Ala	Benign	Benign	64	0.00	C65	Not...,126,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
4628T>C,...atient 7†	F	22	51	SCN5A	38595955  T>C	NM_198056.2	4628T>C	p.Val1543Ala	Benign	Benign	64	0.00	C65	Not...,126,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
119581776 G>A,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Proba...,130,14,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
775A>G,...tient 20	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0....,160,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
967T>C,...: NM_000257.2 c.1231G>A and MYH7: NM_000257.2: c.2967T>C). Re-examination of these two variants by S...,181,605,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
53C>T,"39, PRKAG2: NM_016203.3: c.253C>T, TCAP: NM_003673.2: c.37_39del,4",184,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
35A>C,DES: NM_001927.3: c.935A>C (table 4). Ten patients had a single variant...,189,22,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
38622493 G>A,Patient 29	M	24	17	?	SCN5A	38622493 G>A	NM_198056.2	3157G>A	Glu1053Lys	Probab...,194,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23898517 C>T,MYH7	23898517 C>T	NM_000257.2	1178C>T	Ala393Val	Possibl...,195,11,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
37G>A,...ient 31†	M	65	11	No	MYL2	111356964G>A	NM_000432.3	37G>A	Ala13Thr	Possibly damaging	Benign	58	0.08	C0...,197,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
253C>T,...atient 32	M	?	?	?	PRKAG2	151478451C>T	NM_016203.3	253C>T	Pro85Ser	Possibly damaging	Benign	74	0.12	C...,198,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
156108384G>A,Patient 48	F	56	15	Yes	LMNA	156108384G>A	NM_170707.2	1804G>A	Gly602Ser	Benign	...,214,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47355294 C>T,MYBPC3	47355294 C>T	NM_000256.3	3004C>T	Arg1002Trp	Probab...,215,13,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47355294 C>T,MYBPC3	47355294 C>T	NM_000256.3	3004C>T	Arg1002Trp	Probab...,215,13,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,MYBPC3	47355294 C>T	NM_000256.3	3004C>T	Arg1002Trp	Probably damaging	Probably dama...,215,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23902821G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Pos...,222,11,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Possibly damaging	23	0.13	C...,222,35,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Possibly damaging	23	0.13	C...,222,35,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
093-24C>T,"... particular variants (eg, MYBPC3: NM_000256.3: c.1093-24C>T). A balanced representation of all targe...",255,811,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
182A>G,"...Hypoplastic, hypomineralised	WDR72	NM_182758.3	c.[182A>G];[815G>A]	p.[H61R];[W272*]	Compound heteroz...",97,65,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
815G>A,"...ic, hypomineralised	WDR72	NM_182758.3	c.[182A>G];[815G>A]	p.[H61R];[W272*]	Compound heterozygous	Nov...",97,74,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
383G>A,"... 31, 34, 35, 38, 44, 45, 48	WNT10A	NM_025216.2	c.[383G>A];[=]	p.[R128Q];[=]	Maternal	77	S15",114,107,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[321C>A];[321C>A]	p.[C107*];[C107*]	Homozygous	78	S17",116,152,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
637G>A,"... 22, 23, 24, 28, 31, 41, 45	WNT10A	NM_025216.2	c.[637G>A];[=]	p.[G213S];[=]	?	79	S21",120,79,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[321C>A]	p.[F228I];[C107*]	Compound hetero...",121,135,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 32, 37, 38, 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A ](;)[321C>A]	p.[F228I](;)[C107*]	?	78	S23",122,87,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",124,119,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S25",124,128,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S25",124,128,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A, V2.54	F	49	?	ED	WNT10A	NM_025216.2	c.[682T>A];[c.416C>T]	p.[F228I];[p.A139V]	Compound he...,130,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A, V2.54	F	49	?	ED	WNT10A	NM_025216.2	c.[682T>A];[c.416C>T]	p.[F228I];[p.A139V]	Compound he...,130,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
52G>T, V2.55	F	12	AD	DGI	DSPP	NM_014208.3	c.[52G>T];[=]	p.[V18F];[=]	Maternal	80	S34,136,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
590-3C>A,"...lised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal a...",155,78,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
590-3C>A,"...lised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal a...",155,78,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1903C>T," V2.86	F	6	?	AI hypoplastic	LAMB3	NM_000228.2	c.[1903C>T];[=]	p.[R635*];[=]	Maternal, asymptomatic	...",156,50,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
141+1G>A,...s unaffected at the time of ascertainment. The c.1141+1G>A mutation is predicted to cause either in-...,166,782,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
17G>T,4	c.817G>T (p.Val273Phe)	Pathogeni,104,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
64G>A,5	c.764G>A (p.Cys255Tyr)	Pathogeni,106,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
43G>A,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
76T>C,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,7,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
76T>C,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,7,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
1746T>C,14	c.-1746T>C	associatio,124,7,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
291T>C,...Pyromark Q24 software was used to quantify the m.3291T>C heteroplasmy levels by directly comparing t...,32,246,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
344A>G,...ipomas have been associated primarily with the m.8344A>G mutation in mt-tRNALy,49,365,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
344A>G,"...d in a number of cases, including most notably m.8344A>G [20], pathogenicity is not dependent upon t...",56,70,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
291T>C,"...r, genetic and functional investigation of the m.3291T>C mutation. The identified m.3291T>C mutation...",72,66,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...ng Y.  Leng J.H.   Is mitochondrial tRNALeu(UUR)  3291T>C mutation pathogenic? Mitochondrial DNA 23 ...,82,55,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
72+1G>T,"...matic mutation database, with the exception of c.672+1G>T, c.783‐1G>A and R333C. There is no apparen...",161,200,J_Pathol_Clin_Res_2015_Mar_30_1(3)_125-133.txt
1075A>C,"...sted SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites...",7,365,J_Stroke_2013_May_31_15(2)_115-121.txt
861C>A,"...s1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 58...",7,425,J_Stroke_2013_May_31_15(2)_115-121.txt
5496G>T,"...s: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs...",7,464,J_Stroke_2013_May_31_15(2)_115-121.txt
5496G>T,"...s: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs...",7,464,J_Stroke_2013_May_31_15(2)_115-121.txt
8814T>C,"...9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using ...",7,564,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"... 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using a standar...",7,573,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...VRORC1 (P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>...",10,374,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...VRORC1 (P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>...",10,374,J_Stroke_2013_May_31_15(2)_115-121.txt
7566C>T,"...y interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based on these data, a w...",10,409,J_Stroke_2013_May_31_15(2)_115-121.txt
430C>T,"...oups. We selected 26 SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C)...",36,310,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C), VKORC1 (14 sites; ...",36,330,J_Stroke_2013_May_31_15(2)_115-121.txt
3673A>G,"... (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 64...",36,418,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>T,"...808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9...",36,487,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>T,"...808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9...",36,487,J_Stroke_2013_May_31_15(2)_115-121.txt
7566T>C,"...09C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9...",36,509,J_Stroke_2013_May_31_15(2)_115-121.txt
7566T>C,"...09C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9...",36,509,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), ...",36,518,J_Stroke_2013_May_31_15(2)_115-121.txt
9071G>T,"... 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), gamma-glutamyl carboxylase (GGCX, nine s...",36,558,J_Stroke_2013_May_31_15(2)_115-121.txt
412G>A,"...sites; eight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C>...",36,657,J_Stroke_2013_May_31_15(2)_115-121.txt
6258A>G,"...ight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 1387...",36,665,J_Stroke_2013_May_31_15(2)_115-121.txt
3673G>A,"...ference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]...",50,166,J_Stroke_2013_May_31_15(2)_115-121.txt
1076T>C,...e could not find significant influence of CYP2C9 (1076T>C or 430C>T) on warfarin dose although this ...,59,483,J_Stroke_2013_May_31_15(2)_115-121.txt
75C>T,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,5,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,c.3134‐5T>C	0.87	0.23	0.62	53	2	0	2,184,9,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,5,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
86+2T>C,"... showed a compound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complete C...",246,99,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
86+2T>G,"...mpound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complete CD46 deficien...",246,111,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
538C > T,"...ding 35delG, 176-191del16, 235delC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS...",7,444,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...5A > G and 1494C > T for mtDNA 12S rRNA gene, and 2168A > G (H723R) and IVS7-2A > G for SLC26A4 gene...",18,1232,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...delAT), GJB3 (538C > T), SLC26A4 (IVS7-2A > G and 2168A > G), and mitochondrial 12S rRNA (1555A > G ...",27,657,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,1494C > T (12S rRNA)	1503G > A	1,44,1,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/-	0	7	0	0,75,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/IVS7-2A > G	2	7	0	0,76,16,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,2168A > G/-	1	3	1	0,77,1,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G	0	1	0	0,85,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G	0	1	0	0,85,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/538C > T	0	1	0	0,86,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/538C > T	0	1	0	0,86,4,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,...ported gene mutation. The mutation frequencies of 538C > T for GJB3 were 0.0% (0/199) in Uyghur pati...,96,275,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...A are common mutant loci of SLC26A4 [21], whereas 2168A > G is the primary mutant locus in Japanese ...",106,364,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,"...y, the two locus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequentl...",106,622,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...cus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequently found in Uy...",106,635,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,... DY Zhang X Xue DD Jin ZC Frequency of SLC26A4 IVS7-2A > G mutation in patients with severe to profo...,155,107,J_Transl_Med_2011_Sep_14_9_154.txt
17058639 C>T,...P polymorphisms. Table S3. Association of SLMAP rs17058639 C>T genotypes with clinical phenotypes (o...,366,185,J_Transl_Med_2015_Feb_15_13_61.txt
17058639 C>T,...ANOVA analysis). Table S4. Association of SLMAP rs17058639 C>T genotypes with progression of diabeti...,366,292,J_Transl_Med_2015_Feb_15_13_61.txt
979C>T,"...The structure of TMC1A depicts the position of c.1979C>T, a mutation in exon 20 and p.P660L in TM2 d...",66,903,J_Transl_Med_2016_Jan_28_14_29.txt
29467A>G,...n the 3′ untranslated region as follows: PDE5A:g.129467A>G; g.129281T>C; g.129858C>A; g.130270T>C; g...,104,121,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
29858C>A,...on as follows: PDE5A:g.129467A>G; g.129281T>C; g.129858C>A; g.130270T>C; g.130311G>C; g.130515A>C. A...,104,147,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
421C > A,"...f MDR1 1236C > T (assay ID: C__7586662_10), ABCG2 421C > A (assay ID: C__15854163_70) and ABCC2 1249...",33,682,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
248C>G,"...ee minor alleles at g.-1145A>G, g.-538C>G, and g.-248C>G, and contains a reference sequence accordin...",37,564,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...8C>G. However, H1 and H3 also had the variants g.-1745A>G and g.-1875T>A, respectively, which showed...",40,1704,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...8C>G. However, H1 and H3 also had the variants g.-1745A>G and g.-1875T>A, respectively, which showed...",40,1704,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,".... The results predicted that only one variant, g.-1875T>A, might affect the binding affinity of the ...",43,417,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
256C>G,"...CTN1 promoter, and only two of these variants, g.-256C>G and g.-248C>G, were found in Chinese indivi...",51,512,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
256C>G,"...CTN1 promoter, and only two of these variants, g.-256C>G and g.-248C>G, were found in Chinese indivi...",51,512,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"..., g.-538C>G, and g.-248C>G. Of these variants, g.-1145A>G and g.-248C>G showed significantly decreas...",53,252,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...TN1 regulate promoter activity was determined: g.-1875T>A, a variant present in H3, was associated w...",61,316,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...lity shift analysis of the OCTN1 reference and g.-1875T>A variant sequences. (a) Labeled oligonucleo...,87,78,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",453,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
80G->A,...ister M Rosenblatt DS Nicolas JP  A Polymorphism (80G->A) in the Reduced Folate Carrier Gene and Its...,464,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",475,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
3238C>G,...6ResearchInteractions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on se...,3,163,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...rtaken to detect the interactions of the ApoC-III 3238C>G (rs5128) polymorphism and alcohol consumpt...,4,281,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...mized cluster samples. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,7,173,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...at 4°C until analysis. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,31,180,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...ed t test. The allele frequencies of the ApoC-III 3238C>G were determined by gene counting. A chi-sq...,40,392,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...ed t test. The allele frequencies of the ApoC-III 3238C>G were determined by gene counting. A chi-sq...,40,392,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...A part of the nucleotide sequence of the ApoC-III 3238C>G. (A) CC genotype; (B) CG genotype; (C) GG ...,85,60,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.874	16.157	0.000	1.380-2.545,179,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,The interactions of the ApoC-III 3238C>G polymorphism and alcohol consumption on se...,200,34,Lipids_Health_Dis_2010_Aug_17_9_86.txt
-455T>C,...elly PW Huff MW Hegele RA Association between the -455T>C promoter polymorphism of the APOC3 gene an...,258,141,Lipids_Health_Dis_2010_Aug_17_9_86.txt
-455T>C,...elly PW Huff MW Hegele RA Association between the -455T>C promoter polymorphism of the APOC3 gene an...,258,141,Lipids_Health_Dis_2010_Aug_17_9_86.txt
214C>A,"...ibed within this gene. One missense polymorphism, 214C>A at codon 72 with Met replacing Leu, is outs...",27,320,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,"...ibed within this gene. One missense polymorphism, 214C>A at codon 72 with Met replacing Leu, is outs...",27,320,Lipids_Health_Dis_2014_Aug_5_13_124.txt
202 G>A,"A− (202 G>A, 376 A>G)	GTGGCTGTTCCGGGATGGCCTTCTG AGGGCA...",78,5,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A− (202 G>A, 376 A>G)	GTGGCTGTTCCGGGATGGCCTTCTG AGGGCAACGGCAAGC...",78,14,Malar_J_2015_Aug_7_14_308.txt
376 A>G,A+ (376 A>G)	CTGCGTTTTCTCCGCCAATC AGGGCAACGGCAAGCCTTAC...,79,5,Malar_J_2015_Aug_7_14_308.txt
14T>G,...Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of decti...,104,138,Mamm_Genome_2011_Feb_11_22(1-2)_55-65.txt
1486T>C,"...har L    Association of TLR4 (D299G, T399I), TLR9–1486T>C, TIRAP S180L and TNF-alpha promoter (–1031...",220,85,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
896A>G,47 Chen S   Association between the TLR4 +896A>G (Asp299Gly) polymorphism and asthma: a syst...,222,43,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
1501299 G>T,"...iponectin gene (including ADIPOQ rs2241766 T>G, rs1501299 G>T, and rs266729 C>G SNPs) are correlated...",37,470,Med_Sci_Monit_2016_Sep_26_22_3419-3425.txt
786T>C,...A −2.5 kb (CCTTT)n as well as Ser608Leu and NOS3 −786T>C variants and their correlation with nitrite...,25,718,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...s/nitrates. Here, we first demonstrate that NOS3 −786T>C variant affects nitrite/nitrate levels in I...",25,1523,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...nts NOS2 −2.5 kb (CCTTT)n and Ser608Leu and NOS3 −786T>C in IEI patients,142,344,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...rphic variants NOS2A C2087T (Ser608Leu) and NOS3 −786T>C when patient groups were compared with cont...,144,123,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,Figure 2 Effects of different NOS3 −786T>C genotypes on nitrite/nitrate plasma levels ...,169,37,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,−786T>C NOS3	 	 	 	 ,189,2,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
474C>A,... NOTCH3 genotypes. The distribution of 381C>T and 474C>A polymorphisms did not have a significantly ...,36,125,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,... from the 684GA and 684AA carriers. Meanwhile the 684G>A polymorphism also dramatically affects tumo...,47,323,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,...milar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,499,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"... in these gliomas patients. More importantly, the 684G>A polymorphism is significantly associated wi...",57,385,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,57,537,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,57,537,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,57,537,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684 G>A,"... the seemingly non-functional polymorphisms, like 684 G>A, could affect transcription, splicing, mRN...",63,348,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"... in these gliomas patients. More importantly, the 684G>A polymorphism is significantly associated wi...",65,794,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
460G>A,"...female ratio varies between mutations: 3:1 for m.3460G>A, 6:1 for m.11778G>A and 8:1 for m.14484T>C....",10,533,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
460G>A,"...nd, studies of cybrids with the m.11778G>A and m.3460G>A mitochondrial DNA mutations show a higher s...",25,338,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
84T>C,....265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation of HFE. The affected prob...,43,345,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
8-6C>G,"...he proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorphic variant was found ...",317,396,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
8-6C>G,"...he proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorphic variant was found ...",317,396,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
84T>C,... and III- 5 were also heterozygous for the HFE c.884T>C (p.V295A) mutation. Both parents (II-10 and ...,317,571,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
84T>C,...d the mother was also heterozygous for the HFE c.884T>C (p.V295A) mutation (Figure 2),317,737,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism were associated with pr...,3,2337,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"...tively). Therefore, the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphisms may be associated with...",3,2750,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,... was used to determine the genotypes of the −42 + 1444A>G-HMOX2 polymorphism. PCR assay was performe...,33,139,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,The genotype and allele distributions of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms ...,50,46,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...MD progression. The G/C genotype and the C of the 19G>C-HMOX1 polymorphism and the G/G genotype and ...,52,281,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...d combined genotypes of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms. The distribution of c...,55,132,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...d combined genotypes of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms. The distribution of c...,55,132,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...ion between AMD and the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphism was subjected to strati...,60,63,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
9G>C,...ce of the G/C genotype and the C allele of the c.19G>C polymorphism of the HMOX1 gene increased the ...,71,1215,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...9G>C polymorphism of the HMOX1 gene and the −42 + 1444A>G polymorphism of the HMOX2 gene may be asso...,73,93,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...t that the 19G>C-HMOX1 polymorphism and the −42 + 1444A>G-HMOX2 polymorphism may be linked with the ...,76,85,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1215T>C,"...ucleotide polymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in lin...",3,1296,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1215T>C,"...ucleotide polymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in lin...",3,1296,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1215T>C,"...ucleotide polymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in lin...",3,1296,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
3377C>T,"...ymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in linkage disequil...",3,1309,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
28625C>T,"... at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in linkage disequilibrium with each ...",3,1326,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
43C>T,"...ere A for the CTSB g.72A>C SNP, C for the CTSL g.143C>T SNP and G for the CTSK g.15G>A SNP. Conseque...",87,331,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
5G>A,"...C for the CTSL g.143C>T SNP and G for the CTSK g.15G>A SNP. Consequently, observed heterozygosity (H...",87,363,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
2A>C,...were similar to those observed by [7] for CTSB g.72A>C in Italian Large White pigs (MAF = 0.06 for a...,87,911,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
43T>C,...8].Table 3 Effect of CTSB g.72A>C SNP and CTSL g.143T>C SNP on meat quality traits. Data are present...,144,1550,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
43T>C,...8].Table 3 Effect of CTSB g.72A>C SNP and CTSL g.143T>C SNP on meat quality traits. Data are present...,144,1550,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
933C>T,"... genomic DNA revealed an SCN1A point mutation, c.4933C>T [GenBank: NM_001165963.1] (Figure 1A) as fi...",23,748,Mol_Brain_2013_May_2_6_19.txt
1163T>C,"... primary breast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detec...",15,345,Mol_Cancer_2010_Jul_1_9_173.txt
1163T>C,"... primary breast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detec...",15,345,Mol_Cancer_2010_Jul_1_9_173.txt
83A>T,11.	f	44	-	-	c.583A>T	-	+,87,17,Mol_Cancer_2014_Jan_24_13_11.txt
871C>T,"...-2 analyses consistently identified the MYO15A c.3871C>T (p.L1291F) SNP as “damaging.” Furthermore, ...",47,1079,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
835T>G,"...ation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain, which is hi...",64,65,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
835T>G,"...ation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain, which is hi...",64,65,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
835T>G,"...ation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain, which is hi...",64,65,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
871C>T,...156-327). (E) Sanger sequencing traces for the c.3871C>T carrier (SB156-328). (F) Conservation of mu...,79,666,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
871C> T,B156-272	MYO15A	NM_016239:exon6:c.3871C> T:p.Leu1291Phe	AR	17	C	T	60	100.00%	60	5.01	...,90,36,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
67C>G,c.867C>G	p.Tyr289*	N-terminal	Homozygous	Profound	Cen...,96,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
67C>G,c.867C>G	p.Tyr289*	N-terminal	Homozygous	Profound	Cen...,96,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
67C>G,c.867C>G	p.Tyr289*	N-terminal	Homozygous	Profound	Cen...,96,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
685C>T,c.3685C>T	p.Gln1229*	Motor	Homozygous	Profound	Liburd...,100,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
198G>A,c.4198G>A	p.Val1400Met	Motor	Homozygous	Severe to pro...,106,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to pro...,111,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
835T>G,c.5835T>G	p.Tyr1945*	IQ 2	Heterozygous	Profound	This ...,117,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
731G>A,c.6731G>A	p.Gly2244Glu		Homozygous	Severe to profound...,126,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang et...,129,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
148G>T,c.8148G>T	p.Gln2716His		Homozygous	Profound	Liburd et...,131,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
0474C>T,c.10474C>T	p.Gln3492*	FERM	Homozygous	Severe to profo...,143,4,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
82G>T,"...& c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+6...",12,430,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
82G>T,"...& c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+6...",12,430,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
35+1C>T,"...G>A) and six heterozygous in GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHDC1 ...",5,1081,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
004-1C>T,"SMAD9	Ph-005	13,36325812,36325813,1,C/T	c.1004-1C>T	27 (16)	14 (0)	52% (0%)	Acceptor lost",74,44,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
0242+5G>A,DNAH9	Ph-007	c.10242+5G>A	0.999	0.95/–	0.949/–	14087	0	0	Not expre...,89,17,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
783-1G>A,...nd 14 of ABCC3 (OMIM#604323) gene (NM_003786.3:c.1783-1G>A); it was present with a frequency of 51%....,100,174,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
0242+5G>A,...tic mutation affected position +5 (NM_001372.3:c.10242+5G>A) of the donor splice site of DNAH9 (OMIM...,112,65,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
68-2A>G,...AH9 somatic mutations. (A) KLHDC1 (NM_172193.1:c.568-2A>G) splicing mutation near the 3’ acceptor sp...,153,64,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
662-1G>A,Figure S5. (A) HOOK1 (NM_015888.4:c.1662-1G>A) splicing mutation near the 3’ acceptor s...,155,38,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
025+1G>A,"...g sequence of CCM1 lacking human exon 18 (CCM1:c.2025+1G>A, CCM1:p.N607_K675del) was similarly fused...",22,264,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
30-1G>A,IVS9	c.730-1G>A	p.?	i	Davenport et al. (2001)	27,40,9,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
30-1G>A,IVS9	c.730-1G>A	p.?	i	Davenport et al. (2001)	27,40,9,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
564-1G>A,IVS15	c.1564-1G>A	p.?	f	Novel	32,55,10,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
75-2A>G,IVS8	c.475-2A>G	p.A119Gfs*423	i	Novel	22,78,9,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
58-2A>C,IVS9	c.558-2A>C	p.?	i	Novel	3,80,9,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
025+1G>A,The mutation c.2025+1G>A within CCM1 (CCM1:p.N607_K675del) was fou...,103,17,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
219G>C,"...ons in this study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%...",82,1052,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
860C>T,"....7%. Other frequent mutations included SH3TC2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Ile41...",82,1149,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
505T>A,...g of exons 10 and 14. (A) Exon 10: NM_000132.3 c.1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c.3...,51,86,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
677C>T,...oung IS  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels ...,246,106,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
677C>T,... Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial dise...,254,114,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
677C>T,...b J Hunter DJ  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylen...,255,92,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
595 G > A,"6	1 of 1	1 of 2	11q13.4:70,644,595 G > A	A578V	Deleterious (1)",241,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
595 G > A,"6	1 of 1	1 of 2	11q13.4:70,644,595 G > A	A578V	Deleterious (1)",241,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
202 C > T,"4	1 of 2	0 of 0	15q14:34,331,202 C > T	G16S	Deleterious (1)",281,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
113 G > A,"4	0 of 1	2 of 3	20p13:2,384,113 G > A	V354I	Deleterious",297,30,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
787T > C,...nspecific alkaline phosphatase gene polymorphism (787T > C) associated with bone mineral density . B...,194,165,Mol_Ther_Methods_Clin_Dev_2016_Feb_3_3_15059.txt
787T > C,...nspecific alkaline phosphatase gene polymorphism (787T > C) associated with bone mineral density . B...,194,165,Mol_Ther_Methods_Clin_Dev_2016_Feb_3_3_15059.txt
17G>A,"...s in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four...",15,103,Mol_Vis_2007_Apr_19_13_611-617.txt
37C>T,"...ke c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four missense muta...",15,117,Mol_Vis_2007_Apr_19_13_611-617.txt
37C>T,... RFLP analysis was carried out to identify the c.637C>T mutation using MSP1 restriction enzyme,55,446,Mol_Vis_2007_Apr_19_13_611-617.txt
608C>T,3	608C>T	Pro203Leu	6,64,3,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,6	637C>T	Arg213Trp	6,67,3,Mol_Vis_2007_Apr_19_13_611-617.txt
74C>T,A c.574C>T mutation was found in a 10-year-old male. Hi...,81,6,Mol_Vis_2007_Apr_19_13_611-617.txt
83A>G,A c.583A>G variation was identified in an 11-year-old m...,84,6,Mol_Vis_2007_Apr_19_13_611-617.txt
17G>A,Patient 4 with c.617G>A novel nonsense variatio,89,19,Mol_Vis_2007_Apr_19_13_611-617.txt
83A>G,"Patient 2 was found to have a c.583A>G novel genetic variation, leading to the repl...",111,34,Mol_Vis_2007_Apr_19_13_611-617.txt
42G>A,"2b	Glu114Glu c.342G>A	4 ARRP (003-089, 003-197, 003-285, 003-371)	...",53,17,Mol_Vis_2007_Apr_5_13_588-593.txt
3T>G,3	3'UTR+3T>G	1 ARRP (003-064)	0,55,9,Mol_Vis_2007_Apr_5_13_588-593.txt
198C>T,Exon 12	c.1198C>T	p.R400W	LCA		 [2],53,12,Mol_Vis_2008_Apr_21_14_675-682.txt
495+1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early ons...",63,14,Mol_Vis_2008_Apr_21_14_675-682.txt
14+1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early onset RP		 [9,24]...",63,28,Mol_Vis_2008_Apr_21_14_675-682.txt
14+1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early onset RP		 [9,24]...",63,28,Mol_Vis_2008_Apr_21_14_675-682.txt
496-6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [18]...",65,14,Mol_Vis_2008_Apr_21_14_675-682.txt
6C>A,"...rted to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the donor and acceptor s...",102,758,Mol_Vis_2008_Apr_21_14_675-682.txt
74C>T,c.574C>T	missense	p.Pro192Ser	exon 6	3	2	2	8.93,93,4,Mol_Vis_2008_Dec_12_14_2321-2332.txt
75C>T,c.575C>T *	missense	p.Pro192Leu	exon 6	-	1	1	1.79,94,4,Mol_Vis_2008_Dec_12_14_2321-2332.txt
74C>T,"... 4, who had two different mutations (c.421C>T, c.574C>T) in the RS1 gene, which resulted in apparent...",98,513,Mol_Vis_2008_Dec_12_14_2321-2332.txt
21C>T,"...belonged to two adjoining mutations (c.422G>A, c.421C>T). B: FT values change irrespectively of the ...",126,518,Mol_Vis_2008_Dec_12_14_2321-2332.txt
2A>G,...ows the heterozygous splicing site mutation c.985–2A>G; B: Sequence shows the heterozygous nonsense ...,113,140,Mol_Vis_2008_Dec_29_14_2451-2457.txt
197C>T,The novel nonsense mutation c.2197C>T (p.R733X) detected in family F2 presumably ...,126,32,Mol_Vis_2008_Dec_29_14_2451-2457.txt
60834G>C,13	F7	32 y 2 m	2	1 rc	2 rc	21	g.160834G>C	E737D,106,34,Mol_Vis_2009_Apr_17_15_771-777.txt
48G>A,"...equencing of RHO resulted in identification of c.448G>A, a previously reported mutation in exon 2, r...",141,59,Mol_Vis_2009_Dec_3_15_2526-2534.txt
48G>A,... results of RP21-IV-7 showing the heterozygous c.448G>A sequence. C: Sequence trace of an unaffected...,143,237,Mol_Vis_2009_Dec_3_15_2526-2534.txt
5+30C>T,"...98Lys, OPTN IVS5+38T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,401,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,420,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,420,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"...ocol of our previous studies [3,16]. In WDR36, IVS5+30C>T had been found to be significantly associa...",40,595,Mol_Vis_2009_Jan_16_15_89-98.txt
88T>C,...4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investigated by the TaqMan geno...,40,1064,Mol_Vis_2009_Jan_16_15_89-98.txt
34 G>C,Exon 1	c. 34 G>C	G12R*	3(0.85)	0 (0)	0/3/173	0/0/200,61,11,Mol_Vis_2009_Jan_16_15_89-98.txt
57 G>T,Exon 1	c. 57 G>T	Q19H	0 (0)	1 (0.25)	0/0/176	0/1//199,62,11,Mol_Vis_2009_Jan_16_15_89-98.txt
369 C>T,Exon 1	c. 369 C>T	T123T	2 (0.57)	1 (0.25)	0/2/174	0/1/199,66,11,Mol_Vis_2009_Jan_16_15_89-98.txt
482 A>G,Exon 1	c. 482 A>G	Q161R	0 (0)	1 (0.25)	0/0/176	0/1/199,67,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1+16 G>T,Intron 1	IVS1+16 G>T	-	0 (0)	1 (0.25)	0/0/176	0/1/199,69,13,Mol_Vis_2009_Jan_16_15_89-98.txt
1+16 G>T,Intron 1	IVS1+16 G>T	-	0 (0)	1 (0.25)	0/0/176	0/1/199,69,13,Mol_Vis_2009_Jan_16_15_89-98.txt
611 C>T,Exon 2	c. 611 C>T	T204M	0 (0)	2 (0.5)	0/0/176	0/2/198,70,11,Mol_Vis_2009_Jan_16_15_89-98.txt
927 G>A,Exon 3	c. 927 G>A	Q309Q	0 (0)	1 (0.25)	0/0/176	0/1/199,75,11,Mol_Vis_2009_Jan_16_15_89-98.txt
5+38 T>G,OPTN	IVS5+38 T>G	-	118 (33.5)	121 (30.25)	17/84/75	14/93/9...,93,9,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"... the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, followed th...",100,67,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"... the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, followed th...",100,67,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...n 1 (c.227G>A). Within this block, polymorphisms −83G>A and c.227G>A were the only two variants that...",126,138,Mol_Vis_2009_Jan_16_15_89-98.txt
26C>T,...ed with POAG. When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype ana...,130,340,Mol_Vis_2009_Jan_16_15_89-98.txt
26C>T,...ed with POAG. When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype ana...,130,340,Mol_Vis_2009_Jan_16_15_89-98.txt
88T>C,"... When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype analysis, no com...",130,353,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,...and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in APOE. The combination of these possibly ...,133,375,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"...odel. The hierarchical cluster analysis placed IVS5+30C>T (WDR36), IVS8–53T>C (OPTN), and Met98Lys (...",133,757,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,"...modulating risk of POAG. IVS5+38T>G (OPTN) and IVS2+35A>G (MYOC) were on another branch, revealing a...",133,1004,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,IVS8–53T>C and IVS5+30C>T	52.5	0.377	7/10,138,19,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945	9/10",140,16,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,46,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,46,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,"...mmon polymorphisms (MAF>1%), −83G>A, R76K, and IVS2+35A>G, were not statistically associated with PO...",148,1925,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,Intron 2	IVS2+35A>G	-	119 (20.2)	69 (19.6)	0.81	91 (16.2)	84 (...,157,13,Mol_Vis_2009_Jan_16_15_89-98.txt
5+38T>G,Intron 5	IVS5+38T>G	-	73 (12.4)	118 (33.5)	3.8×10–15	29 (5.2)	...,161,13,Mol_Vis_2009_Jan_16_15_89-98.txt
427 T>C,Promoter	−427 T>C	-	5 (0.9)	25 (7.1)	1.3×10–7	5 (0.9)	36 (9....,166,11,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...t al. [35] found the APOE promoter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) t...",175,1016,Mol_Vis_2009_Jan_16_15_89-98.txt
1000C>G,"...oter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) to increase IOP in POAG patient...",175,1046,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...ctions for normal tension glaucoma (between MYOC −83G>A and the APOE ε2/ε3/ε4, MYOC IVS2+35A>G and A...",175,1471,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491A>T). In this present study, a best interaction...",175,1702,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"...he interaction dendrogram, the variants, WDR36 IVS5+30C>T and OPTN IVS8–53T>C, are expected to have ...",175,2093,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"...he interaction dendrogram, the variants, WDR36 IVS5+30C>T and OPTN IVS8–53T>C, are expected to have ...",175,2093,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...ram, the variants, WDR36 IVS5+30C>T and OPTN IVS8–53T>C, are expected to have a strong synergistic i...",175,2115,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...ree variants in the first branch. Moreover, APOE −491A>T may have the least degree of interaction wi...",175,2436,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...ree variants in the first branch. Moreover, APOE −491A>T may have the least degree of interaction wi...",175,2436,Mol_Vis_2009_Jan_16_15_89-98.txt
4C>T,"...ults showed a substitution of C to T in CRYAA (c.34C>T), which led to a R12C amino acid change. In t...",292,106,Mol_Vis_2009_Jun_4_15_1127-1138.txt
3C>G,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,4,Mol_Vis_2009_Nov_21_15_2442-2447.txt
3C>G,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,4,Mol_Vis_2009_Nov_21_15_2442-2447.txt
95C>T,c.295C>T	p.Gln99X	bilateral anopthalmia	[11],70,4,Mol_Vis_2009_Nov_21_15_2442-2447.txt
43G>A,SNX5 (NM_152227)	c.543G>A	p.Glu181Glu	rs2273448	Y (hetero) Score=25	Y ...,80,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
3A>T,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y...,82,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
47T>G,PTMAP3 (NG_001180)	c.347T>G	p.Val116Gly	-	N*	N*	Y (hetero)	Y (hetero),85,23,Mol_Vis_2010_Dec_18_16_2829-2838.txt
53T>C, 	c.553T>C	p.Cys185Arg	rs3748493	N*	N*	Y (hetero)	Y (ho...,89,6,Mol_Vis_2010_Dec_18_16_2829-2838.txt
437C>T, 	c.1437C>T	p.Pro479Pro	rs1205194	N	N	N	N,96,6,Mol_Vis_2010_Dec_18_16_2829-2838.txt
223T>C, 	c.2223T>C	p.Pro741Pro	rs2747404	Y (homo) Score=25	Y (...,98,6,Mol_Vis_2010_Dec_18_16_2829-2838.txt
36C>G,RPS19P1 (NG_001295)	c.136C>G	p.Pro46Ala	rs2009092	Y (hetero) Score=12	Y (...,109,24,Mol_Vis_2010_Dec_18_16_2829-2838.txt
172C>T,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N...,131,14,Mol_Vis_2010_Dec_18_16_2829-2838.txt
63G>A,c.163G>A	p.Val55Ile	rs1569767	N	Y (hetero) Score=17	N...,140,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
54T>C,c.654T>C	p.Ile218Ile	rs3790279	Y (homo) Score=26	Y (h...,143,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
46T>C,"...nal screening criterion, with the exception of c.846T>C in C20orf72 (inadequate coverage, 4 reads). ...",168,1299,Mol_Vis_2010_Dec_18_16_2829-2838.txt
531C>T,"...fied in Family 1. Two known hotspot mutations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg),...",13,143,Mol_Vis_2010_Feb_15_16_224-230.txt
876A>G,"...otspot mutations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg), were revealed in Family 2 an...",13,172,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...ross structural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531...,13,589,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...nd 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were present in the corneas ...,13,636,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"...02G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in ...",16,76,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...d 1706T>A) (p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were associated with more se...,16,249,Mol_Vis_2010_Feb_15_16_224-230.txt
702G>C,"...ee families. In Family 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in...",61,128,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,".... In Family 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of...",61,139,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,... results of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Fa...,63,70,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"...equencing results of the heterozygote mutation c. 531C>T (p. Arg124Cys) of TGFBI in Family 2, and th...",65,61,Mol_Vis_2010_Feb_15_16_224-230.txt
702G>C,"...erved c.1702G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polymorp...",69,125,Mol_Vis_2010_Feb_15_16_224-230.txt
702G>C,... TGFBI locus markers D5S816 and D5S393 and the c.1702G>C and 1706T>A variants could not conclusively...,69,297,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...s markers D5S816 and D5S393 and the c.1702G>C and 1706T>A variants could not conclusively identify p...,69,308,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...20s. This indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T...,77,228,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...20s. This indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T...,77,228,Mol_Vis_2010_Feb_15_16_224-230.txt
87+34T>C,"... on the RP1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered be...",15,298,Mol_Vis_2010_Jul_15_16_1353-1360.txt
116G>C,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
615G>A,Exon 4	c.2615G>A	p.R872H	rs444772	43/55	130/190,56,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
175A>G,Exon 4	c.5175A>G	p.Q1725Q	rs441800	44/55	106/190,63,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
045A>G,Exon 4	c.6045A>G	p.L2015L	Novel	20090	0/190,64,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
423T>C,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,13,Mol_Vis_2010_Jul_15_16_1353-1360.txt
266A>G,c266A>G	Q89R	FEVR; LBM; spinal osteoarthritis	Unkno...,29,2,Mol_Vis_2011_Apr_8_17_894-902.txt
724G>A,c724G>A	A242T	HBM	Increase	Decreases Dkk1 and SOST ...,36,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1330C>T,c1330C>T	R444C	FEVR	Decrease	Inhibits Norrin-FZD4 m...,39,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1330C>T,c1330C>T	R444C	FEVR	Decrease	Inhibits Norrin-FZD4 m...,39,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1708C>T,c1708C>T	R570W	OPPG	Decrease	Increases Dkk1 inhibit...,42,2,Mol_Vis_2011_Apr_8_17_894-902.txt
144 G>T,...variation (Figure 1). The Gln48His variation is a 144 G>T transversion which resulted in a non-conse...,89,126,Mol_Vis_2011_Dec_15_17_3243-3253.txt
4484T>C,"... primary mutations (m.3460G>A, m.11778G>A, and m.14484T>C). In recent studies, we and others have sh...",4,166,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,"... the MT-ND1 protein. In recent years, mutation m.3635G>A was occasionally reported in various Chines...",20,294,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,"... the MT-ND1 protein. In recent years, mutation m.3635G>A was occasionally reported in various Chines...",20,294,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,"...eton cases with LHON [5,7,8]. The frequency of m.3635G>A was found to be similar to that of m.3460G>...",20,417,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,...ence variation in these patients with LHON and m.3635G>A has been conducted to date,20,673,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,Though mutation m.3635G>A has been reported in several families with ...,35,20,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,"...logroup status, indicating multiple origins of m.3635G>A, similar to the other mtDNA pathogenic muta...",37,1082,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,... web server [24]. No other sequence containing m.3635G>A was identified (Table 1),37,1358,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,...vate variants in complete mtDNA sequences with m.3635G>A,41,89,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,Allg	m.3635G>A (p.S110N)	MT-ND1	No	Yes	No	4/15859	1	0.797,43,9,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,Allg	m.3635G>A (p.S110N)	MT-ND1	No	Yes	No	4/15859	1	0.797,43,9,Mol_Vis_2012_Dec_30_18_3087-3094.txt
773G>A,"Le569	m.5773G>A	MT-TC	Yes	Yes	Yes (L0d3, A5a1a1, M13a, M24,...",48,10,Mol_Vis_2012_Dec_30_18_3087-3094.txt
773G>A,"Le569	m.5773G>A	MT-TC	Yes	Yes	Yes (L0d3, A5a1a1, M13a, M24,...",48,10,Mol_Vis_2012_Dec_30_18_3087-3094.txt
551T>C,EU807741.1	m.8551T>C (p.F9L)	MT-ATP6	Yes	Yes	No	10/15859	1	0.745...,49,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
071C>T, 	m.9071C>T (p.S182L)	MT-ATP6	Yes	Yes	Yes (H16c)	5/1585...,51,6,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...n 10 August, 2012 (e.g., both “G3635A mtDNA” and “3635G>A mtDNA” were queried). cThe haplogroup-spec...",54,285,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,"...functional mutations could act in synergy with m.3635G>A, the non-synonymous, mitochondrial tRNA and...",56,241,Mol_Vis_2012_Dec_30_18_3087-3094.txt
4063T>C,... Le329 and Le337 (m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y...,56,673,Mol_Vis_2012_Dec_30_18_3087-3094.txt
2811T>C,...e predicted by the TMPRED program. A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed...,58,196,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5237T>C,"...tional non-synonymous variants (m.14063T>C and m.15237T>C, Table 1, Figure 1). These two variants, t...",60,515,Mol_Vis_2012_Dec_30_18_3087-3094.txt
868C>T,... and high pathogenic score (Table 1). Mutation m.7868C>T was considered the reason for the high pene...,62,655,Mol_Vis_2012_Dec_30_18_3087-3094.txt
071C>T,"... potentially functional non-synonymous variant m.9071C>T in this lineage, with the ability to influe...",62,842,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,...excluding their potentially synergic role with m.3635G>A. Through analyzing all private variants in ...,64,1121,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,... Zhang Q  Yao Y-G   Mitochondrial DNA mutation m.3635G>A may be associated with Leber hereditary opt...,78,84,Mol_Vis_2012_Dec_30_18_3087-3094.txt
635G>A,8 Jia X  Li S  Wang P  Guo X  Zhang Q   mtDNA m.3635G>A may be classified as a common primary mutat...,79,50,Mol_Vis_2012_Dec_30_18_3087-3094.txt
71G>A,"...is study identified a disease-causing mutation c.471G>A in CRYGC in a Chinese family with cataracts,...",16,53,Mol_Vis_2012_Jul_11_18_1874-1880.txt
71G>A,"..., in our paper, the site of G>A transition was c.471G>A (TGG→TGA) in CRYGC (Table 2). The previous p...",99,917,Mol_Vis_2012_Jul_11_18_1874-1880.txt
71G>A,...The two families have different pedigrees. The c.471G>A transition in CRYGC is the first reported. A...,99,1125,Mol_Vis_2012_Jul_11_18_1874-1880.txt
70G>A,...ximately 9 mm. The previous W157X report was a c.470G>A transition and the clinical phenotype also w...,99,1327,Mol_Vis_2012_Jul_11_18_1874-1880.txt
3A>C,c.13A>C	T5P	GKM1	Coppock-like	[21],103,4,Mol_Vis_2012_Jul_11_18_1874-1880.txt
00G>A,CA4	17–58235763	c.700G>A,34,20,Mol_Vis_2013_Mar_21_19_654-664.txt
52+11G>A,CRX	None (c.252+11G>A)	50	99	48	67	0*	-	0*	-	0*	-,82,14,Mol_Vis_2013_Mar_21_19_654-664.txt
13C>A,"...cluding c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672...",12,107,Mol_Vis_2013_Nov_16_19_2298-2305.txt
30G>T,"...p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup30 (p.Ala224_Ala2...",12,131,Mol_Vis_2013_Nov_16_19_2298-2305.txt
30G>T,"....Ala224_Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure 3). These mutations were al...",53,194,Mol_Vis_2013_Nov_16_19_2298-2305.txt
30G>T,...Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromatogr...,55,214,Mol_Vis_2013_Nov_16_19_2298-2305.txt
30G>T,"...p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han Chin...",82,109,Mol_Vis_2013_Nov_16_19_2298-2305.txt
13C>A,"...S type II, while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected in...",82,301,Mol_Vis_2013_Nov_16_19_2298-2305.txt
13C>A,"...S type II, while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected in...",82,301,Mol_Vis_2013_Nov_16_19_2298-2305.txt
02C>G,...associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,276,Mol_Vis_2013_Nov_16_19_2298-2305.txt
325 T>C,"...regation of the compound heterozygous changes, c.4325 T>C and c.15188 T>G within the USH2A gene in a...",57,128,Mol_Vis_2013_Nov_7_19_2187-2195.txt
325T>C,...e USH2A gene at genomic positions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pat...,60,829,Mol_Vis_2013_Nov_7_19_2187-2195.txt
5188T>G,...tions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were found...,60,857,Mol_Vis_2013_Nov_7_19_2187-2195.txt
325T>C,...ontrol individuals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequencing...,72,218,Mol_Vis_2013_Nov_7_19_2187-2195.txt
027T>G,".../F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,56,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,2	c.215–2A>G	Splicing acceptor	2/0	ND	4/184	Reported,68,9,Mol_Vis_2014_Dec_31_20_1806-1814.txt
32G>A,6	c.732G>A	p.W244X	0/1	ND	1/184	Reported,72,6,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1027T>G,"...nese control individuals. A missense mutation, c. 1027T>G, was identified in patient 31 (Figure 4A,B...",84,395,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1C>T,"...yr343Asp). In patient 60, a nonsense mutation (c.31C>T) that converts a glutamine (CAG) into a prema...",84,555,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1C>T,"...yr343Asp). In patient 60, a nonsense mutation (c.31C>T) that converts a glutamine (CAG) into a prema...",84,555,Mol_Vis_2014_Dec_31_20_1806-1814.txt
13+2T >G,"..., one novel heterozygous splice-site mutation, c.413+2T >G, was detected in the 3′- acceptor in intr...",84,1047,Mol_Vis_2014_Dec_31_20_1806-1814.txt
027T>G,"...e heterozygous mutant single base-pair change (c.1027T>G,p.Y343D). B: Control (wild type, WT). C: Th...",88,130,Mol_Vis_2014_Dec_31_20_1806-1814.txt
768 G>T,... aunt (age 69) was compound heterozygote for the c768 G>T and c2894 A>G mutations and had autosomal ...,10,184,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...of the proband were asymptomatic carriers of the c768 G>T mutation. In family 2, the proband (age 25...",10,367,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,... the youngest child (age 9; heterozygote for the c5882 G>A mutation) had a normal phenotype. In fami...,10,918,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,... the youngest child (age 9; heterozygote for the c5882 G>A mutation) had a normal phenotype. In fami...,10,918,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,...e proband (age 43) was compound heterozygote for c768 G>T and c3113 C>T and had been diagnosed with ...,10,1026,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	CRD,78,8,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	STGD,87,30,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...d by other authors [8,23,38] in association with c5882 G>A. In one study [38], however, a combinatio...",172,1522,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,"...d as a component of the complex allele c1622 T>C;c3113 C>T (L541P/A;A1038V) [11,25,38], but it is al...",174,687,Mol_Vis_2014_Jan_7_20_89-104.txt
73+1G>T,"... One of the variants, the splice-site mutation c.873+1G>T in intron 5, was in a known WMS-like syndr...",51,857,Mol_Vis_2014_Jun_12_20_790-796.txt
26G>A,... of unknown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome 10...,70,88,Mol_Vis_2014_Jun_12_20_790-796.txt
721+1G>A,"...ous mutations [c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 g...",72,108,Mol_Vis_2014_Jun_12_20_790-796.txt
60C>T,"....2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 gene in three Sau...",72,124,Mol_Vis_2014_Jun_12_20_790-796.txt
721+1G>A,2	c.1721+1G>A	Intron 12	Splice site	Homozygous	Saudi Ar...,90,6,Mol_Vis_2014_Jun_12_20_790-796.txt
416G>A,"...>A) and three recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causative ...",12,309,Mol_Vis_2016_Jun_16_22_646-657.txt
557G>A,"...recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causative in the four fa...",12,323,Mol_Vis_2016_Jun_16_22_646-657.txt
416G>A,...e allele with the reported pathogenic mutation c.6416G>A. The two novel variants were further confir...,12,569,Mol_Vis_2016_Jun_16_22_646-657.txt
093T>C,"ARRP08	RP	6: 65,300,667	c.5093T>C	p.I1698T	missense	Het	E26	DA (0)	B (0.082)	...",69,28,Mol_Vis_2016_Jun_16_22_646-657.txt
416G>A,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.797)...",71,18,Mol_Vis_2016_Jun_16_22_646-657.txt
416G>A,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.797)...",71,18,Mol_Vis_2016_Jun_16_22_646-657.txt
228+1 G>A,"6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	N...",73,18,Mol_Vis_2016_Jun_16_22_646-657.txt
248G>A,...genic mutation c.6416G>A. The missense variant c.9248G>A would induce a change from the neutral glyc...,78,356,Mol_Vis_2016_Jun_16_22_646-657.txt
416G>A,"...operties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from the...",78,712,Mol_Vis_2016_Jun_16_22_646-657.txt
416G>A,"...operties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from the...",78,712,Mol_Vis_2016_Jun_16_22_646-657.txt
557G>A,...e carried by patient ARRP09-II:1. The missense c.6557G>A was the same recurrent mutation carried by ...,80,148,Mol_Vis_2016_Jun_16_22_646-657.txt
228+1G>A,...t ARRP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular spli...,80,254,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:7	RP	32/M	25...,95,16,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:1	RP	49/F	42...,106,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[9368A>C];[6416G>A]	p.[N3123T];[C2139Y]	W5–1	IRDs	34/M	14	20/...,109,17,Mol_Vis_2016_Jun_16_22_646-657.txt
3489T>A,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	6...,112,7,Mol_Vis_2016_Jun_16_22_646-657.txt
2644T>C,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	63/M	41	20/...,112,17,Mol_Vis_2016_Jun_16_22_646-657.txt
093T>C,"...of its neighboring β-sheet, and a missense VUS c.5093T>C colocalized in the same allele with the rep...",118,687,Mol_Vis_2016_Jun_16_22_646-657.txt
228+1G>A,"...ient ARRP10-II:3, the same patient who carries c.7228+1G>A. This mutation has not been previously re...",118,908,Mol_Vis_2016_Jun_16_22_646-657.txt
48C>G,c.148C>G (p.His50Asp)	Damagin,80,4,Mol_Vis_2016_May_16_22_491-502.txt
62G>A,c.362G>A (p.Arg121Gln)	Damagin,87,4,Mol_Vis_2016_May_16_22_491-502.txt
34G>A,...cts on gefitinib toxicities were evaluated. ABCG2 34G>A was statistically associated with occurrence...,10,430,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...se variants, two major functional variants, ABCG2 34G>A (rs2231137), resulting in a Val12Met substit...",22,214,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C > T,"...any). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the TaqMan assay (Appl...",58,159,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...n 1.4.1 of Applied Biosystems. We sequenced ABCG2 34G>A after performing a single polymerase chain r...,58,363,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,51,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,ABCG2 34G>A	GG	GA	AA,80,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,ABCG2 421C>A	CC	CA	AA,82,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...4 Association between genetic polymorphisms ABCG2 421C>A and toxicit,104,57,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...l impact on gefitinib-induced toxicities of ABCG2 34G>A. Our results suggested that ABCG2 34G>A woul...,135,423,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...l impact on gefitinib-induced toxicities of ABCG2 34G>A. Our results suggested that ABCG2 34G>A woul...,135,423,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,Variant allele of ABCG2 34G>A caused apical plasma membrane dislocalizatio...,139,25,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...currence of diarrhea.17) The frequencies of ABCG2 421C>A are reported to be 20–40% in Asian populati...,141,227,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...ssociation between genetic polymorphisms of ABCG2 421C>A and toxicities, although ABCG2 16702G>A was...",143,690,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"In summary, our study suggested that ABCG2 34G>A might be the predictor of skin toxicity in g...",147,44,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
487A>T,"... and identified a somatic truncating mutation, c.3487A>T; p.R1163X (Fig. 1b). While the phase of thi...",25,332,Nat_Commun_2014_Aug_7_5_4398.txt
21G>A,c.921G>A(p.=)	rs368868162	 	 	No effect	1	 ,171,4,Nat_Commun_2014_Aug_7_5_4398.txt
21G>A,c.921G>A(p.=)	rs368868162	 	 	No effect	1	 ,171,4,Nat_Commun_2014_Aug_7_5_4398.txt
873-4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,4,Nat_Commun_2014_Aug_7_5_4398.txt
445-8T>C,c.2445-8T>C	 	 	 	No effect	 	1,181,4,Nat_Commun_2014_Aug_7_5_4398.txt
211G>A,c.3211G>A; p.Gly1071Ser	rs35766432	Benign	Tolerated	N...,192,4,Nat_Commun_2014_Aug_7_5_4398.txt
292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerated	...,195,4,Nat_Commun_2014_Aug_7_5_4398.txt
402G>A,c.3402G>A(p.=)	rs147016884	 	 	No effect	1	1,196,4,Nat_Commun_2014_Aug_7_5_4398.txt
896G>A,...hanges35. Albino rats carry a single SNP mutation 896G>A in exon 2 of the Tyr gene resulting in an A...,25,457,Nat_Commun_2014_Jun_26_5_4240.txt
93+3A>G,0/1	c.993+3A>G	Intron 12	4.37			10.8,157,8,Nat_Commun_2015_Jun_16_6_7092.txt
7A>G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/657 AU...,121,8,Nat_Commun_2016_Apr_15_7_11253.txt
585T>G, p.S195R	585T>G	6	1/30 SP FALS	0/967 AU control exomes	Abse...,123,10,Nat_Commun_2016_Apr_15_7_11253.txt
1525T>C, p.S509P	1525T>C	13	1/99 IT FALS1/168 CA SALS	0/361 CA cont...,124,10,Nat_Commun_2016_Apr_15_7_11253.txt
11+1G>C,"...9)) and the splice disrupting CARD9 variant (c.IVS11+1G>C, MAF=0.58%, OR=0.29 (0.22–0.37))7, R179X e...",42,806,Nat_Commun_2016_Aug_9_7_12342.txt
758-2A>G,"...nt to cause JATD. However, a similar genotype (c.2758-2A>G/P209L or C552X/P209L) leads to early-onse...",44,787,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
758-2 A>G,NPHP+	A34-II1	Portuguese	P209L	c.2758-2 A>G	0/440	0/440	0/356	0/356,153,35,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
264-3C>G,NPHP+	F514	N. European	W150R	c.3264-3C>G	0/440	0/440	0/356	0/356,155,33,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
931G>A,c.2931G>A	p.Trp977X	UK	4 wks	+	+	10.52	1.1/1.0 [0.55-...,184,5,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
588C>T,c.2588C>T	p.Ser863Phe	NL	5 wks	+	+	27.52	11.8/38 [8.5...,233,5,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
68T>C,"...s 1 and 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ARN...",24,778,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
68T>C,"...s 1 and 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ARN...",24,778,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
68T>C,"...s 1 and 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ARN...",24,778,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
68T>C,"...s 1 and 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ARN...",24,778,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
92G>C,...F117 (Fig. 1c) were found to be homozygous for c.192G>C (p.Glu64Asp) in CIB2. This new locus is desi...,26,322,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
92G>C,...F117 (Fig. 1c) were found to be homozygous for c.192G>C (p.Glu64Asp) in CIB2. This new locus is desi...,26,322,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
92G>C,...phenotype of family PKDF117 co-segregates with c.192G>C (p.Glu64Asp) mutation of CIB2. These four re...,118,823,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
23508437A>G,"...nts (Supplementary Figure 2). This variant, chr10:23508437A>G, was located ~25kb downstream of PTF1A...",25,1254,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508305A>G,"...us chr10:23508363A>G mutation, a homozygous chr10:23508305A>G mutation and compound heterozygous chr...",27,774,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
262 A>G,PARN	c.1262 A>G	Lys421Arg	Novel	Novel	Novel	< 1st,103,9,Nat_Genet_2015_May_13_47(5)_512-517.txt
940 C>T,RTEL1	c.1940 C>T	Pro647Leu	Novel	Novel	Novel	< 1st,108,10,Nat_Genet_2015_May_13_47(5)_512-517.txt
940 C>T,RTEL1	c.1940 C>T	Pro647Leu	Novel	Novel	Novel	< 1st,108,10,Nat_Genet_2015_May_13_47(5)_512-517.txt
005 C>T,RTEL1	c.2005 C>T	Gln693*	Novel	Novel	Novel	< 1st,109,10,Nat_Genet_2015_May_13_47(5)_512-517.txt
059G>A,"...two heterozygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126,...",29,210,Nature_2011_Jan_27_469(7331)_539-542.txt
51-2 A > T,"Patient S3	Lung, left	KRAS G12 V; CDKN2A c.151-2 A > T	Lung, right	STK11 D194Y",100,45,Neoplasia_2016_Sep_20_18(9)_577-583.txt
1763C>T,4	14	1763C>T	Ala588Val,97,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1763C>T,4	14	1763C>T	Ala588Val,97,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1195C>T,5a	10	Homozygous 1195C>T	Arg399Cys,99,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
497C>T,6	3	497C>T	Ala166Val,100,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,7	18	2221G>A	Gly741Arg,102,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,105,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2883+1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,109,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2996A>G,14	26	2996A>G	Tyr999Cysc,116,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2996A>G,14	26	2996A>G	Tyr999Cysc,116,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
710G>A,16	5	710G>A	Gly237Aspc,120,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1825+1G>T,14	1825+1G>T	Intron 14 5′ splice site lost,123,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1196G>T,18b	10	1196G>T	Arg399Leuc,124,8,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,129,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
3053G>A,26	3053G>A	Arg1018Gln,146,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1351T>A,33	11	1351T>A	Ser451Thrc,153,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,35	18	Homozygous 2221G>A	Gly741Arg,157,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,159,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,159,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
524A>C,"... Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, enco...",164,90,Neural_Plast_2016_Dec_27_2016_9817089.txt
226A>G,"...gene (c.84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (...",342,630,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
504C>T,"...4L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 r...",342,714,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
9G>C,"...as been shown to yield no protein, whereas the c.79G>C does.6 Patients had decreased α-dystroglycan ...",1230,237,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
243A>G,...ase. Whilst common point mutations such as the m.3243A>G mutation and three primary Leber hereditary...,18,586,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
540G>A,The m.5540G>A mutation in the mitochondrial (mt-) tRNATrp...,20,8,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
344A>G,"...or common mtDNA mutations including m.3243A>G, m.8344A>G, m.8993T>C/G and m.13513G>A were negative w...",40,60,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
540G>A,... MT-TW pathogenic gene variants (including the m.5540G>A mutation) have been reported to occur as de...,49,449,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
080A>G,"... eight missense mutations: M694V (p.Met694Val, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>A...",22,579,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
040G>C,"...e, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>C...",22,667,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
1-14A > G,... transcribed from constructs carrying mutation IVS1-14A > G. (B) Splicing pattern of LIPC minigenes ...,146,517,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
1-14A > G,... transcribed from constructs carrying mutation IVS1-14A > G. (B) Splicing pattern of LIPC minigenes ...,146,517,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
9A->G,"...e 9 edited adenosines were mutated to guanosines (9A->G) and a reporter with compensatory mutations,...",56,627,Nucleic_Acids_Res_2012_Oct_30_40(19)_9876-9886.txt
243A>G,...ion associated with syndromic deafness was the m.3243A>G mutation in the tRNALeu(UUR) gene (8). The ...,8,787,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7511T>C,"...ASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle 4295A>G muta...",8,948,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
295A>G,"... of the tRNASer(UCN) precursor (16), while the m.4295A>G mutation may affect the nucleotide modifica...",8,1265,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
2201T>C,"...er investigate the pathogenic mechanism of the m.12201T>C mutation in the Chinese family, cybrid cel...",10,909,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
2201T>C,... tRNAHis. An arrow denotes the location of the m.12201T>C mutation,11,104,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
2201T>C,"To further examine whether the m.12201T>C mutation affects the stability of tRNAHis,...",54,35,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
2201T>C,...r uncharged tRNAHis in cell lines carrying the m.12201T>C mutation migrated slower than those of cel...,60,547,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
445A>G,... previous studies with the deafness-associated m.7445A>G mutation in the precursor of tRNASer(UCN) g...,66,1378,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
445A>G,... previous studies with the deafness-associated m.7445A>G mutation in the precursor of tRNASer(UCN) g...,66,1378,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
2201T>C,"...aminoacylation of mutant tRNAHis. In fact, the m.12201T>C mutation changed the conformation of tRNAH...",96,794,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
15927G>A,"...wild-type molecule, as in the case of the tRNAThr 15927G>A mutation (24). However, the aminoacylatio...",96,982,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,The respiratory deficiency caused by the tRNAHis 12201T>C mutation results in decreased efficiency ...,100,50,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
3243A>G,"...tRNALys 8344A>G and MELAS-associated tRNALeu(UUR) 3243A>G mutations (42,43). Alternatively, the redu...",100,346,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...ll lines carrying the deafness-associated tRNAHis 12201T>C mutation. The m.12201T>C mutation alters ...,102,187,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7505T>C,...ciated with the novel mitochondrial tRNASer(UCN)  7505T>C mutation in a Han Chinese family Mol. Gene...,127,184,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
6A>G,...T) and the methionine synthase reductase (MTRR c.66A>G) polymorphisms (both genes are involved in fo...,12,1090,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
677C>T,...tion with maternal risk in combination with MTHFR 677C>T or MTHFR 1298A>C polymorphisms [19]. Subseq...,14,480,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...observing an independent association of the RFC-1 80A>G polymorphism with the maternal risk of DS in...,14,633,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...alone or combined [25,26,27]. Moreover, the RFC-1 80A>G polymorphism has been associated with reduce...",14,939,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...erformed in 2009 to address the role of the RFC-1 80A>G polymorphism as a maternal risk factor for t...,16,176,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
0A>G,... examine the association of the maternal RFC-1 c.80A>G polymorphism with the risk of birth of a chil...,92,126,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...used to examine the association between the RFC-1 80A>G polymorphism and maternal risk of birth of a...,97,346,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
66A>G,16. Amorim M.R.  Lima M.A.   MTRR 66A>G polymorphism as maternal risk factor for Dow...,175,35,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
0G>A,...lty H.    The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell fola...,187,189,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
85G>C,"... one likely pathogenic variant in exon 7 (EYA4:c.385G>C, p.Gly129Arg) of sample H23 that converts a ...",27,514,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
1025T>T,"...>H/R in codon 3140, and the silent mutation C>CT, 1025T>T in codon 3075 (Fig. 1). These samples were...",26,403,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1025T>T,"...d GIII tumors. The genetic changes, 1047H>H/R and 1025T>T, have already been reported in the COSMIC ...",35,209,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
5G>A,"..., 77%). Three mutations were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T...",57,289,Oncoscience_2015_Feb_9_2(2)_125-130.txt
4G>A,"...35G>T (p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>...",57,384,Oncoscience_2015_Feb_9_2(2)_125-130.txt
5G>A,"...atient 1) harbored a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. ...",59,424,Oncoscience_2015_Feb_9_2(2)_125-130.txt
95G>A,...he wild-type human IDH1 and IDH1-R132H mutant (c.395G>A) were generously provided by Dr. Kun-Liang G...,148,52,Oncotarget_2014_Aug_16_5(17)_7342-7356.txt
335A>G,"...ree SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31)) (Figure 4, Supplement table 2), but...",86,528,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
211A>G,"...equence analysis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively...",89,59,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
31T > G, 131	p.Y177Ter (c.531T > G)		6,74,20,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
59G > A, 264	p.R130Q (c.359G > A),84,18,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
9G > T, 273	p.S10I (c.29G > T)		1,86,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
264T > C, 61	ERBB2: L755S (c.2264T > C) KIT: R49C (c.145C > T),109,22,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
470G > A, 264		PDGFRA: V824I (c.2470G > A)*,112,25,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
109G > A,MSI-H25		FGFR3: G370D (c.1109G > A)*,116,27,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
777C > T,MSI-H29		ERBB4: T926M (c.2777C > T)* FGFR1: R148H (c.443G > A),117,27,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
43G > A,...H29		ERBB4: T926M (c.2777C > T)* FGFR1: R148H (c.443G > A),117,55,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
01A>G,"...identified the synonymous mutation, Ala167Ala (c.501A>G, rs71653621), in exon 7 of DJ-1 in two PD pa...",27,70,Open_Neurol_J_2011_Mar_22_5_8-11.txt
01A>G,"... Heterozygous for the DJ-1 Mutation Ala167Ala (c.501A>G, rs71653621) in Exon",42,132,Open_Neurol_J_2011_Mar_22_5_8-11.txt
71G>A,"...espectively), the other being a mild mutation (c.571G>A) [18]. In patients 4 and 5, only one heteroz...",182,250,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
71G>A,"...arry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.1361A>...",209,77,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
50C>T,"...or c.526G>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situat...",209,133,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
50C>T,"...or c.526G>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situat...",209,133,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
48+1G>A,"..., the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situation in non-l...",209,145,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
12G>A,...ygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dominant negative ef...,209,436,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
12G>A,...ygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dominant negative ef...,209,436,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
70A-->G,...ir hypoplasia: ancient founder origin of the major70A-->G mutation of the untranslated RMRP Eur J Hu...,767,155,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
20C > T,c.820C > T	5	p.R274X	+	2	Present study,70,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
474G > T,"c.4474G > T	21	p.E1492X	+	2	Bernal et al., 2005",76,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
645C > T,"c.4645C > T	22	p.R1549X	+	1	Baux et al., 2007",78,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2067-2A > G,c.12067-2A > G	IVS61	Ex62 splice defect	+	4	Auslender...,130,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
30G > A,c.130G > A	2	p.G44R	+	1	Present Study,146,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
08G > A,"c.908G > A	6	p.R303He	UV3	1	Yan et al., 2009",150,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
137G > C,"c.2137G > C	12	P.G713R	UV2	2	Dreyer et al., 2000",160,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
276G > T,"c.2276G > T	13	p.C759F	+	3	Dreyer et al., 2000",162,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
522C > A,"c.2522C > A	13	p.S841Y	UV2	1	Jaijo et al., 2009",164,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
457G > A,"c.4457G > A	21	p.R1486K	-	75	Dreyer et al., 2000",166,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
975A > G,"c.5975A > G	30	p.Y1992Ce	UV3	1	McGee et al., 2010",172,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
587G > C,"c.6587G > C	34	p.S2196T	UV2	2	Jaijo et al., 2009",178,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
624G > A,"c.8624G > A	43	p.R2875Q	-	9	Aller et al., 2006",194,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
595A > G,"c.9595A > G	49	p.N3199D	-	9	Baux et al., 2007",206,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1680A > G,c.11680A > G	60	p.N3894D	UV3	1	Present Study,222,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4453C > T,"c.14453C > T	66	p.P4818L	+	1	Aller et al., 2006",228,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4513G > A,"c.14513G > A	66	p.G4838E	-	1	McGee et al., 2010",230,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
945T > C,c.3945T > C	18	p.N1315N	UV2	3	Present Study,264,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
031C > A,"c.5031C > A	25	p.G1671G	-	22	Aller et al., 2006",268,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
751C > T,"c.5751C > T	28	p.Y1917Y	UV2	1	McGee et al., 2010",270,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1907A > T,"c.11907A > T	61	p.P3969P	-	2	Dreyer et al., 2008",278,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2666A > G,"c.12666A > G	63	p.T4222T	-	58	Dreyer et al., 2008",286,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
3191G > A,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2067-2A > G,RP1310*	c.12067-2A > G/c.12067-2A > G		USHNC,306,27,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
486-43T > A,c.6486-43T > A	IVS33	UV2	1,388,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
372-50A > G,c.9372-50A > G	IVS47	UV2	1,400,4,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
128A > G,c.9958 + 128A > G	IVS50	-	4,404,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2062-2A > G,"...ke non-Ashkenazi Jews. The splice-site variant c.12062-2A > G was detected in three patients, in hom...",473,507,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
3272-26A>G,"...nclude mostly alternative splicing mutants (e.g., 3272-26A>G) which allow synthesis of some normal C...",9,670,Orphanet_J_Rare_Dis_2012_Nov_22_7(Suppl_2)_A19.txt
18+6C>T,c.118+6C>T	 	 	CT: 5 (4.5%)	CT: 13 (6.5%),90,4,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
18+6C>T,c.118+6C>T	 	 	CT: 5 (4.5%)	CT: 13 (6.5%),90,4,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
0100401C>T,g.30100401C>T	rs56098093	exon 4	GG: 97 (86.6%)	GG: 19...,95,4,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
14-6C>T,c.914-6C>T	 	 	CT: 3 (2.7%)	CT: 6 (3%),105,4,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
5295505G>C,g.35295505G>C	-	exon 1	GG: 111 (99.1%)	GG: 180 (100%)...,132,4,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
22-2A>T,"...inding domain, the T-box [55]. We identified a c.622-2A>T splice site mutation in two patients (one ...",156,501,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
52-2A>G,"...0delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,972,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
75G>A,"...fibres	Low	19% of LLR	Pu, Me, Ico	c.240+1G >T, c.575G>A",48,140,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
16-2A>G,...NA	UD	CT brain: GP and cerebellar atrophy	Homo c.516-2A>G,55,198,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
16-2A>G,"...a, RF	10	6y 6 m	NA	NA	NA	CT brain: normal	Homo c.516-2A>G",56,130,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
40+1G>T,"... grey matter involvement of cerebellum, Mb, Pu	c.240+1G>T, c.574C>T",73,207,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
24-11T>G,...n had the novel c.799_800delCT mutation or the c.324-11T>G mutation. The c.516-2A>G mutation segrega...,160,920,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
51+5G>A,"...rth and died at 2 years. The novel splice site c.751+5G>A mutation, generating an aberrant transcrip...",167,218,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
51+5G>A,"...rth and died at 2 years. The novel splice site c.751+5G>A mutation, generating an aberrant transcrip...",167,218,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
85A>G,1	c.985A>G	c.199T>C	2.85	2.3	Normal	39	36	-	-	-	-	-	-	-...,56,6,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
99T>C,"3	c.985A>G	c.199T>C	0.35	2.3	Trace N-HG, SG, DC	48	43	48	-	-	-	-...",58,15,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
85A>G,"...ical ACADM genotypes, and from carriers of the c.985A>G mutation (i.e. siblings or parents of patien...",73,763,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
71G>A,"...fied a homozygous DHCR24 mutation (NM_014762.3:c.571G>A; p.E191K), a recognized cause of desmosterol...",26,114,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
71G>A,...isters with the biallelic mutation NM_014762.3:c.571G>A in DHCR24. The recurrence of this mutation [...,31,67,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
307C>T,...91K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] ...,45,97,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
918G>C,...38G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > C;918G>C] p.[Y471S] + [N294T; K306N]	 ,45,202,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
27C>A,...osomal recessive congenital ichthyosis	NIPAL4: c.527C>A; p.A176D (homozygous)	No,46,56,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
27C>A,...osomal recessive congenital ichthyosis	NIPAL4: c.527C>A; p.A176D (homozygous)	No,46,56,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
27C>A,...osomal recessive congenital ichthyosis	NIPAL4: c.527C>A; p.A176D (homozygous)	No,46,56,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
3G>A,"...A2 mutations cause ADNSHL. A missense variant, c.53G>A (p.Arg18His), was identified in CELA1 (chymot...",115,603,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
3G>A,"...A2 mutations cause ADNSHL. A missense variant, c.53G>A (p.Arg18His), was identified in CELA1 (chymot...",115,603,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
202G>C,...candidate region on chromosome 20: The variant c.1202G>C (p.Arg401Pro) in GTPBP5 affects an evolutio...,117,123,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
7+1G>C,"5		37,6	4		c.1065+1G>C heterozygous	IVS7+1G>C ds	Splice site mutation",42,40,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
565+2T>G,"12		30,0	2	1	c.2565+2T>G heterozygous	IVS17+2T>G ds	Splice site mu...",54,17,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
742C>T,"17		16,6	2	1	c.3742C>T heterozygous	p.Gln1248",62,17,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
686G>A,"30,7	1	0	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	S...",76,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
321C>A,"25		47,0	2	1	c.6321C>A heterozygous	p.Cys2107",81,17,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
321C>A,"25		47,0	2	1	c.6321C>A heterozygous	p.Cys2107",81,17,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
792 C>T,(NM_001376.4)	2	c.1792 C>T	p.Arg598Cys,156,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
498-1G>A,(NM_014845.5)	1	c.[498-1G>A];[122T>C],165,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1G>T,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
36 C>T,(NM_014874.3)	1	c.436 C>T	p.Leu146Phe,213,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
574A>G,(NM_014874.3)	1	c.1574A>G	p.Asn525Ser,234,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,(NM_015046.5)	1	c.[1656G>T(;)1658C>T]	p.[(Gln552His(;)Ser553Phe)],252,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
34T>A,(NM_030962.3)	1	c.[134T>A];[c.134T>A]	p..[Ile45Asn];[Ile45Asn],255,33,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
144G>C,(NM_004863.3)	1	c.1144G>C	p.Gly382Arg,270,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
144G>C,(NM_004863.3)	1	c.1144G>C	p.Gly382Arg,270,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
42 C>T,NDRG1 (NM_001135242.1): c.442 C>,302,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
25G>A,(NM_021629.3)	c.125G>A	p.Arg42Gln	SIFT:,350,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
298C>T,(NM_138361.5)	c.1298C>T	p.Ser433Leu	SIFT:,361,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
3243A>G,...disease and was confirmed by demonstration of the 3243A>G transition in blood and urine. The heterop...,13,686,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...disease and was confirmed by demonstration of the 3243A>G transition in blood and urine. The heterop...,13,686,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
229C>T,...7-7ResearchTopoisomerase IIβ Binding Protein 1 c.*229C>T (rs115160714) Gene Polymorphism and Endomet...,3,195,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
124 G>A,"...ere as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A,...",27,97,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1659 G>A,"... 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864...",27,138,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"..._138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 ...",27,159,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...elT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_1974 insG, 2291 G>A, 2539_2542 del ...",27,204,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2950 G>C,"...90 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 ...",27,344,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...CYP2D6*9), 1863_1864 ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T...",34,174,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3189 G>A,"...17), 100 C>T (CYP2D6*10), 31 G>A (CYP2D6*35), and 3189 G>A (CYP2D6*29)",34,262,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,"... 31 samples (65%)had a 2850C>T SNP, 13 (27%) had a100C>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) ha...",58,346,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) h...",58,400,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"... G>A SNP, 2 (4%) had a 3183 G>A SNP, 1 (2%) had a 77 G>A SNP, 1 (2%) had a 1863_1864ins(TTTCGCCCC)2 ...",58,561,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...er, only 9 were availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TT...",60,255,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_...",60,271,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...TCGCCCC)2, 2615_2617 delAAG,2850C>T, 2988G>A, and 3183 G>A).We tested those 9TaqMan® Drug Metabolism...",60,355,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,...een the two platforms. Representative data of the 1846G>A and 100 C>T SNPs from the TaqMan® Drug Met...,60,522,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,...platforms. Representative data of the 1846G>A and 100 C>T SNPs from the TaqMan® Drug Metabolism assa...,60,534,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...m in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2549 delA,...",73,315,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"...11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2549 delA, , 2615_2617 del AAG,...",73,336,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"...3260 insGT [CYP2D6*42], 3201 C>T [CYP2D6*56], and 2291 G>A [CYP2D6*59]). For the RETINA assays for w...",99,1842,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"*4	100 C>T, 1846 G>A, (exon 9 converstion with CYP2D7 for CYP2...",139,13,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2935 A>C,*7	2935 A>C,141,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2935 A>C,*7	2935 A>C,141,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*17	1023 C>T, 2850 C>T",148,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"*29	1659 G>A, 3183 G>A, 2850 C>T",153,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*35	31 G>A, 2850 C>T",154,13,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*40	1023 C>T, 1863_1864 ins(TTTCGCCCC)2, 2850 C>T",157,42,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*41	2850 C>T, 2988 G>A",158,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"*56	2850 C>T, 3201 C>T",164,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
521T > C,...M4 metabolites were significantly affected by the 521T > C polymorphism.56 Individuals expressing th...,109,537,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
516G>T,"...hose associated with high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,959,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
21563C>T,"... high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,979,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
1563C>T,"...42_40), g.3003T>C (assay ID C_2818167_10), and g.21563C>T (assay ID C_22275631_10). The genotyping o...",41,319,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
85A>G,"... primers and probes were the following: CYP2B6 c.785A>G, TGGAGAAGCACCGTGAAACC (forward), TGGAGCAGGTA...",41,513,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
8492T>C,...tient who had CYP2B6*6/*6+ heterozygous mutant g.18492T>C (TC) had normal EFV level. This might be e...,91,411,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,... normal EFV level. This might be explained by the 18492T>C mutation associated with low EFV concentr...,91,477,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
88T>C,"...e single‐nucleotide polymorphisms, NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg1...",170,740,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
88T>C,"...e single‐nucleotide polymorphisms, NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg1...",170,740,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
545020	C-> A,chrV: 545020	C-> A,72,8,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
499172	C-> T,chrXIII: 499172	C-> T,81,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
299460	C-> A,S8c2	chrXIV: 299460	C-> A,88,14,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
47386	C-> G,chrIV: 47386	C-> G,91,9,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
198 V>D,"...ression (Fig. 7C), of which 1,467 D>V genes and 1,198 V>D genes satisfied our criteria of 20% more e...",115,714,PLoS_Comput_Biol_2015_Jan_23_11(1)_e1004032.txt
8+181G>A,"...id not, confirming the mutation as pathogenic. c.58+181G>A does not affect splicing but disrupts a p...",5,1576,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
8+181G>A,... (B) c.58+181G is evolutionarily conserved and c.58+181G>A disrupts a consensus binding sequence for...,61,380,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
8+181G>A,...Zeb1os cDNA transcripts confirmed no effect of c.58+181G>A on splicing,67,1355,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
560A>C,"...the combination of two common variants in APOA1, −560A>C (MAF = 3.5%, tagging the haplotype-560A>C, ...",121,804,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
278C>T,"...and observed a heterozygous mutational change, c.2278C>T, in exon12 which generated a stop codon pre...",157,450,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
278C>T,... WT (c.2278C) (P1 and P3C) versus the mutated (c.2278C>T) (P2 and P3C) alleles. The WT PCR product i...,162,924,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
278C>T,... WT (c.2278C) (P1 and P3C) versus the mutated (c.2278C>T) (P2 and P3C) alleles. The WT PCR product i...,162,924,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
278C>T,...e amplification of the WT and mutant products (c.2278C>T mutant as well as the mis-spliced product)....,164,139,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...P3C selectively amplify the mutated (maternal) c. 2278C>T allele (Figure 2C). As expected, the mutan...",164,530,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
278C>T,... (Figure 2C). The results also showed that the c.2278C>T and the WT (c.2278C) alleles were expressed...,164,893,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
278C>T,...probe 1) allele. We confirmed detection of the c.2278C>T allele exclusively in the patient and mothe...,168,558,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
278C>T,... to rescue ATR–SS cells. Finally expression of c.2278C>T ATRIP cDNA in WT cells did not affect G2/M ...,173,1524,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...ged ATRIP cDNA expressing plasmids (wild type and 2278C>T ATRIP) together with ATR cDNA, followed by...",237,160,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
3477G>T,...19-8BI. RT-PCR sequencing revealed a heterozygous 3477G>T mutational change in both patients causing...,275,182,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
3477G>T,...19-8BI. RT-PCR sequencing revealed a heterozygous 3477G>T mutational change in both patients causing...,275,182,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
67334934 G>T,...ion on the peaks for T and G are the T or G at g. 67334934 G>T. (F) Summary of the detection of diff...,26,1680,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
7320217A>G,g.67320217A>,53,4,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
7320779A>G,g.67320779A>,56,4,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
7334934G>T,g.67334934G>,113,4,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
7335932T>C,g.67335932T>,116,4,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,...he 18 hexamers. A fragment containing the SNP (g. 67334934 G>T) in exon 5 was amplified with forward...,283,385,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
21U>G,"...nth to adenosine (21U>A transgenes) or guanosine (21U>G transgenes), such that the transgenes encode...",238,548,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
02	C>T,Chr14:60974378	----	0	0.002	C>T	----	2.77,88,27,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
02	G>C,Chr14:60976393	rs78954112	0	0.002	G>C	Glu93Gln	5.52,97,33,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
02	G>A,Chr14:60976501	rs146737847	0.008	0.002	G>A	Glu129Lys	5.38,100,38,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>T,Chr14:60977954	rs139302405	0.002	0	G>T	Ser242Ile	5.19,112,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
034T>C,"...d was found to carry a de novo USP9X mutation (c.3034T>C, p.Ser1012Pro) at a highly conserved residu...",131,278,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
17704	C>T,Q97Stop	17704	C>T	n/a	n/a	Severe	2.4	n/a	n/a	n/a,34,9,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17704	C>T,Q97Stop	17704	C>T	n/a	n/a	Severe	2.4	n/a	n/a	n/a,34,9,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>A,R116R	17761	C>A	5–7	3–6	Mild/Moderate	2.0	96±5	96±8	I,35,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>T,R116Stop	17761	C>T	<1–3	<1–1	Severe	7.0	n/a	n/a	n/a,37,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>T,R116Stop	17761	C>T	<1–3	<1–1	Severe	7.0	n/a	n/a	n/a,37,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17776	C>T,Q121Stop	17776	C>T	<1	<1	Severe	20.6	n/a	n/a	n/a,39,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17776	C>T,Q121Stop	17776	C>T	<1	<1	Severe	20.6	n/a	n/a	n/a,39,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17764	C>T,L117F	17764	C>T	n/a	<1	Severe	27.7	0	0	III,42,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17783	C>G,S123C	17783	C>G	n/a	15	Mild	69.5	n/a	n/a	n/a,45,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
276C>T,"...ur promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-synonymous (ns) substitution ...",47,232,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
48912G>A,"...plotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Table 2. Six haplotypes...",99,99,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
871G>A,...ase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodia...,267,151,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
2667G>C,"... and of these, Zee et al.,[15] which included SNP 2667G>C, Casas et al.,[19] which included SNP 3014...",17,386,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1440C>T,"...tagSNPs polymorphic in EAs, included a triallelic 1440C>T>A (rs3091244) and a commonly studied rare ...",36,497,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,... Project[33] showed that two tagSNPs [1919A>T and 3872C>T] were sufficient to assess the variation i...,36,918,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...igned by Applied Biosystems: 1919A>T (rs1417938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T ...",38,346,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...ystems: 1919A>T (rs1417938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs...",38,367,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...17938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs3093080), 4741G>C (rs...",38,388,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362A>T,"...s1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G ...",38,406,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...erved allele frequencies for all SNPs, except for 5237A>G among women (p = 0.03) and 4741G>C among m...",49,515,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"... men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0.95), wherea...",49,811,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"... men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0.95), wherea...",49,811,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...men and men (Table 4). Under the same model, SNPs 2667G>C and 3872C>T were associated with 22–37% lo...",130,525,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"... associated with 22–37% lower CRP levels, whereas 4741G>C was associated with ∼40% higher CRP levels...",130,599,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,... was associated with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approxima...,130,656,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,5237A>G	241/476	0.93 (0.72–1.19)	0.56	0.98	0.86	24...,140,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...r allele of 5237A>G, and H3, with minor allele of 3872C>T, had estimated frequencies ranging from 25...",148,306,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,...and H4 may be attributable to the minor allele of 2667G>C,148,663,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"3014G>A	[13], [16], [19], [20], [22]		[18]			[19],...",195,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"3872C>T		[16], [20], [22], [23]				[22]",196,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"... together, these results suggest that 2667G>C and 3872C>T, though associated with lower CRP levels, ...",203,1112,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,... CRP levels.[17] The major alleles of 3872C>T and 5237A>G together serve as a proxy for the triallel...,205,437,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
917A > G,...2 diabetes: an analysis of the m.4216T > C and m.4917A > G variants. Ann Hum Genet 70 488 495 167591...,170,220,PLoS_ONE_2008_Mar_12_3(3)_e1764.txt
24T>A,"...oned above, neither of the mutations CD17A>T or CD24T>A was genotyped to the fullest by the Tm match...",87,765,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17A>T,"...genotyping assays, the probes for the mutations CD17A>T and CD24T>A were redesigned (MSAW method iii...",89,74,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,...he wild-type probe. Shorter probes for mutation CD24T>A resulted in heterozygote ratios of about 0.5...,89,444,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
1555A>G,... allele are detected. Row 3. Negative control. B) 1555A>G in MTRNR1. Row 1. Wild-type genotype for n...,31,421,PLoS_One_2010_Jul_26_5(7)_e11804.txt
919-2A>G,(GJB2; V27I*)/SLC26A4; 919-2A>G/919-2A>G	1	SLC26A4; IVS1-2A>G**/L236P	1	G...,38,24,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,GJB2; R127H*	2	SLC26A4; V609G/SLC26A5; IVS2-2A>G**	1,43,47,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,SLC26A5; IVS2-2A>G**	2,51,17,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,...s). Four individuals were heterozygous for the IVS2-2A>G variant in SLC26A5. Similar to IVS1-2A>G in...,69,2563,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,"...ly, a single, homoplasmic mitochondrial mutation (1555A>G in the MTRNR1 gene) was identified. Both m...",69,3015,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...n hot-spot regions associated with NSHL [26]. The 1555A>G mutation predisposes affected individuals ...,69,3164,PLoS_One_2010_Jul_26_5(7)_e11804.txt
41G>A,...epresents the allele change from the wild type c.341G>A for RETR114H; T represents the high risk SNP...,57,475,PLoS_One_2010_Jun_2_5(6)_e10918.txt
41G>A,...epresents the allele change from the wild type c.341G>A for RETR114H; T represents the high risk SNP...,57,475,PLoS_One_2010_Jun_2_5(6)_e10918.txt
623 G>A,GG	Irish-French Canadian	623 G>A	A97T	1	1	this report,35,26,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,F123	Italian	639 A>G	N102S	1	1	7,36,14,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Q	American	639 A>G	N102S	1	1	8,39,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,BB	Czechoslavakian	639 A>G	N102S	1	1	9,43,20,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,R	American	639 A>G	N102S	1	1	9,47,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,R	American	639 A>G	N102S	1	1	9,47,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,II	American	639 A>G	N102S	1	1	this report,49,13,PLoS_One_2010_May_21_5(5)_e10760.txt
897 T>A,EE	Chinese-Taiwan	897 T>A	L188H	2	2	this report,72,19,PLoS_One_2010_May_21_5(5)_e10760.txt
8938C>T,+[8938C>T]	+[3425C>G]	+[3425C>G]	+[11313_11316delTAG...,26,4,PLoS_One_2011_Apr_26_6(4)_e19081.txt
20C>T,... grandfather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three indi...,20,214,PLoS_One_2011_Dec_14_6(12)_e29248.txt
20C>T,... grandfather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three indi...,20,214,PLoS_One_2011_Dec_14_6(12)_e29248.txt
295T>C,...3 coding region (R130Q) and IL-16 gene promoter (−295T>C) and allergic asthma.              Iran J A...,229,260,PLoS_One_2011_Feb_28_6(2)_e16522.txt
295T>C,...3 coding region (R130Q) and IL-16 gene promoter (−295T>C) and allergic asthma.              Iran J A...,229,260,PLoS_One_2011_Feb_28_6(2)_e16522.txt
293A>G,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our proba...,24,16,PLoS_One_2011_Jun_9_6(6)_e20854.txt
293A>G,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our proba...,24,16,PLoS_One_2011_Jun_9_6(6)_e20854.txt
77G>A,"...en found in the Soat1 gene, and individuals with −77G>A variant have significantly higher plasma HDL...",82,1258,PLoS_One_2011_Oct_14_6(10)_e25344.txt
77G>A,"...en found in the Soat1 gene, and individuals with −77G>A variant have significantly higher plasma HDL...",82,1258,PLoS_One_2011_Oct_14_6(10)_e25344.txt
331T>A,2	Atypical	c.7331T>A	p.L2444X	Nonsense			Novel,61,15,PLoS_One_2011_Sep_13_6(9)_e24511.txt
210+5G>C,"...g analysis of the novel splice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 ...",170,74,PLoS_One_2011_Sep_13_6(9)_e24511.txt
405-7G>A,"...on-trapping analysis of splice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 26 o...",176,64,PLoS_One_2011_Sep_13_6(9)_e24511.txt
3243A>G,"...ntified 33 diabetes-suspected mutations, 1/33 was 3243A>G. Most patients (91%) and their mothers had...",5,1139,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9803A>G,CO3	9803A>G	syn				Novel Variant,50,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
385A>G,7	HVII	385A>G					-,58,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16137A>G,HVI	16137A>G					-,74,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16526G>A,HVI	16526G>A					-,75,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"The 3243A>G variant in tRNA leucine, which is the muta...",92,5,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5093T>C,"...ed in complex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11...",92,698,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,"...L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%)...",92,819,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,"...L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%)...",92,819,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16526G>A,"... D-Loop (18%) (HVI: 16048G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G), followed by RNRs (...",92,1167,PLoS_One_2012_Apr_19_7(4)_e34956.txt
951G>A,"...16526G>A; HVII:293T>C, 385A>G), followed by RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>...",92,1217,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...s 2, 6, 9, 10 and 15). Patient 5 carried mutation 3243A>G and was not further investigated because t...",97,382,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...es [1], [20] started with the search for mutation 3243A>G in patients affected by both diabetes and ...",111,65,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...abetic patient (patient 5) who had a heteroplasmy 3243A>G level of 34%. The heteroplasmic level of t...,115,665,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...sis of MIDD usually focuses on the search for the 3243A>G mutation in selected diabetic patients aff...,117,88,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...ificance of these suspected mutations, apart from 3243A>G [4], has been scarcely investigated [7], [...",119,560,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...titative PCR (qRT-PCR) the level of heteroplasmic 3243A>G mutation detected in one patient and his m...,133,157,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...titative PCR (qRT-PCR) the level of heteroplasmic 3243A>G mutation detected in one patient and his m...,133,157,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...nd from her mother (m5) showing the heteroplasmic 3243A>G mutation. Levels of heteroplasmy were high...,153,191,PLoS_One_2012_Apr_19_7(4)_e34956.txt
216T>C,...216	5′-cgCCACTCACCCTAGCATTACTTATATG A-3′	4189F	m.4216T>C,66,53,PLoS_One_2012_Aug_28_7(8)_e44128.txt
4766C>T,... development of ischemia in our study. The SNP m.14766C>T causes the amino acid substitution of a th...,147,150,PLoS_One_2012_Aug_28_7(8)_e44128.txt
1016G>A,...reported haplogroup N9b specific polymorphisms m.11016G>A (p.Ser86Asn in NADH dehydrogenase 4) and m...,147,1279,PLoS_One_2012_Aug_28_7(8)_e44128.txt
3183A>G,...16G>A (p.Ser86Asn in NADH dehydrogenase 4) and m.13183A>G (p.Ile283Val in NADH dehydrogenase 5) conf...,147,1331,PLoS_One_2012_Aug_28_7(8)_e44128.txt
-336A>G,...  Ching JC  So TM  Lai ST    2010 CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute res...,263,68,PLoS_One_2012_Feb_27_7(2)_e32273.txt
330 A>G,"...nce and the United Kingdom, the missense mutation 330 A>G was independently identified in six famili...",141,945,PLoS_One_2012_Jul_11_7(7)_e40543.txt
11573156 C >G,... 6 Luciferase Assay Activity Analysis Comparing rs11573156 C >G,55,90,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,"For rs3767221 T>G, a 303 bp fragment downstream of the P...",105,7,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,The effects of rs11573156 C>G on gene expression was assessed using...,159,18,PLoS_One_2012_Jul_17_7(7)_e41139.txt
61A>G,...0 Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epi...,110,84,PLoS_One_2012_Jul_19_7(7)_e41470.txt
12-6T>C,"...for RRM1 C-524T. Besides, the results of hMSH2 IVS12-6T>C and XRCC1 T194C were inconsistent between ...",149,963,PLoS_One_2012_Jun_26_7(6)_e38150.txt
2168G> A,...XJ  Zhou HH    2011 ABCC1 polymorphism Arg723Gln (2168G> A) is associated with lung cancer susceptib...,246,82,PLoS_One_2012_Jun_26_7(6)_e38150.txt
1468C>T,237	536	no	75.0	n.a.	exon1	1068G>A	V356X	exon3	1468C>T	R490X,27,48,PLoS_One_2012_Mar_20_7(3)_e33667.txt
25C>T,"A homozygous c.325C>T transition, introducing a premature stop cod...",37,17,PLoS_One_2012_Mar_20_7(3)_e33667.txt
25C>T,"A homozygous c.325C>T transition, introducing a premature stop cod...",37,17,PLoS_One_2012_Mar_20_7(3)_e33667.txt
468C>T,"...affected sisters did not carry the mutation. A c.1468C>T transition, resulting in R490X in exon 3, w...",37,250,PLoS_One_2012_Mar_20_7(3)_e33667.txt
73G>A,"...omosomes. Two heterozygous transitions, 52A>G and 73G>A, were found in the 3′UTR, each in one of two...",125,490,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1068G>A,Number of chromosomes with 1068G>A (W356X)		0	0	1	0	1,174,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
677C>T,"...ylation (χ2 = 8.82, p = 0.003) and maternal MTHFR 677C>T genotype with IGF2 methylation (χ2 = 2.77, ...",5,1878,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1298A>C,"...arbon metabolism (MTHFR 677C>T (rs1801133), MTHFR 1298A>C (rs1801131), MTRR 66G>A (rs1801394), FOLH1...",37,123,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,Maternal GCPII 1561C>T*		0.247	0.272	0.366		0.300	0.411	0.090,103,18,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"RFC1 80G>A	IGFBP3 Site 4	94	6.98	6.33, 8.01	158	7.50	6....",131,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	IGFBP3 Mean	47	5.58	5.13, 6.58	60	5.89	5.45,...",142,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,...t the ZNT5 site 5 locus. The maternal GCPII/FOLHI 1561C>T SNP had a low MAF so data were tested unde...,150,679,PLoS_One_2012_Mar_30_7(3)_e33290.txt
11187870 G>C,... another unreported potentially functional SNP (rs11187870 G>C) of PLCE1 in a hospital-based case-co...,6,315,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...e reported a shared susceptible locus at 10q23 (rs2274223A>G, exon 26) in the PLCE1 gene associated ...",19,479,PLoS_One_2012_Mar_6_7(3)_e31932.txt
753724 G>T,"... novel SNPs revealed in GWAS of gastric cancer (rs753724 G>T, r2 = 0.823; rs11187842 C>T, r2 = 0.823...",21,978,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187870G>C,"...result, we genotyped two SNPs (rs2274223A>G and rs11187870G>C) of PLCE1 using genomic DNA isolated f...",28,891,PLoS_One_2012_Mar_6_7(3)_e31932.txt
510+118T>C,"rs3771280, c.1510+118T>C	TT vs CC/CT	1.99(0.47−8.39)	0.350	0.94(...",59,15,PLoS_One_2012_May_18_7(5)_e36962.txt
635-765G>A,"... (rs17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three i...",204,913,PLoS_One_2012_May_18_7(5)_e36962.txt
635-765G>A,"... (rs17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three i...",204,913,PLoS_One_2012_May_18_7(5)_e36962.txt
091-2A>G,"...0del17insGC	c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-...",76,73,PLoS_One_2012_May_31_7(5)_e33673.txt
091-2A>G,"...del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-...",76,108,PLoS_One_2012_May_31_7(5)_e33673.txt
091-2A>G,"...del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-...",76,143,PLoS_One_2012_May_31_7(5)_e33673.txt
091-2A>G,"...these two mutations, c.802-8_810del17insGC and c.1091-2A>G. Only patients were found to carry both m...",93,140,PLoS_One_2012_May_31_7(5)_e33673.txt
091-2A>G,...itial analysis of exome sequencing showed that c.1091-2A>G in CYP4V2 was first carried by the 3 pati...,109,208,PLoS_One_2012_May_31_7(5)_e33673.txt
091-2A>G,"...ong the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the sp...",111,53,PLoS_One_2012_May_31_7(5)_e33673.txt
11615G>A,"...functional SNPs (rs2298881C>A, rs3212986C>A and rs11615G>A) and two XPF/ERCC4 functional SNPs (rs227...",11,63,PLoS_One_2012_Nov_15_7(11)_e49308.txt
1800067G>A,"...studies have mainly focused on a functional SNP rs1800067G>A, and few case-control studies reported ...",26,493,PLoS_One_2012_Nov_15_7(11)_e49308.txt
2298881C>A,"...e published GWASs. For the ERCC1 gene, we chose rs2298881C>A that may affect the TFBS activity, in a...",82,438,PLoS_One_2012_Nov_15_7(11)_e49308.txt
3212986C>A,"...idely investigated potentially functional SNPs (rs3212986C>A and rs11615G>A, the former may be assoc...",82,560,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615G>A,"...d potentially functional SNPs (rs3212986C>A and rs11615G>A, the former may be associated with transc...",82,577,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615G>A,"...d potentially functional SNPs (rs3212986C>A and rs11615G>A, the former may be associated with transc...",82,577,PLoS_One_2012_Nov_15_7(11)_e49308.txt
6498486A>C,".... For the ERCC4 gene, we chose rs2276466C>G and rs6498486A>C; the former may affect the miRNA bindin...",82,769,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615T>C,"...sk of gastric cancer, both of which studied the rs11615T>C only in a relatively small Italy populati...",176,1166,PLoS_One_2012_Nov_15_7(11)_e49308.txt
95G>A,".... Steven Laval (Newcastle Upon Tyne, UK). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C l...",97,196,PLoS_One_2012_Nov_20_7(11)_e49603.txt
022T>C,...DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into t...,97,238,PLoS_One_2012_Nov_20_7(11)_e49603.txt
2578C>A,"...olymorphisms that may influence VEGF expression: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C ...",16,1033,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...sion: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C (rs2010963), and 936C>T (rs3025039) [26], [...",16,1076,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"... (rs2010963) (D′ = 0.92), −2578C>A (rs 699947)and 1154G>A (rs1570360) (D′ = 0.89). There was strong ...",40,112,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"....0047158.t002Table 2 The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphis...",42,71,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"....0047158.t002Table 2 The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphis...",42,71,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between control s...",42,91,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,62,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"...tudy was to evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −60...",70,222,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 11...",70,242,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,"...KDR −604T>C (rs2071559), 1192G>A (rs2305948), and 1719T>A (rs1870377) polymorphisms in Korean patien...",70,315,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,"...8.t003Table 3 The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between control...",72,78,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,210,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...bp (C allele) or 326 bp (A allele) product; VEGF −1154G>A polymorphism, forward 5′-CGC GTG TCT CTG G...",227,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...TTC AG-3′, that amplifies a 173 bp product; VEGF −634G>C polymorphism, forward 5′-CAG GTC ACT CAC TT...",227,367,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,The VEGF −2578C>A and −634G>C polymorphisms were identified ...,229,11,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...New England Biolabs, Beverly, MA, USA). The VEGF −1154G>A polymorphism was identified by digesting t...",229,181,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...ients and control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms and the...",244,204,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,... S1). Our results potentially implicate the VEGF −634G>C polymorphism in the development of collater...,250,412,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,... S1). Our results potentially implicate the VEGF −634G>C polymorphism in the development of collater...,250,412,PLoS_One_2012_Oct_12_7(10)_e47158.txt
36A>G,...dentification of PD-specific SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in...,19,140,PLoS_One_2013_Aug_15_8(8)_e71096.txt
049C>T,"... transgenic variants of SLC41A1, namely wt and c.1049C>T, by the quantitative real time PCR (q-RT-PC...",37,98,PLoS_One_2013_Aug_15_8(8)_e71096.txt
049C>T,...gnificantly higher amount of ∼14.25 fold (+tet c.1049C>T ddCt mean 144.9±34.62/-tet c.1049C>T ddCt m...,76,338,PLoS_One_2013_Aug_15_8(8)_e71096.txt
049C>T,"... mean 10.17±0.79; P = 1.84e-08) of the SLC41A1-c.1049C>T transcript was detected, when compared with...",76,436,PLoS_One_2013_Aug_15_8(8)_e71096.txt
14C>T,"...stic callus formation. The causative mutation, c.-14C>T in the 5'-untranslated region of IFITM5, was...",7,562,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,...variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50 : ...,121,174,PLoS_One_2013_Aug_20_8(8)_e72337.txt
1308530 T>C,...e entire study cohort was found for the SNP BICF2P1308530 T>C at g.22785650 bp for the T allele (p =...,98,452,PLoS_One_2013_Aug_7_8(8)_e70903.txt
-826C>T,"...r TNFA -308G>A, NFkB1 -94ATTG ins/del and NFKBIA (-826C>T and 3’UTRA>G) polymorphisms using PCR alon...",14,174,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826C>T,"...sed risk of ESCC in females. Haplotypes of NFKBIA -826C>T and 3’UTRA>G polymorphisms, C-826G3’UTR an...",18,237,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826C>T,TNFA-308 and NFKBIA (-826C>T and 3’UTRA>G) polymorphisms may play role ...,21,22,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,... NFKB1 (-94 ATTG ins/del; rs28720239) and NFKBIA (-826 C>T; rs2233406) and 3’UTR region of NFKBIA (3...,30,1291,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,... NFKB1 (-94 ATTG ins/del; rs28720239) and NFKBIA (-826 C>T; rs2233406) and 3’UTR region of NFKBIA (3...,30,1291,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...rd salting out method [31]. The genotyping of TNFA-308 G>A and NFKB1 -94ins/del ATTG polymorphisms w...,42,250,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...n each case). When genotypic distribution of TNFA -308 G>A polymorphism was compared between cases a...,90,188,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,"...t of TNFA-308 G>A, NFKB1 -94ATTG ins/del, NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms on the survi...",125,130,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,TNFA -308 G>A polymorphism,228,6,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,"...f TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphism",264,84,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,...types. Bioinformatics analysis showed that NFKBIA -826 C>T polymorphism may affect binding of transc...,305,208,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Table S1 Details of genotyping methods of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",314,47,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Table S1 Details of genotyping methods of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",314,47,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,"...f TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms",314,91,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308G>A,"...Sachan R , Mittal B  (2009 ) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphism...",339,73,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-819C>T,... (2009 ) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervi...,339,93,PLoS_One_2013_Dec_4_8(12)_e81999.txt
20210 G->A,...atient was heterozygous for the prothrombin gene G20210 G->A mutation. The Jak2 mutation was detecte...,112,734,PLoS_One_2013_Dec_5_8(12)_e81574.txt
107C>A,"...rmation of a heterozygous mutation in CACNA1A (c.6107C>A, NM_001127221.1, p.Tyr1957Ter, NP_001120693...",59,349,PLoS_One_2013_Feb_18_8(2)_e56362.txt
41+2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end of exon 7...,61,14,PLoS_One_2013_Feb_22_8(2)_e57173.txt
16+1G>T,IVS16+1G>T	c.4986+1G>T	D	retention of 65 bp at the5′-...,63,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5+1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475d...,68,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,IVS13−2A>Te*	c.7008−2A>T	A	skipping of exon 14;skipping of 10 bp at 5′...,70,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
097G>A,4216G>A	c.4097G>A	A	none	r.[4097g>a]	bi-allelic	aa change at ...,96,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
484G>T,4603G>Te	c.4484G>T	D	skipping of exon 14	r.[4358_4484del]	mono...,97,13,PLoS_One_2013_Feb_22_8(2)_e57173.txt
484G>T,4603G>Te	c.4484G>T	D	skipping of exon 14	r.[4358_4484del]	mono...,97,13,PLoS_One_2013_Feb_22_8(2)_e57173.txt
16+5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-...,98,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
986+5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end of intr...,98,15,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755−1G>A and c.8954−1_8955delGTTinsAA in BRCA2) [18], ...",125,155,PLoS_One_2013_Feb_22_8(2)_e57173.txt
75+1G>A,"...87−1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A...",125,334,PLoS_One_2013_Feb_22_8(2)_e57173.txt
332+1G>A,"... particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss of the whole exons 8, 17 ...",125,405,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,...end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found to give rise to an abnormal transcr...,125,795,PLoS_One_2013_Feb_22_8(2)_e57173.txt
484G>T,"...s caused the skipping of an entire exon: BRCA1 c.4484G>T (exon 14) (Fig. 2A), BRCA2 c.631G>A (exon 7...",130,338,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,"...cryptic splice sites was observed for BRCA1 c.213−11T>G (59 bp at the 3′-end of intron 5) (Fig. 2D),...",130,558,PLoS_One_2013_Feb_22_8(2)_e57173.txt
114C>A,...e of the constitutional heterozygosity for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A s...,135,520,PLoS_One_2013_Feb_22_8(2)_e57173.txt
114C>A,...e of the constitutional heterozygosity for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A s...,135,520,PLoS_One_2013_Feb_22_8(2)_e57173.txt
986+1G>T,...ot be assessed for 2 intronic mutations (BRCA1 c.4986+1G>T and c.134+3_134+6delAAGT) due to the lack...,137,335,PLoS_One_2013_Feb_22_8(2)_e57173.txt
986+1G>T,...ot be assessed for 2 intronic mutations (BRCA1 c.4986+1G>T and c.134+3_134+6delAAGT) due to the lack...,137,335,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,c.213−11T>G	YES	−100%; S (C)	−100%; S (C)			−4.1%; S (C)...,161,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,c.594−4A>G	NO	0.0%; NS (C)	+1.5; NS (C)	−1.6%; NS (C)	+1...,163,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
986+5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S (C...,166,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
754+3G>C,c.8754+3G>C	YES	−6.3%; S (C)	−31.5; S (C)	−35.5%; S (...,170,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
754+3G>C,c.8754+3G>C	YES	−6.3%; S (C)	−31.5; S (C)	−35.5%; S (...,170,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
116C>T,c.9116C>T	NO		−43.6%; S (D)	−100%; S (D)		0.0%; NS (C...,171,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... above, we detected 2 such mutations (BRCA2 c.476−2A>G and c.8755−1G>A). However, quantitative analy...",181,1154,PLoS_One_2013_Feb_22_8(2)_e57173.txt
853A>G,...A2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant . Hum Mutat 30 : 1543 –5...,293,161,PLoS_One_2013_Feb_22_8(2)_e57173.txt
708-1G>C,M4166	II:1	F	20	17	c.1708-1G>C/Pro840Leu	Hepatic	Absent	Present	Present	...,41,23,PLoS_One_2013_Jul_2_8(7)_e66526.txt
708-1G>C,M4166	II:1	F	20	17	c.1708-1G>C/Pro840Leu	Hepatic	Absent	Present	Present	...,41,23,PLoS_One_2013_Jul_2_8(7)_e66526.txt
8+27G>A,"...eu), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A), in the ATP7B gene were observed by scree...",73,227,PLoS_One_2013_Jul_2_8(7)_e66526.txt
27T>C,"Exon 4	c.927T>C (rs139884)	H309H	II-6, II-4, III-6, III-7",82,11,PLoS_One_2013_Jun_26_8(6)_e66631.txt
27T>C,"Exon 4	c.927T>C (rs139884)	H309H	II-6, II-4, III-6, III-7",82,11,PLoS_One_2013_Jun_26_8(6)_e66631.txt
1554	N>R,...rontal Gyrus/Temporal Pole	35.8	−23.5	−16.1	13.35	1554	N>R,100,66,PLoS_One_2013_May_3_8(5)_e63220.txt
982	N>R,Right Lingual Gyrus	−18.4	77.6	−15.9	13.86	982	N>R,101,44,PLoS_One_2013_May_3_8(5)_e63220.txt
564	N>R,...ght Lateral Occipital Gyrus	−37.9	72.4	−9.8	11.97	564	N>R,104,53,PLoS_One_2013_May_3_8(5)_e63220.txt
507	N>R,Left Fusiform Gyrus	35	36.5	−21.6	13.92	507	N>R,106,41,PLoS_One_2013_May_3_8(5)_e63220.txt
347	N>R,...ight Inferior Temporal Gyrus	−48.1	68.8	0.8	11.92	347	N>R,109,52,PLoS_One_2013_May_3_8(5)_e63220.txt
255	N>R,Right Lingual Gyrus	−19.5	85.4	0.8	12.61	255	N>R,112,42,PLoS_One_2013_May_3_8(5)_e63220.txt
229	N>R,Left Posterior Cingulate	3.6	46.2	14.9	12.31	229	N>R,113,46,PLoS_One_2013_May_3_8(5)_e63220.txt
1778G>A,"...ries of three affected patients harbouring the m.11778G>A mutation, we provide evidence suggesting t...",7,879,PLoS_One_2013_May_7_8(5)_e63446.txt
1778G>A,...ntually revealed the presence of a homoplasmic m.11778G>A LHON mutation as the cause of this patient...,16,1466,PLoS_One_2013_May_7_8(5)_e63446.txt
4484T>C,"...DNA LHON mutations (m.3460G>A, m.11778G>A, and m.14484T>C)	1 in 8,460	[32]",61,87,PLoS_One_2013_May_7_8(5)_e63446.txt
08G>T,"....37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were...",99,409,PLoS_One_2013_Oct_29_8(10)_e76973.txt
84C>T,"... , Kay GW , et al (2006 ) A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofu...",159,103,PLoS_One_2013_Oct_4_8(10)_e75963.txt
675C>T,NFKBIA rs2233409 g.4675C>T	−310 bp	CC CT TT	22 19 1	31 14 4	0.294,92,21,PLoS_One_2013_Sep_16_8(9)_e73926.txt
3666064A>T,"...h the Silver coat color [12,13]. One of these, g.73666064A>T is located in intron 9 and not within a...",47,760,PLoS_One_2013_Sep_23_8(9)_e75639.txt
3665304C>T,"...reated as a result of the SNP. The second SNP, g.73665304C>T, is positioned 760 bp downstream of the...",47,1113,PLoS_One_2013_Sep_23_8(9)_e75639.txt
3665304C>T,"...reated as a result of the SNP. The second SNP, g.73665304C>T, is positioned 760 bp downstream of the...",47,1113,PLoS_One_2013_Sep_23_8(9)_e75639.txt
3665304C>T,"...reated as a result of the SNP. The second SNP, g.73665304C>T, is positioned 760 bp downstream of the...",47,1113,PLoS_One_2013_Sep_23_8(9)_e75639.txt
268T>C,I-3	66	F	4.75	1.21	1.13	3.87	p.IIe402Thr (c.1268T>C),108,46,PLoS_One_2014_Apr_10_9(4)_e94697.txt
129T>G,II-1	28	F	4.47	1.47	1.26	4.02	p.Cys356Gly (c.1129T>G),109,47,PLoS_One_2014_Apr_10_9(4)_e94697.txt
268T>C,II-3	44	M	5.01	1.38	2.01	4.11	p.IIe402Thr (c.1268T>C),111,47,PLoS_One_2014_Apr_10_9(4)_e94697.txt
129T>G,"..., but the C356G mutation (nucleotide change to c.1129T>G) has not been reported previously. In this ...",119,765,PLoS_One_2014_Apr_10_9(4)_e94697.txt
33T>C,"...agment of DARC, comprising polymorphic positions −33T>C and 125G>A, was amplified by PCR using the f...",36,1416,PLoS_One_2014_Apr_7_9(4)_e93782.txt
125G>A,"...DARC, comprising polymorphic positions −33T>C and 125G>A, was amplified by PCR using the forward pri...",36,1426,PLoS_One_2014_Apr_7_9(4)_e93782.txt
93C>T,...r IHC and the hotspot mutation testing at MLH1 c.793C>T followed by comprehensive mutation scanning ...,17,404,PLoS_One_2014_Apr_7_9(4)_e94170.txt
93C>T,...r IHC and the hotspot mutation testing at MLH1 c.793C>T followed by comprehensive mutation scanning ...,17,404,PLoS_One_2014_Apr_7_9(4)_e94170.txt
90+1G>A,"MLH1/Intron 9	c.790+1G>A	Splicing change, skipping of exons 9 and 1...",80,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
216C>T,MSH2/Exon 7	c.1216C>T	p. Arg406X	Malay	1	2	Pathogenic	Dis causing...,88,16,PLoS_One_2014_Apr_7_9(4)_e94170.txt
93C>T,"... cohort, it is premature to conclude that MLH1 c.793C>T is also a founder mutation in Singapore due ...",193,526,PLoS_One_2014_Apr_7_9(4)_e94170.txt
03G>A,"...tudy, we identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium ATP...",7,582,PLoS_One_2014_Aug_13_9(8)_e104790.txt
-418 G>C,...nical Research DesignNo Correlation between TIMP2 -418 G>C Polymorphism and Increased Risk of Cancer...,3,649,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...ed studies based on the association between TIMP2 -418 G>C polymorphism and cancer risk are inconsis...,8,254,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...ed studies based on the association between TIMP2 -418 G>C polymorphism and cancer risk are inconsis...,8,254,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,... cover all studies based on relationship of TIMP2 -418 G>C polymorphism and risk of cancer until Oct...,11,107,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...0088184.t001Table 1 Main characteristics of TIMP2 -418 G>C polymorphism included in this meta-analys...,45,72,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,... ORs on overall cancer risk associated with TIMP2 -418 G>C gene polymorphism,93,109,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,... in the meta-analysis. The results indicated that -418 G>C polymorphism is not significantly associa...,102,299,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...meta-analysis evaluated the relationship of TIMP2 -418 G>C polymorphism with the risk of cancer and ...,109,299,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,Figure S3 Sensitivity analysis of TIMP2 -418 G>C polymorphism,124,42,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-735C>T,... association of matrix metalloproteinase [MMP]-2 (-735C>T) and tissue inhibitor of metalloproteinase...,158,112,PLoS_One_2014_Aug_19_9(8)_e88184.txt
72C>T,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
72C>T,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
72C>T,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
334A>G,c.1334A>G	p.Y445C	35	—	—	—	—	—,56,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
543C>T,FOXH1	5'UTR	c.-543C>T	n/a	60	M	0.4	—		—,64,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
38G>C,exon 3	c.338G>C	p.S113T	500	—	0.8	0.66	0.2	rs144830740,69,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
09+25G>A,intron 3-4	c.909+25G>A	n/a	507	—	0.9	0.72	0.003	rs147860174,71,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
037C>T,exon 5	c.1037C>T	p.A346V	59	—	0.4	0.31	0.13	rs115372595,74,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
333T>C,"... c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that were found in two patients each, and t...",98,266,PLoS_One_2014_Aug_5_9(8)_e95453.txt
09+25G>A,"...d in two patients each, and the intronic GATA4 c.909+25G>A that was found in 3 patients. We included...",98,337,PLoS_One_2014_Aug_5_9(8)_e95453.txt
271C>T,"...ernal in origin); the second carried BOP/SMYD1 c.*271C>T and TBX1 c.129_185del, p.P43_G61del PPPPRYD...",98,771,PLoS_One_2014_Aug_5_9(8)_e95453.txt
99G>A,...igene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA profile identical to...,119,65,PLoS_One_2014_Aug_5_9(8)_e95453.txt
46G>T,...OTCH3 mutation at the nucleotide position 446 (c.446G>T; p.G149V) in a Chinese family with CADASIL,15,104,PLoS_One_2014_Aug_6_9(8)_e104533.txt
46G>T,... primers (Table 1) in wild type allele but not c.446G>T mutant allele of NOTCH3 gene,64,235,PLoS_One_2014_Aug_6_9(8)_e104533.txt
46G>T,...th respect to the normal control (B). P.G149V (c.446G>T) was indicated with an arrow,76,732,PLoS_One_2014_Aug_6_9(8)_e104533.txt
46G>T,...pathogenic nucleotide change was detected. The c.446G>T change causes a loss of MscI restriction enz...,81,444,PLoS_One_2014_Aug_6_9(8)_e104533.txt
31T>C,.... The black box shows a heterozygous mutation (c.131T>C) in exon 2. E: Conservation analysis of p.V4...,73,571,PLoS_One_2014_Dec_17_9(12)_e115406.txt
31T>C,"...sequencing, we identified a novel heterozygous c.131T>C mutation in the GJA8 gene (RefSeq NM_005267....",76,62,PLoS_One_2014_Dec_17_9(12)_e115406.txt
31T>C,"In summary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chi...",116,51,PLoS_One_2014_Dec_17_9(12)_e115406.txt
31T>C,"In summary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chi...",116,51,PLoS_One_2014_Dec_17_9(12)_e115406.txt
15+5G>A,...tations and the mRNA product from the mutation c.615+5G>A. This study aims to investigate the effect...,8,294,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,"...sion number KJ128074), which was resulted from c.615+5G>A, was detected by RT-PCR and cDNA sequencin...",11,340,PLoS_One_2014_Feb_21_9(2)_e89267.txt
064G>A,"...ture of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mutati...",14,251,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,"...n along with the possible splice-site mutation c.615+5G>A. In this paper, by using an agc1Δ yeast mo...",23,181,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,...l blood lymphocytes (PBLs) due to the mutation c.615+5G>A was also explored. We herein reported the ...,23,387,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,...l blood lymphocytes (PBLs) due to the mutation c.615+5G>A was also explored. We herein reported the ...,23,387,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,...plification the transcript from the allelewith c.615+5G>A,44,81,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,...eterozygote of a maternally-inherited mutation c.615+5G>A and a novel missense mutation c.1064G>A (p...,103,140,PLoS_One_2014_Feb_21_9(2)_e89267.txt
064G>A,"...ation c.615+5G>A and a novel missense mutation c.1064G>A (p.Arg355Gln), which was inherited from his...",103,181,PLoS_One_2014_Feb_21_9(2)_e89267.txt
064G>A,... right demonstrated that the patient habored a c.1064G>A mutation which was inherited from his fathe...,106,585,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,...lanation for intron 6 retention in cDNA due to c.615+5G>A in SLC25A13 gene. The retention may lead t...,134,727,PLoS_One_2014_Feb_21_9(2)_e89267.txt
15+5G>A,...nitely diagnosed as a compound heterozygote of c.615+5G>A and a novel c.1064G>A mutation by means of...,139,89,PLoS_One_2014_Feb_21_9(2)_e89267.txt
064G>A,"...ompound heterozygote of c.615+5G>A and a novel c.1064G>A mutation by means of a clinical, genetic, t...",139,112,PLoS_One_2014_Feb_21_9(2)_e89267.txt
064G>A,"...ture of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mutati...",139,336,PLoS_One_2014_Feb_21_9(2)_e89267.txt
-77T>C,"... C , Zhang X , Guo H , et al (2011 ) A functional -77T>C polymorphism in XRCC1 is associated with ri...",283,81,PLoS_One_2014_Jan_2_9(1)_e84532.txt
70+70G>A,...rs17096918	C	C/T	0.083	0.069	0.52	0.081	0.93	G	c.170+70G>A		intron,93,64,PLoS_One_2014_Jul_14_9(7)_e102065.txt
45+129C>T,...	rs4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
-110 G>A,"...de distribution of a selected mutation (e.g. IVS I-110 G>A) as well as information (frequencies, org...",130,1074,PLoS_One_2014_Jul_24_9(7)_e103020.txt
1801173 C>T,p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associated with increased ris...,17,29,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,...ed SNPs	p21 rs2395655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53...,72,58,PLoS_One_2014_May_12_9(5)_e96958.txt
1801270 C>A,...655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP5...,72,76,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173C>T,... C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	p73 rs1801173C>T,72,150,PLoS_One_2014_May_12_9(5)_e96958.txt
1801270 C>A,p21 rs1801270 C>A,124,7,PLoS_One_2014_May_12_9(5)_e96958.txt
762623 C>A,"...t the p21 rs2395655 G>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>C polymorphisms wer...",169,411,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,"...>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>C polymorphisms were not associated with...",169,432,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,Stratification analyses on the p21 rs3176352 G>C and p73 rs1801173 C>T polymorphism and...,173,38,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,... decreased risk of ESCC associated with the p73 rs1801173 C>T polymorphism was evident among older p...,174,427,PLoS_One_2014_May_12_9(5)_e96958.txt
3212948 G>C,"Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk...",20,51,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,"...ther ERCC1 polymorphisms (rs3212961 (17677A>C), rs3212948 G>C, and rs2298881 C>A) with lung cancer r...",25,2773,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,rs3212948 G>C	0.171,61,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T >C,...ma	2012	mixed	European	Caucasian	HB	HumanHap300	rs11615 T >C	0.185	2679	4226,77,54,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T >C,...ma	2012	mixed	European	Caucasian	HB	HumanHap300	rs11615 T >C	0.185	2679	4226,77,54,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A,106,3,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,ERCC1 3212948 G>C polymorphis,143,7,PLoS_One_2014_May_19_9(5)_e97616.txt
7-21086A>T,"... region of HIF2A gene (rs11125070, NM_001430.4:c.27-21086A>T; minor allele frequency: 30.4% in phase...",260,402,PLoS_One_2014_Nov_18_9(11)_e113513.txt
1+8939A>G,...riable analyses. HIF2B rs12593988 (NM_014862.3:c.31+8939A>G) and HIF2A rs4953352 (NM_001430.4:c.27-8...,262,215,PLoS_One_2014_Nov_18_9(11)_e113513.txt
-124 G>A,... be accounted for by a gain-of-function mutation (-124 G>A) in the hTERT promoter region (Table S1 a...,45,813,PLoS_One_2014_Nov_6_9(11)_e112438.txt
7632T>A,"... four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and the frequencies were 11...",57,326,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3113G>A,"...and 2E1 (Table 2). Five SNPs in CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used...",94,153,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3113A>G,-3113A>G,111,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"...t b5 contents and Vmax and CLint of CYP2B6 516GG (516 G>T) and 785AA (785A>G) genotypes. However, th...",146,124,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3113G>A,"...ype [14]. In the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2...",161,1145,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...ancer region of the CYP1A2 gene. Both -163C>A and 2159G>A are intronic mutations, whereas 5347C>T is...",161,2207,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,"...nymous variant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to ...",161,2314,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516G>T,SNPs 516G>T and 785A>G in CYP2B6 are exonic mutations a...,163,6,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...vely correlated with the Km of CYP2B6 516 G>T and 785 A>G wild-type genes. However, no association w...",163,749,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...vely correlated with the Km of CYP2B6 516 G>T and 785 A>G wild-type genes. However, no association w...",163,749,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-333T>A,"...4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP2E1 acti...",167,225,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-333T>A,"...4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP2E1 acti...",167,225,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,...th the Vmax and CLint of CYP2E1 SNPs -1293G>C and 7632T>A wild-type homozygote and variant heterozyg...,167,383,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,...te. This tendency may be because the -1293G>C and 7632T>A mutations can link together to construct a...,167,484,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-163C>A,... coffee consumption is associated with the CYP1A2 -163C>A polymorphism . Eur J Clin Pharmacol . 2010...,208,133,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-163C>A,... coffee consumption is associated with the CYP1A2 -163C>A polymorphism . Eur J Clin Pharmacol . 2010...,208,133,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-11426A>G,"...nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSC...",7,1091,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11391G>A,"...ymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSCLS risk. Addit...",7,1105,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...dded two other adiponectin gene promoter SNPs (SNP-11426A>G and SNP-11391G>A) to evaluate the associ...,19,427,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...method. Four adiponectin promoter SNPs, namely SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), S...",29,148,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...>G (rs16861194), SNP-11391G>A (rs17200539) and SNP-11377C>G (rs266729), were genotyped using PCR amp...",29,230,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...>G (rs16861194), SNP-11391G>A (rs17200539) and SNP-11377C>G (rs266729), were genotyped using PCR amp...",29,230,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...tion of adiponectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSC...",51,62,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...rSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,94,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"The allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-1137...",52,44,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NS...",52,58,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...rison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCL...",54,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,SNP-12140G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,56,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,SNP-11426A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,59,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G...,62,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...nectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,92,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...eritance model with the lowest AIC and BIC for SNP-12140G>A and SNP-11426A>G was the log-additive mo...,66,481,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...eritance model with the lowest AIC and BIC for SNP-12140G>A and SNP-11426A>G was the log-additive mo...,66,481,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...th the lowest AIC and BIC for SNP-12140G>A and SNP-11426A>G was the log-additive model. The best fit...,66,498,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...eritance model with the lowest AIC and BIC for SNP-11377C>G was the dominant and log-additive model....,66,602,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...additive model. No significant differences for SNP-11426A>G and SNP-11377C>G were found between the ...,66,827,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...and haplotype analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",107,83,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ficant LD (D') values between theSNP-12140G>A, SNP-11426A>G and SNP-11377C>G loci were found in all ...",108,56,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ficant LD (D') values between theSNP-12140G>A, SNP-11426A>G and SNP-11377C>G loci were found in all ...",108,56,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...and Table 6 shows the estimated frequencies of SNP-12140G>A-SNP-11426A>G-SNP-11377C>G haplotypes wit...,108,398,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...mated frequencies of SNP-12140G>A-SNP-11426A>G-SNP-11377C>G haplotypes with frequencies of more than...,108,424,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...1.t006Table 6 Different haplotypes analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponect...",110,78,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,SNP-12140G>A	SNP-11426A>G	SNP-11377C>G	NSCLC[n(%)]	Control[n(%)]	P...,111,17,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-12140G>A	SNP-11426A>G	SNP-11377C>G	NSCLC[n(%)]	Control[n(%)]	P value	P valu...,111,30,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...rison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between path...",123,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages ...",123,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages ...",123,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,SNP-11426A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,128,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...6 Association analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with ade...",134,53,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (AC) and squamous ce...",134,85,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table 8)",135,114,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table 8)",135,114,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140 G>A,SNP-12140 G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	...,139,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ui et al. failed to observe an association for SNP-11377C>G (rs266729), which is located in the adip...",151,294,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"In 2009, Laumen et al. found that SNP-11426A>G, SNP-11391G>Aand SNP-11377C>G within the...",153,38,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...hree adiponectin gene promoter SNPs, including SNP-11377C>G, were not correlated with NSCLC in the c...",153,635,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"... with those of Cui et al. [30], indicated that SNP-11377C>G is not associated with NSCLC risk and su...",153,1524,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...e, e.g.,SNP-12140G>A maybe more important than SNP-11377C>G in the Chinese population. Based on thes...",153,1842,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...n linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed this could be pos...",153,2497,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...n Chinese population, but not SNP-11426A>G and SNP-11377C>G",153,2690,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...llele and genotype frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC (Tab...",155,118,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...ectin by subcutaneous adipose tissue [3].Thus, SNP-12140G>A may be merely a susceptibility factor fo...",155,878,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"... an association study for adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC...",160,78,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"... an association study for adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC...",160,78,PLoS_One_2015_May_27_10(5)_e0127751.txt
48G>C,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,9,PLoS_One_2015_May_6_10(5)_e0126679.txt
97V>A,"...n one RCUD patient. Thus, the mutation led to the 97V>A amino-acid change in the protein sequence. S...",157,139,PLoS_One_2015_May_8_10(5)_e0126555.txt
1633G>A,E545K	1633G>A	47	4.7,67,7,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>T,H1047L	3140A>T	27	2.7,69,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3139C>T,H1047Y	3139C>T	1	0.1,72,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3146G>A,G1049D	3146G>A	1	0.1,74,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
-511 C>T,"...), clear trends of association were seen for IL1B -511 C>T and IL1RN 86bp VNTR in several of the con...",9,1598,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...45 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C for select ancestral subgroups. The hints...",9,2880,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"... hand, Mixed Ancestry (MA) subgroup carrying IL1B -511 C>T, IL1RN 86bp VNTR or IL1RN +8006 T>C polym...",9,3308,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"... hand, Mixed Ancestry (MA) subgroup carrying IL1B -511 C>T, IL1RN 86bp VNTR or IL1RN +8006 T>C polym...",9,3308,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"...reported lack of association of 3 SNPs (i.e. IL1B -511 C>T, IL1B+3954 C>T and IL1RN 86bp VNTR) resid...",15,1903,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,"...lymorphisms of the IL-1 gene cluster, namely: IL1A-889 C>T (rs1800587), IL1A+4845 G>T (rs17561), IL1...",17,157,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,"...889 C>T (rs1800587), IL1A+4845 G>T (rs17561), IL1B-1903 C>T (rs1143627), IL1B-3954 C>T (rs1143634), ...",17,208,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,"...3 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1R...",17,262,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1RN+9589 A>T (rs454078), IL1RN+8006 T>C (rs419598), IL...",17,314,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,Interleukin-1 SNPs included- IL1A-889 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1...,86,34,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...C>T (rs1143633); IL1B -3954 C>T (rs1143634); IL1B -1903 C>T (rs1143627); IL1RN 86bp VNTR (PMID 14563...,86,167,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...1143627); IL1RN 86bp VNTR (PMID 14563376); IL1RN +8006 T>C (rs419598),86,230,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...range = 0.34–0.90). Apart from the MEA, in which +4845 G>T polymorphism (in the dominant genetic mod...",91,1187,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,+4845 G>T (rs17561),105,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,-1903 C>T (rs1143627),126,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,-1903 C>T (rs1143627),126,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,-1903 C>T (rs1143627),126,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,-1903 C>T (rs1143627),126,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,+8006 T>C (rs419598),162,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...>T; TT+CT vs. CC for B-511 C>T; TT+CT vs. CC for B-1903 C>T; TT+CT vs. CC for B-3954 C>T; TT+CT vs. ...,175,130,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...l: TT vs. CT+CC for A-889 C>T; TT vs. CT+GG for A+4845 G>T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC...,177,75,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...vs. X/2+X/X for RN 86bp VNTR; CC vs. CT+TT for RN+8006 T>C,177,254,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...lele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; Allele T vs. Allele C for B-1903 C>T; Al...,179,128,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,"...otal of 4 SNPs from the IL1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected ...",184,54,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,"...L1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected for the present meta-anal...",184,79,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,"... present study, two studies[38] were included for -1903 C>T (total sample: 1,041 with 524 cases and ...",189,64,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... plots depicting meta-analysis results for IL1RN +8006 T>C (rs419598) polymorphism,198,96,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...three funnel plots for IL1RN 86bp VNTR and IL1RN +8006 T>C polymorphisms. Each point in these plots ...,202,722,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,"...analysis deduced any significant associations for -889 C>T. Such result was expected, as none of the...",211,314,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,...ary angioplasty (PTCA) has also been reported for -889 C>T which probably testifies its lack of asso...,211,545,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,...ary angioplasty (PTCA) has also been reported for -889 C>T which probably testifies its lack of asso...,211,545,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,...5] No published data reporting the association of -889 C>T polymorphism with levels of systemic/card...,211,672,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"...f the association tests for all 4 IL1B SNPs (i.e. -511 C>T, -1903 C>T, -3954 C>T and -5887 C>T), in ...",218,66,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"...dy been established,[47] the protective nature of -511 C>T polymorphism seen against CAD, probably s...",218,1530,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...r (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN 86bp VNTR) which duly qualifies...",229,358,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511C>T,...Ps hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been ...,231,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...45 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C. The hints of associations deduced for su...",236,374,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...r’s estimates for recessive genetic model of IL1B -511 C>T polymorphism. Panel C: Begg’s funnel plot...,283,391,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...r’s estimates for allelic genetic model of IL1RN +8006 T>C polymorphism. Abbreviations- EA: European...,290,838,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
168A>G,"...ns in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a novel ...",7,1136,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...d S1 Fig. A novel homozygous missense mutation c.5254G>A (p.Gly1752Arg) in gene RAI1 (retinoic acid ...,44,186,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,... previously known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 (pe...,44,529,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,... previously known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 (pe...,44,529,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,...(Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,69,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,Cosegregation of homozygosity for mutation c.5254G>A in the RAI1 gene with congenital bilateral ...,79,47,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...l.pone.0153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene in...,81,65,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...l.pone.0153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene in...,81,65,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...ly1752Arg) in the RAI1 gene. (B) Validation of c.5254G>A by Sanger sequencing. WES was performed for...,82,183,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...ly1752Arg) in the RAI1 gene. (B) Validation of c.5254G>A by Sanger sequencing. WES was performed for...,82,183,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...ly1752Arg) in the RAI1 gene. (B) Validation of c.5254G>A by Sanger sequencing. WES was performed for...,82,183,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...ly1752Arg) in the RAI1 gene. (B) Validation of c.5254G>A by Sanger sequencing. WES was performed for...,82,183,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,"... F42, and F43 (Fig 1). Subjects homozygous for c.5254G>A (42-II-1 and 43-III-1) had congenital profo...",86,159,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,"...ng Altaians four individuals were heterozygous c.5254G>A carriers (4/120, 3.33%)",86,863,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...ditional deleterious variants in compound with c.5254G>A in affected heterozygotes for c.5254G>A and...,88,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,...esmut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote wh...,88,1208,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,... del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote which was suggested as the commo...,88,1238,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,"...ommon allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the haplotypes were reconstr...",88,1334,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,...his affected sister (53-II-2) and heterozygous c.2168A>G state in their normal hearing mother (53-I-...,101,270,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
254G>A,"...of the NGS annotations pipelines. All detected c.5254G>A homozygotes (in total, 10 patients from 6 u...",114,885,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,Variant c.1111C>G found in this study has been predicted ‘pro...,126,12,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,... We also found segregation of homozygosity for c.1111C>G with recessive HL in Altaian family F54: al...,126,245,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,...G with recessive HL in Altaian family F54: all c.1111C>G homozygous siblings from this family were a...,126,300,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,...the combined pedigree F24-F54 (Fig 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 a...,126,697,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,...mutations differs across populations. Mutation c.2168A>G (p.His723Arg) found in Altaian family F53 i...,128,413,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,"...f all alleles with mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified ...",130,65,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,"...f all alleles with mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified ...",130,65,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,"...ations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified in Altaian patients, t...",130,87,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,"...n district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian fam...",130,1064,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,"...n district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian fam...",130,1064,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,"...n district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian fam...",130,1064,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
111C>G,"...ig 3 Prevalence of mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) on the terr...",132,85,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,...54G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by green. (B) Distribution of stu...,133,198,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,...54G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by green. (B) Distribution of stu...,133,198,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
168A>G,...54G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by green. (B) Distribution of stu...,133,198,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
-938C>A,...e manufacturer’s protocols. Genotypes of the BCL2 -938C>A polymorphism were determined by Slowdown P...,26,178,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...the 231 patients with primary THA revealed a BCL2 -938C>A genotype distribution with 81 patients car...,33,225,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,Time to aseptic loosening and BCL2 -938C>A genotype,83,36,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,BCL2 -938C>A,102,6,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,"...loosening analysis, individual comparison of BCL2 -938C>A genotypes showed similar curve progression...",117,102,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...ients. Our goal was to determine whether the BCL2 -938C>A polymorphism influences the course and occ...,120,573,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...ype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients w...,160,78,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
2-938C>A,BCL2-938C>A and CALCA-1786T>C polymorphisms in asepti...,188,4,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
3528A>G,"...plasmic in the patient’s muscle and blood, the m.13528A>G mutation was heteroplasmic in the patient’...",190,465,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
25C>A,...described previously. A novel de novo variant (c.225C>A; p.Tyr75*) was identified in the PAX6 gene i...,14,150,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
49C>T,"...s with aniridia. In addition, a known variant (c.649C>T; p.Arg217*) in PAX6 segregated in a family w...",14,273,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
54T>C,"... the FOXC1 gene, a novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease in...",14,389,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
25C>A,The same variation (c.225C>A; p.Tyr75*) was identified in another unrelat...,46,24,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
49C>T,".... In addition, a previously reported mutation (c.649C>T; p.Arg217*) was identified in the PAX6 gene ...",69,330,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
57-2A>G,"...or family studies. The results identified LMNA c.357-2A>G, a novel heterozygous splice-site mutation...",7,1874,PLoS_One_2016_May_16_11(5)_e0155421.txt
93G>A,11. KCNMB1	chr5:169810796	c.193G>A	Glu65Lys	rs11739136	9.8	10	Risk allele for h...,92,30,PLoS_One_2016_May_16_11(5)_e0155421.txt
8053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
57-2A>G,"...HOM Normal (F): lane 2), proband with mutation c.357-2A>G (HET Mutation: lane 3), and non-family con...",134,188,PLoS_One_2016_May_16_11(5)_e0155421.txt
698C>T,...riant located in exon 10 (rs4641: NM_1701707.3:c.1698C>T). These findings are consistent with the LM...,136,435,PLoS_One_2016_May_16_11(5)_e0155421.txt
57-2A>G,...iduals (>60 years old). We found only the LMNA c.357-2A>G variant completely segregated with the phe...,146,399,PLoS_One_2016_May_16_11(5)_e0155421.txt
502T>C,...nother SNP in TLR1 (−7202G>A) and a SNP in TLR6 (−502T>C) were also significantly associated with Td...,114,351,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,...nother SNP in TLR1 (−7202G>A) and a SNP in TLR6 (−502T>C) were also significantly associated with Td...,114,351,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
2192T>C,All samples	Td	TLR1	rs5743595	−2192T>C	-	C	Add	1.27	0.001a,118,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,rs5743551	−7202G>A	-	A	Add	-0.95	0.002,120,15,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.56	<0.001a,126,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
645C>T,rs5744080	645C>T	His215His	C	Add	-1.37	0.008,131,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
3121T>C,TLR8	rs1548731	+3121T>C	-	T	Add	0.86	0.004,133,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
28A>G, 	 	 	rs5744077	28A>G	Met10Val	G	Add	-1.22	0.008,134,17,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,All samples	REC	TLR6	rs2381289	4224C>T	-	T	Dom	13.26	0.007,141,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,All samples	REC	TLR6	rs2381289	4224C>T	-	T	Dom	13.26	0.007,141,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1607T>C,Caucasian	PPD	TLR4	rs10759932	−1607T>C	-	C	Dom	18.12	0.005,145,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"Most previous studies did not include 597T>C [12,19,22,23]. One study, conducted in 2 No...",174,39,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,"...th TLR1/6 lipopeptide ligands [74]. In addition, −502T>C is in strong LD with 4224C>T (S3 Table), lo...",176,839,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
933G>T,...6	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,56,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
933G>T,...6	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,56,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,10	F	55	Proximal weakness LL	IVS1-13T>G	c.2173C>T	359	Yes	48	N	N,116,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
173C>T,...kness LL + respiratory insufficiency	c.2173C>T	c.2173C>T	508	Yes	45	N	Y,120,71,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,...oximal weakness LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	709	Yes	45	N	Y,121,61,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
657C>T,... and LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	458	Yes	46	N	Y,122,79,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
781G>A,17	M	22	HyperCKemia	IVS1-13T>G	c.1781G>A	1268	No	-	N	N,123,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,24,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
194+5G>A,...kness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,71,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
781G>A,...oximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,61,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
781G>A,...oximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,61,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
781G>A,...oximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,61,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
194+5G>A,...kness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,71,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
889-1G>A,25	M	8	HyperCKemia	IVS1-13T>G	c.1889-1G>A	1077	No	-	N	N,131,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,27	M	46	Proximal weakness LL	IVS1-13T>G	c.1532 C>A	882	Yes	43	N	Y,133,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
933G>T,29	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	432	No	-	N	Y,135,44,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,33	F	20	HyperCKemia	IVS1-13T>G	c.1551+1G>A	928	No	-	N	N,139,24,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
409	C>M,"...ecall	21.47±4.06	17.15±4.39	10.91±3.71	111.87*	2, 409	C>M>A",153,67,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...ecall	21.47±4.06	17.15±4.39	10.91±3.71	111.87*	2, 409	C>M>A",153,67,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
403	C>M,"...T-copy	32.41±3.87	28.87±5.32	22.50±7.63	66.91*	2, 403	C>M>A",156,54,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
358	C>M,"... ㅇ, ㅅ	26.35±11.01	20.41±9.78	13.83±8.95	27.51*	2, 358	C>M>A",159,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",193,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",226,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...g speed	12.24±4.31	10.47±4.03	6.35±3.40	38.78*	2, 409	C>M>A",231,60,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
2T>C,"...ation of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and su...",160,140,PLoS_One_2016_Sep_29_11(9)_e0163626.txt
055T>G,...nd homo-/heterozygous variants for [rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V36...,56,929,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
102G>A,...s2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of CPT II and mitochondrial ener...,56,966,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1075A > C,...he Yakuts and the Russians. The study of CYP2C9 + 1075A > C polymorphisms in the groups established ...,32,771,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
21T>C,...LE  Uitterlinden AG  Klungel OH    The SLCO1B1 c.521T>C polymorphism is associated with dose decreas...,68,97,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
-403 G-->A,... RC Makki R Tavernier G Smilie FI Custovic A  The -403 G-->A promoter polymorphism in the RANTES gen...,340,105,Respir_Res_2003_Dec_4_4(1)_14.txt
2643 C>G,...wed the presence of the homozygous c2772 A>G and c2643 C>G polymorphisms. ABCA3 sequencing showed a ...,42,184,Respir_Res_2011_Aug_25_12(1)_115.txt
200A > C,...2; c.374G > A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu376Asp). The allelic frequency of t...,28,486,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"Intron 1C, c.-5 + 1G > A. Splicing site variant, causing no expressi...",78,20,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...plice donor site of intron 1C (NM_000295.4:c.-5 + 1G > A), previously described as QOPorto splicing ...",138,285,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...nerated six new ones, Tr10, Tr11 and Tr12 (c.-5 + 1G > A), and Tr3, Tr4 and Tr9 (c.-5 + 2dupT). The ...",183,205,Respir_Res_2014_Oct_7_15(1)_125.txt
7G>C,"...s in the β-globin gene, such as Hb D-Iran (HBB:c.67G>C) and Hb D-Ibadan (HBB:c.263C>A). However, ind...",13,112,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
7G>C,"...s in the β-globin gene, such as Hb D-Iran (HBB:c.67G>C) and Hb D-Ibadan (HBB:c.263C>A). However, ind...",13,112,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
0A>T,"...s termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the po...",17,245,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
0A>T,"...s termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the po...",17,245,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
-181A>G,"...polymorphisms exist in the MMP-7 promoter region, -181A>G and –153C>T, which are known to modify the...",21,117,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...Previous studies have shown association of MMP-7 (-181A>G) (rs11568818) polymorphisms with esophagea...,21,253,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,The MMP-7 polymorphism (–181A>G) was genotyped in subjects by polymerase ch...,31,26,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,The genotype frequencies of the MMP-7 (-181A>G) polymorphism among cases and controls are...,43,40,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,"When tumor histopathologies were analyzed, MMP-7 (-181A>G) GG genotype was found to be significantly...",48,51,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,"When tumor histopathologies were analyzed, MMP-7 (-181A>G) GG genotype was found to be significantly...",48,51,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,Interaction of MMP-7 (-181A>G) genotypes with environmental factor,52,23,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...y significant modulation of cancer risk by MMP-7 (-181A>G) genotypes with salted tea and smoking [Ta...,53,217,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 4 Interaction of MMP-7 (–181A>G) genotypes with salted te,55,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...associations was found. The association of MMP-7 (-181A>G) polymorphism with cancer has been observe...,62,717,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...associations was found. The association of MMP-7 (-181A>G) polymorphism with cancer has been observe...,62,717,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...ographical differences in the influence of MMP-7 (-181A>G) on the susceptibility of various cancers,62,887,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
81+1G>T,"...9). We next genotyped the LoF site in SLCO1B1 (c.481+1G>T) among the entire ARIC participants (10,26...",57,729,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
81+1G>T,"...ion, three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both hom...",77,78,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
33+2T>A,"... (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous ...",86,71,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
33+2T>A,"... (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous ...",86,71,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
33+2T>A,"... (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous ...",86,71,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
799T > A,...oth the normal and mutant alleles for the BRAF c.1799T > A mutation were calculated for three repres...,54,180,Sci_Rep_2013_Dec_13_3_3494.txt
799T > A,"HT144	BRAF c.1799T > A, V600E	Yes	100%	Yes	99%",168,15,Sci_Rep_2013_Dec_13_3_3494.txt
799T > A,"SK-MEL28	BRAF c.1799T > A, V600E	Yes	100%	Yes	94%",169,18,Sci_Rep_2013_Dec_13_3_3494.txt
257C > T," 	EGFR c.2257C > T, p.P753S	Yes	98%	Yes	99%",170,11,Sci_Rep_2013_Dec_13_3_3494.txt
82A > G,"ERBB4	c.882A > G, P294P (MeWo)",181,10,Sci_Rep_2013_Dec_13_3_3494.txt
609C > T," 	c.2609C > T, M766I (MeWo)",183,6,Sci_Rep_2013_Dec_13_3_3494.txt
8919 G > A,"ATM	c. 8919 G > A, W2845X (HT144)",184,8,Sci_Rep_2013_Dec_13_3_3494.txt
169 G > A," 	c.4169 G > A, p.L1270F (MeWo)",189,6,Sci_Rep_2013_Dec_13_3_3494.txt
760G>A,CNGB1	c.2760G>A	p.W920*	8*10−6	arRP	Ashkenazi Jew	CHRD	—	Ho...,92,10,Sci_Rep_2015_Aug_26_5_13187.txt
289C>T,"C2ORF71	c.3289C>T	p.Q1097*	4*10−5	arRP	Jew (Iran, Turkey)	MOL...",96,12,Sci_Rep_2015_Aug_26_5_13187.txt
960C>T,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Homozy...,101,10,Sci_Rep_2015_Aug_26_5_13187.txt
95C>A,RDH12	c.295C>A	p.L99I	7*10−5	arRP	Moroccan Jew Moroccan Jew...,105,10,Sci_Rep_2015_Aug_26_5_13187.txt
88T>A,SPATA7	c.288T>A	p.C96*	3*10−5	arLCA	Arab Muslim	MOL0758	—	Ho...,109,11,Sci_Rep_2015_Aug_26_5_13187.txt
200G>A,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated	0	...,132,9,Sci_Rep_2015_Aug_26_5_13187.txt
494C>A,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	0	0...,134,10,Sci_Rep_2015_Aug_26_5_13187.txt
6+1G>A,...essential splice site variant CFH 1:196648924 (IVS6+1G>A) or missense variant rs139360826 (R175P). I...,3,2887,Sci_Rep_2016_Aug_30_6_31531.txt
1-1639G>A,. Association of VKORC1-1639G>A polymorphism with susceptibility to ossi...,216,23,Sci_Rep_2016_Feb_12_6_21580.txt
868G>A,...terozygous mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (NM_0...,36,1216,Sci_Rep_2016_Jan_20_6_19432.txt
868G>A,...pound heterozygous changes c.8422G>A (MU1) and c.7868G>A (MU2). Genotypes are presented as follows: ...,76,81,Sci_Rep_2016_Jan_20_6_19432.txt
4606C>G,RP:S-10	c.[4606C>G];[5038A>G]	55/M	40	NA	NA	NA	NA,93,12,Sci_Rep_2016_Jan_20_6_19432.txt
7187G>A,RP:S-34	c.[7187G>A]	44/F	14	NA	NA	NA	NA,97,12,Sci_Rep_2016_Jan_20_6_19432.txt
3024C>A,RP:S-48	c.[3024C>A]	20/F	15	R-a/b	R-a/b	PD/ODW	PD/ODW,99,12,Sci_Rep_2016_Jan_20_6_19432.txt
418G>T,RP:S-18	9	c.1418G>T	het	p.G473V	missense	novel	Unknown region	N...,111,14,Sci_Rep_2016_Jan_20_6_19432.txt
418G>T,RP:S-18	9	c.1418G>T	het	p.G473V	missense	novel	Unknown region	N...,111,14,Sci_Rep_2016_Jan_20_6_19432.txt
388C>A,RP:S-22	43	c.8388C>A	hom	p.Y2796X	stopgain	novel	LamG	NA/NA,113,15,Sci_Rep_2016_Jan_20_6_19432.txt
187G>C,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging (0...,114,15,Sci_Rep_2016_Jan_20_6_19432.txt
259+1 G>A,RP:S-40	15	c.2259+1 G>A	hom	–	splicing	novel	–	NA/NA,115,15,Sci_Rep_2016_Jan_20_6_19432.txt
259+1 G>A,RP:S-40	15	c.2259+1 G>A	hom	–	splicing	novel	–	NA/NA,115,15,Sci_Rep_2016_Jan_20_6_19432.txt
187C>A,...dentified as #2; the two patients carrying the c.2187C>A homozygous mutations will be identified as ...,15,444,Sci_Rep_2016_Mar_18_6_23213.txt
584G>A,c.3584G>A	25	p.Arg1195AGln	Missense	Paternal,110,4,Sci_Rep_2016_Mar_18_6_23213.txt
652G>T,c.6652G>T	41	p.Glu2218*	Nonsense	Paternal,113,4,Sci_Rep_2016_Mar_18_6_23213.txt
417C > T,...lattice corneal dystrophy type I in patients with 417C > T (R124C) and 1762A > G (H572R) mutations i...,267,75,Sci_Rep_2016_Mar_31_6_23836.txt
3+1 G>A,The analysis of the DEL type RHD*DEL8 (RHD IVS3+1 G>A) shows a surprising result: Körmöczi et al...,54,47,Sci_Rep_2016_Sep_1_6_32317.txt
02C>G,"...Very low expression	multiple missense mutationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (...",166,81,Sci_Rep_2016_Sep_1_6_32317.txt
1911A > G,"...ion, and transient receptor potential vanilloid 1 1911A > G (rs8065080, I585V) was associated with c...",58,2906,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
3435C > T,"...ted phenotypes. In addition to the aforementioned 3435C > T ABCB1 alleles, 1236C > T and 2677G > T/A...",68,874,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
-857C>T,"...4061/2011/920584Research ArticleAssociation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymor...",3,143,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...esearch ArticleAssociation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ische...",3,160,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...A36A>G, and 85 subjects in each group for TNFRSF1B676T>G polymorphism, if  the study power required ...",46,739,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...stigated the association of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms with ische...",58,80,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...ation of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms with ischemic stroke, under t...",58,99,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,...s polymorphism. Most groups have worked on the TNF-308G>A  polymorphism with Pereira et al. suggesti...,60,303,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,"... recent study conducted by our group [10], the TNF-308G>A polymorphism is not in Hardy-Weinberg equi...",62,114,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,"... recent study conducted by our group [10], the TNF-308G>A polymorphism is not in Hardy-Weinberg equi...",62,114,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,... to exclude this polymorphism and focus on the TNF-857C>T polymorphism. Our study exerted that this ...,62,299,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...B on ischemic stroke predisposition, with TNFRSF1B676T>G polymorphism showing the closest associatio...",73,260,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...B on ischemic stroke predisposition, with TNFRSF1B676T>G polymorphism showing the closest associatio...",73,260,Stroke_Res_Treat_2011_May_29_2011_920584.txt
420 C>T,"The 420 C>T substitution of CYP2C9*2, the 1075 A>C sub...",15,5,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"...*2, the 1075 A>C substitution of CYP2C9*3 and the 1173 C>T substitution of VKORC1 had minor allele f...",15,85,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"....5%, respectively), whereas homozygotes of VKORC1 1173 C>T (T/T) was 13.2%. The frequencies of the t...",50,312,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,...und heterozygotes of CYP2C9*2/*3 was 0.9%. VKORC1 1173 C>T heterozygotes was 46.7%. Minor allele fre...,50,514,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,...und heterozygotes of CYP2C9*2/*3 was 0.9%. VKORC1 1173 C>T heterozygotes was 46.7%. Minor allele fre...,50,514,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"Table 1 Genotype distributions of VKORC1 1173 C>T, CYP2C9*2 and CYP2C9*3 polymorphisms in t...",52,42,Thromb_J_2008_Jun_17_6_7.txt
81C>A,"...found in one FTC. Two NRAS codon 61 mutations (c.181C>A, p.Q61K) were also found, one in FTC and one...",77,462,Thyroid_2016_Feb_1_26(2)_227-234.txt
81C>A,"...found in one FTC. Two NRAS codon 61 mutations (c.181C>A, p.Q61K) were also found, one in FTC and one...",77,462,Thyroid_2016_Feb_1_26(2)_227-234.txt
2083G>A,"...any). CYP3A5-genotyping (rs776746; NG_007938.1:g.12083G>A, A=CYP3A5*1 and G=CYP3A5*3) was performed ...",39,210,Transpl_Int_2013_Dec_15_26(12)_1198-1207.txt
678C>A,"...oint profile. Although rare, the finding of MTHFR 678C>A polymorphism indicates that this might be t...",20,163,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
4 C >T,...ozygous polymorphism at the 3’ downstream region +4 C >T in the Turkish population Lab Hematol 2006 ...,35,148,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
1279G>A,"... confirmed due to mutation in the TCIRG1 gene [g.11279G>A(IVS18+1) paternal allele, g.8280_9560del (...",15,106,Turk_J_Haematol_2014_Sep_5_31(3)_335-336.txt
189	E>K,189	E>K	S>L,81,1,Virol_J_2009_Nov_16_6_198.txt
226	R>K,226	R>K	L>F,91,1,Virol_J_2009_Nov_16_6_198.txt
327	N>D,327	N>D	S>F,99,1,Virol_J_2009_Nov_16_6_198.txt
383	I>M,383	I>M	no change,109,1,Virol_J_2009_Nov_16_6_198.txt
383	I>M,383	I>M	no change,109,1,Virol_J_2009_Nov_16_6_198.txt
456	L>I,456	L>I	R>M,127,1,Virol_J_2009_Nov_16_6_198.txt
522	L>F,522	L>F	R>K,133,1,Virol_J_2009_Nov_16_6_198.txt
723	N>D,723	N>D	F>S	no change,149,1,Virol_J_2009_Nov_16_6_198.txt
413C>T,"...ants at 4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and th...",7,97,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,...h non-atopic eczema (P = 0.004) and those of HNMT 939A>G polymorphism were significantly associated ...,10,225,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,...h non-atopic eczema (P = 0.004) and those of HNMT 939A>G polymorphism were significantly associated ...,10,225,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
654T>C,"... atopy groups (P = 0.048). However, those of HNMT 654T>C and 413C>T polymorphisms were not. In addit...",10,339,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
6-2A>G,"...]. Her specific germline TP53 mutation, namely IVS6-2A>G, might be predicted to yield a mild phenoty...",32,736,Yale_J_Biol_Med_2015_Jun_1_88(2)_181-185.txt
46 A>G,"... the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a sing...",8,487,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...ic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base extensio...",8,503,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,".... The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated...",11,186,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...reover, in subjects with the AG or GG genotype at 46 A>G and haplotype [GAA] of ADRB2, the prevalenc...",11,326,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47 T>C,...d extension 5'-CXCGCAGAGCXCCGCCGTGGGTCCGCC-3' for -47 T>C; forward 5'-CAGGAAACAGCTATGACCGCACATAACGGG...,34,594,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
79C>G,"...ing processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for ...",36,323,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...sons. The results of power analysis were 0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (...",52,393,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (effect size 0.15)",52,434,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...en the haplotype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate of work-...",54,114,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47 T>C,"...egard to other ADRB2 SNPs, polymorphisms at ADRB2 -47 T>C located in the β upstream peptide were rep...",66,57,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252G>A,"*The haplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic receptor polymorp...",99,45,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523C>A,"...aplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic receptor polymorphisms",99,57,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
69C>T,"... British and Norwegian patients (23), p.R257* (c.769C>T) is present in more than 85 % of the Finnish...",69,248,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],98,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],98,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],102,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],116,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],126,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
